TRINITY CAPITAL INC.

Consolidated Statements of Operations

(In thousands, except share and per share data)

(Unaudited)


	Three Months Ended			Three Months Ended
	March 31, 2025			March 31, 2024
INVESTMENT INCOME:
Interest and dividend income:
Control investments	$	2,328		$	852
Affiliate investments		1,272			385
Non-Control / Non-Affiliate investments		59,073			48,155
Total interest and dividend income		62,673			49,392
Fee and other income:
Affiliate investments		693			866
Non-Control / Non-Affiliate investments		2,019			195
Total fee and other income		2,712			1,061
Total investment income		65,385			50,453

EXPENSES:
Interest expense and other debt financing costs		17,656			12,144
Compensation and benefits		10,645			9,864
Professional fees		2,027			720
General and administrative		2,466			1,929
Total gross expenses		32,794			24,657
Allocated expenses to Trinity Capital Adviser, LLC		(408	)		—
Total net expenses		32,386			24,657

NET INVESTMENT INCOME/(LOSS) BEFORE TAXES		32,999			25,796
Excise tax expense		616			639
NET INVESTMENT INCOME		32,383			25,157

NET REALIZED GAIN/(LOSS) FROM INVESTMENTS:
Non-Control / Non-Affiliate investments		(2,154	)		1,351
Net realized gain/(loss) from investments		(2,154	)		1,351

NET CHANGE IN UNREALIZED APPRECIATION/(DEPRECIATION) FROM INVESTMENTS:
Control investments		2			1,963
Affiliate investments		430			254
Non-Control / Non-Affiliate investments		(3,574	)		(14,217	)
Net change in unrealized appreciation/(depreciation) from investments		(3,142	)		(12,000	)

NET INCREASE/(DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS	$	27,087		$	14,508

NET INVESTMENT INCOME PER SHARE - BASIC	$	0.52		$	0.54
NET INVESTMENT INCOME PER SHARE - DILUTED	$	0.52		$	0.52

NET CHANGE IN NET ASSETS RESULTING FROM OPERATIONS PER SHARE - BASIC	$	0.43		$	0.31
NET CHANGE IN NET ASSETS RESULTING FROM OPERATIONS PER SHARE - DILUTED	$	0.43		$	0.30

WEIGHTED AVERAGE SHARES OUTSTANDING - BASIC		62,555,531			46,748,386
WEIGHTED AVERAGE SHARES OUTSTANDING - DILUTED		62,555,531			50,595,651

See accompanying notes to unaudited consolidated financial statements.

TRINITY CAPITAL INC.

Consolidated Statements of Changes in Net Assets

(In thousands, except share and per share data)

(Unaudited)

Three Months Ended March 31, 2025:


									Distributable
						Paid In Capital			Earnings /
	Common Stock					in Excess of			(Accumulated			Total
	Shares			Par Value		Par Value			Deficit)			Net Assets
Balance as of December 31, 2024		61,669,059		$	62	$	829,626		$	(6,706	)	$	822,982
Issuance of common stock pursuant to distribution reinvestment plan		20,349			—		297			—			297
Stock-based compensation		—			—		2,609			—			2,609
Issuance of restricted stock awards		319,956			—		—			—			—
Issuance of common stock, net of issuance costs		1,977,463			2		30,466			—			30,468
Retired and forfeited shares of restricted stock		(106,497	)		—		(1,695	)		—			(1,695	)
Additional paid-in capital in connection with Convertible Notes Redemption		—			—		(15,772	)		—			(15,772	)
Distributions to stockholders		—			—		—			(32,581	)		(32,581	)
Net increase/(decrease) in net assets resulting from operations		—			—		—			27,087			27,087
Balance as of March 31, 2025		63,880,330		$	64	$	845,531		$	(12,200	)	$	833,395

Three Months Ended March 31, 2024:


									Distributable
						Paid In Capital			Earnings /
	Common Stock					in Excess of			(Accumulated			Total
	Shares			Par Value		Par Value			Deficit)			Net Assets
Balance as of December 31, 2023		46,323,712		$	46	$	633,740		$	(22,627	)	$	611,159
Issuance of common stock pursuant to distribution reinvestment plan		23,456			—		340			—			340
Stock-based compensation		—			—		2,459			—			2,459
Issuance of restricted stock awards		753,051			1		(1	)		—			—
Issuance of common stock, net of issuance costs		1,652,632			2		24,238			—			24,240
Retired and forfeited shares of restricted stock		(109,657	)		—		(1,582	)		—			(1,582	)
Distributions to stockholders		—			—		—			(24,808	)		(24,808	)
Net increase/(decrease) in net assets resulting from operations		—			—		—			14,508			14,508
Balance as of March 31, 2024		48,643,194		$	49	$	659,194		$	(32,927	)	$	626,316

See accompanying notes to unaudited consolidated financial statements.

TRINITY CAPITAL INC.

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)


	Three Months Ended			Three Months Ended
	March 31, 2025			March 31, 2024
Cash flows provided by/(used in) operating activities:
Net increase/(decrease) in net assets resulting from operations	$	27,087		$	14,508
Adjustments to reconcile net increase/(decrease) in net assets resulting from operation to net cash provided by/(used in) operating activities:
Purchase of investments, net of deferred fees		(218,458	)		(240,700	)
Proceeds from sales and paydowns of investments		157,087			148,541
Net change in unrealized (appreciation)/depreciation from investments		3,142			12,000
Net realized (gain)/loss from investments		2,154			(1,351	)
Accretion of original issue discounts and end of term payments on investments		(11,044	)		(7,172	)
Amortization of deferred financing costs		1,276			1,075
Stock-based compensation		2,609			2,459
Change in operating assets and liabilities
(Increase)/Decrease in interest receivable		(84	)		(2,106	)
(Increase)/Decrease in other assets		(17,323	)		(872	)
Increase/(Decrease) in security deposits		(1,457	)		(1,173	)
Increase/(Decrease) in accounts payable, accrued expenses and other liabilities		(8,330	)		(6,610	)
Net cash provided by/(used in) operating activities		(63,341	)		(81,401	)

Cash flows provided by/(used in) investing activities:
Disposal/(Acquisition) of fixed assets		(106	)		(33	)
Net cash provided by/(used in) investing activities		(106	)		(33	)

Cash flows provided by/(used in) financing activities
Issuance of common stock, net of issuance costs		30,468			24,240
Retirement of employee shares		(1,695	)		(1,582	)
Cash distributions paid		(31,154	)		(22,821	)
Issuance of debt, net of issuance costs		3,343			111,803
Repayment of Unsecured Notes		(217,756	)		—
Borrowings under Credit Facility		398,000			148,000
Repayments under Credit Facility		(119,000	)		(171,000	)
Net cash provided by/(used in) financing activities		62,206			88,640

Net increase/(decrease) in cash, cash equivalents and restricted cash		(1,241	)		7,206
Cash, cash equivalents and restricted cash at beginning of period		9,627			4,761
Cash, cash equivalents and restricted cash at end of period	$	8,386		$	11,967


	Three Months Ended		Three Months Ended
	March 31, 2025		March 31, 2024
Supplemental and non-cash investing and financing activities:
Cash paid for interest	$	13,966	$	10,338
Income tax, including excise tax, paid		2,722		2,524
Distribution payable		32,579		24,808
Distributions reinvested		297		340

See accompanying notes to unaudited consolidated financial statements.


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States

Artificial Intelligence & Automation
Applied Digital Corporation	Equipment Financing	March 13, 2024	October 1, 2025	Fixed interest rate 19.0%; EOT 0.0%	$	3,001	$	3,001	$	3,063	(9)(10)(14)
	Equipment Financing	March 25, 2024	March 1, 2026	Fixed interest rate 19.0%; EOT 0.0%		5,708		5,707		5,848	(9)(10)(14)(19)
	Equipment Financing	April 24, 2024	April 1, 2026	Fixed interest rate 19.0%; EOT 0.0%		3,084		3,084		3,163	(9)(10)(14)(19)
	Equipment Financing	May 28, 2024	May 1, 2026	Fixed interest rate 16.0%; EOT 0.0%		1,391		1,391		1,424	(9)(10)(14)
	Equipment Financing	June 21, 2024	April 1, 2026	Fixed interest rate 19.0%; EOT 0.0%		4,996		4,996		5,123	(9)(10)(14)(19)
Total Applied Digital Corporation						18,180		18,179		18,621

Augmented Reality Concepts, Inc.	Secured Loan	June 17, 2024	June 18, 2029	Variable interest rate SOFR 3 Month Term + 7.3%; EOT 0.0%	$	19,270	$	18,916	$	19,319	(8)(14)(19)

Cirrascale Cloud Services, LLC	Equipment Financing	June 27, 2024	September 1, 2026	Fixed interest rate 12.7%; EOT 4.0%	$	16,201	$	16,746	$	16,894	(9)(14)(19)
	Equipment Financing	October 22, 2024	April 1, 2027	Fixed interest rate 10.2%; EOT 5.0%		14,947		15,304		15,366	(9)(14)(19)
Total Cirrascale Cloud Services, LLC						31,148		32,050		32,260

Sortera Technologies, Inc.	Equipment Financing	February 11, 2025	March 1, 2028	Fixed interest rate 12.5%; EOT 4.0%	$	7,316	$	6,914	$	6,914	(14)(19)

Sub-total: Artificial Intelligence & Automation (9.3%)*					$	75,914	$	76,059	$	77,114

Biotechnology
Pendulum Therapeutics, Inc.	Secured Loan	December 31, 2021	July 1, 2026	Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0%	$	4,292	$	4,473	$	4,472	(8)(14)
	Secured Loan	February 28, 2022	July 1, 2026	Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0%		4,581		4,762		4,765	(8)(14)
	Secured Loan	March 30, 2022	July 1, 2026	Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0%		4,722		4,904		4,909	(8)(14)
	Secured Loan	May 6, 2022	July 1, 2026	Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0%		5,000		5,181		5,191	(8)(14)
	Secured Loan	June 17, 2022	July 1, 2026	Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0%		5,000		5,181		5,191	(8)(14)
	Secured Loan	February 1, 2024	July 1, 2026	Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0%		1,405		1,191		1,153	(8)(14)
Total Pendulum Therapeutics, Inc.						25,000		25,692		25,681

Taysha Gene Therapies, Inc.	Secured Loan	November 13, 2023	December 1, 2028	Variable interest rate Prime + 4.5% or Floor rate 12.8%; EOT 5.0%	$	30,000	$	30,290	$	30,998	(8)(9)(14)

Sub-total: Biotechnology (6.8%)*					$	55,000	$	55,982	$	56,679


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Connectivity
Tarana Wireless, Inc.	Secured Loan	September 23, 2024	October 1, 2029	Variable interest rate Prime + 4.5% or Floor rate 12.5%; EOT 4.0%	$	14,800	$	14,150	$	14,351	(8)(9)(14)(19)

Vertical Communications, Inc.	Secured Loan	August 23, 2021	November 1, 2026	Variable interest rate Prime + 4.0% or Floor rate 11.0%; EOT 23.8%	$	12,600	$	15,769	$	15,769	(8)(22)
	Secured Loan	February 11, 2025	April 15, 2025	Fixed interest rate 11.5%; EOT 0.0%		1,300		1,298		1,298	(22)
Total Vertical Communications, Inc.						13,900		17,067		17,067

Sub-total: Connectivity (3.8%)*					$	28,700	$	31,217	$	31,418

Consumer Products & Services
Eterneva, Inc.	Equipment Financing	November 24, 2021	June 1, 2026	Fixed interest rate 7.8%; EOT 11.5%	$	189	$	225	$	198
	Equipment Financing	March 16, 2022	October 1, 2026	Fixed interest rate 8.1%; EOT 11.5%		326		360		320	(14)
	Equipment Financing	June 17, 2022	January 1, 2027	Fixed interest rate 11.9%; EOT 11.5%		1,011		1,062		958	(14)
Total Eterneva, Inc.						1,526		1,647		1,476

Molekule Group, Inc.	Equipment Financing	June 19, 2020	June 30, 2025	Fixed interest rate 8.8%; EOT 10.0%	$	312	$	595	$	380	(18)
	Equipment Financing	September 29, 2020	June 30, 2025	Fixed interest rate 12.3%; EOT 10.0%		273		347		333	(18)
	Equipment Financing	December 18, 2020	June 30, 2025	Fixed interest rate 11.9%; EOT 10.0%		473		584		577	(18)
	Equipment Financing	August 25, 2021	June 30, 2025	Fixed interest rate 11.3%; EOT 10.0%		385		454		470	(18)
Total Molekule Group, Inc.						1,443		1,980		1,760

Ogee, Inc.	Secured Loan	February 14, 2023	March 1, 2027	Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8%	$	4,700	$	4,768	$	4,759	(8)(14)(19)
	Secured Loan	September 29, 2023	March 1, 2027	Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8%		4,700		4,742		4,772	(8)(14)(19)
	Secured Loan	August 1, 2024	March 1, 2027	Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8%		4,700		4,648		4,657	(8)(14)(19)
Total Ogee, Inc.						14,100		14,158		14,188

Portofino Labs, Inc.	Secured Loan	April 1, 2021	November 1, 2025	Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 6.0%	$	789	$	891	$	905	(8)(14)

Quip NYC, Inc.	Secured Loan	March 9, 2021	April 1, 2026	Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.0%	$	6,319	$	6,799	$	6,818	(8)(14)
	Secured Loan	February 10, 2022	April 1, 2026	Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.0%		903		973		977	(8)(14)
Total Quip NYC, Inc.						7,222		7,772		7,795

Rinse, Inc.	Secured Loan	May 10, 2022	June 1, 2027	Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.8%	$	3,528	$	3,646	$	3,671	(8)(14)
	Secured Loan	September 22, 2023	October 1, 2028	Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.8%		4,000		4,012		4,077	(8)(14)
Total Rinse, Inc.						7,528		7,658		7,748

SI Tickets, Inc.	Secured Loan	May 11, 2022	September 1, 2026	Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 3.0%	$	1,684	$	1,750	$	1,714	(8)(14)

UnTuckIt, Inc.	Secured Loan	January 16, 2020	December 1, 2025	Fixed interest rate 12.0%; EOT 5.0%	$	3,844	$	4,787	$	4,722

VitaCup, Inc.	Secured Loan	June 23, 2021	February 1, 2026	Variable interest rate Prime + 7.5% or Floor rate 11.5%; EOT 5.0%	$	6,000	$	6,301	$	5,816	(8)(14)

Sub-total: Consumer Products & Services (5.5%)*					$	44,136	$	46,944	$	46,124


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Digital Assets Technology and Services
Cleanspark, Inc.	Equipment Financing	April 22, 2022	May 1, 2025	Fixed interest rate 10.3%; EOT 5.0%	$	638	$	1,638	$	1,630	(10)(14)

Sub-total: Digital Assets Technology and Services (0.2%)*					$	638	$	1,638	$	1,630

Education Technology
Edblox, Inc.	Secured Loan	March 19, 2024	April 1, 2029	Variable interest rate Prime + 4.5% or Floor rate 11.8%; EOT 2.5%	$	15,000	$	14,891	$	13,574	(8)(9)(14)

Medical Sales Training Holding Company	Secured Loan	March 18, 2021	May 1, 2025	Variable interest rate Prime + 8.8% or Floor rate 12.0%; EOT 6.3%	$	5,175	$	5,547	$	4,852	(8)
	Secured Loan	July 21, 2021	August 1, 2025	Variable interest rate Prime + 8.8% or Floor rate 12.0%; EOT 6.3%		1,825		1,944		1,711	(8)
Total Medical Sales Training Holding Company						7,000		7,491		6,563

Yellowbrick Learning, Inc.	Secured Loan	February 1, 2021	March 1, 2026	Fixed interest rate 2.0%; EOT 5.0%	$	7,500	$	7,875	$	6,922
	Secured Loan	August 10, 2021	March 1, 2026	Fixed interest rate 2.0%; EOT 5.0%		2,500		2,625		2,309
Total Yellowbrick Learning, Inc.						10,000		10,500		9,231

Sub-total: Education Technology (3.5%)*					$	32,000	$	32,882	$	29,368


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Finance and Insurance
Beam Technologies, Inc.	Secured Loan	August 30, 2024	April 1, 2027	Variable interest rate PRIME + 2.8% or Floor rate 11.0%+PIK Fixed Interest Rate 1.5%; EOT 2.0%	$	29,483	$	28,879	$	29,282	(8)(9)(15)(19)

Bestow, Inc.	Secured Loan	August 1, 2024	December 1, 2027	Variable interest rate Prime + 6.0% or Floor rate 13.0%; EOT 1.5%	$	40,000	$	38,639	$	38,472	(8)(14)

Busbot, Inc.	Secured Loan	April 1, 2024	October 1, 2026	Variable interest rate SOFR 30 Day Forward + 11.5% or Floor rate 13.5%; EOT 0.0%	$	9,200	$	9,075	$	9,075	(8)(10)(12)(21)

Centivo Corporation	Secured Loan	July 31, 2024	August 1, 2029	Variable interest rate PRIME + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0%	$	3,775	$	3,697	$	3,754	(8)(9)(14)(15)(19)
	Secured Loan	December 20, 2024	August 1, 2029	Variable interest rate PRIME + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0%		3,761		3,558		3,588	(8)(9)(14)(15)(19)
	Secured Loan	February 3, 2025	August 1, 2029	Variable interest rate PRIME + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0%		3,756		3,568		3,568	(8)(9)(14)(15)(19)
Total Centivo Corporation						11,292		10,823		10,910

Cherry Technologies, Inc.	Secured Loan	March 29, 2024	April 1, 2029	Variable interest rate PRIME + 2.5% or Floor rate 9.5%; EOT 2.0%	$	7,235	$	7,506	$	7,469	(8)(9)(14)(15)(19)
	Secured Loan	July 31, 2024	April 1, 2029	Variable interest rate PRIME + 2.5% or Floor rate 9.5%; EOT 2.0%		7,235		7,512		7,457	(8)(9)(14)(15)(19)
Total Cherry Technologies, Inc.						14,470		15,018		14,926

Empower Financial, Inc.	Secured Loan	October 13, 2023	May 1, 2028	Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8%	$	11,622	$	11,556	$	11,703	(8)(9)(14)(19)
	Secured Loan	January 5, 2024	May 1, 2028	Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8%		2,902		2,825		2,869	(8)(9)(14)(19)
	Secured Loan	February 8, 2024	May 1, 2028	Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8%		4,353		4,234		4,301	(8)(9)(14)(19)
	Secured Loan	April 9, 2024	May 1, 2028	Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8%		4,348		4,114		4,171	(8)(9)(14)(19)
	Secured Loan	May 15, 2024	May 1, 2028	Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8%		14,495		14,623		14,917	(8)(14)(19)
Total Empower Financial, Inc.						37,720		37,352		37,961


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Eqis Capital Management, Inc.	Secured Loan	June 15, 2022	July 1, 2026	Variable interest rate Prime + 7.5% or Floor rate 10.8%; EOT 3.0%	$	6,469	$	6,679	$	6,259	(8)(14)

Gravie, Inc.	Secured Loan	June 4, 2024	July 1, 2029	Variable interest rate Prime + 4.5% or Floor rate 13.0%; EOT 2.5%	$	15,980	$	15,711	$	15,476	(8)(9)(14)(19)

Kafene, Inc.	Secured Loan	January 5, 2024	February 1, 2029	Variable interest rate Prime + 4.0% or Floor rate 12.0%; EOT 1.0%	$	12,500	$	12,419	$	12,594	(8)(14)

Mesa Financial, Inc.	Secured Loan	August 29, 2024	February 28, 2027	Variable interest rate SOFR 30 Day Forward + 10.3% or Floor rate 13.0%; EOT 0.0%	$	12,851	$	12,680	$	12,680	(8)(10)(12)(21)

Pagaya Structured Products LLC	Secured Loan	August 23, 2024	August 23, 2025	Fixed interest rate 20.0%; EOT 0.0%	$	12,778	$	12,717	$	12,717	(10)(12)

Parafin SPV 2, LLC	Secured Loan	February 22, 2024	December 21, 2026	Variable interest rate SOFR 1 Month Term + 10.8% or Floor rate 12.8%; EOT 0.0%	$	22,670	$	22,380	$	22,380	(8)(10)(12)

Parafin SPV 3, LLC	Secured Loan	July 25, 2024	January 25, 2027	Variable interest rate SOFR 1 Month Term + 10.8% or Floor rate 13.8%; EOT 0.0%	$	16,951	$	16,756	$	16,756	(8)(10)(12)

PatientFi, Inc.	Secured Loan	March 14, 2025	April 1, 2030	Variable interest rate Prime + 3.5% or Floor rate 10.5%; EOT 2.5%	$	9,400	$	9,172	$	9,172	(8)(14)(19)

Slope Tech, Inc.	Secured Loan	October 5, 2022	February 27, 2026	Variable interest rate SOFR 1 Month Term + 11.8% or Floor rate 11.8%; EOT 0.0%	$	3,243	$	3,180	$	3,180	(8)(10)(12)(21)

Under Technologies, Inc.	Secured Loan	September 13, 2024	June 1, 2029	Variable interest rate PRIME + 3.8% or Floor rate 12.0%; EOT 4.3%	$	7,400	$	7,287	$	7,397	(8)(9)(19)
	Secured Loan	November 27, 2024	June 1, 2029	Variable interest rate PRIME + 3.8% or Floor rate 12.0%; EOT 4.3%		7,400		7,264		7,281	(8)(9)(19)
Total Under Technologies, Inc.						14,800		14,551		14,678

Wisetack, Inc.	Secured Loan	November 14, 2024	December 1, 2029	Variable interest rate Prime + 5.0% or Floor rate 12.5%; EOT 2.5%	$	12,150	$	11,975	$	12,093	(8)(9)(19)

Sub-total: Finance and Insurance (33.4%)*					$	281,957	$	278,006	$	278,611


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Food and Agriculture Technologies
Bowery Farming, Inc.	Secured Loan	September 10, 2021	September 10, 2026	Variable interest rate SOFR 1 Month Term + 10.0% or Floor rate 1.0%; EOT 0.0%	$	7,652	$	6,939	$	—	(8)(18)

Daring Foods, Inc.	Equipment Financing	April 29, 2022	May 1, 2025	Fixed interest rate 10.2%; EOT 7.5%	$	32	$	107	$	106	(14)
	Equipment Financing	July 6, 2022	August 1, 2025	Fixed interest rate 10.9%; EOT 7.5%		57		91		90	(14)
	Equipment Financing	August 25, 2022	September 1, 2025	Fixed interest rate 12.1%; EOT 7.5%		169		247		246	(14)
Total Daring Foods, Inc.						258		445		442

DrinkPak, LLC	Equipment Financing	February 17, 2023	September 1, 2026	Fixed interest rate 12.9%; EOT 7.0%	$	6,279	$	7,126	$	7,130	(9)(14)(19)

Emergy, Inc.	Equipment Financing	December 15, 2021	July 1, 2026	Fixed interest rate 12.7%; EOT 11.5%	$	3,183	$	3,992	$	1,809	(18)
	Equipment Financing	December 13, 2022	July 1, 2027	Fixed interest rate 9.4%; EOT 11.5%		6,183		6,970		3,513	(9)(18)
Total Emergy, Inc.						9,366		10,962		5,322

Sub-total: Food and Agriculture Technologies (1.5%)*					$	23,555	$	25,472	$	12,894


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Green Technology
Commonwealth Fusion Systems, LLC	Equipment Financing	June 16, 2023	July 1, 2030	Fixed interest rate 13.0%; EOT 10.0%	$	3,341	$	3,478	$	3,566	(9)(14)(19)
	Equipment Financing	June 27, 2024	July 1, 2030	Fixed interest rate 13.2%; EOT 10.0%		9,664		9,783		10,053	(9)(14)(19)
	Equipment Financing	January 14, 2025	July 1, 2029	Fixed interest rate 11.2%; EOT 6.0%		19,069		18,992		18,992	(14)(19)
Total Commonwealth Fusion Systems, LLC						32,074		32,253		32,611

Crusoe Energy Systems LLC	Equipment Financing	March 1, 2024	March 1, 2029	Fixed interest rate 12.7%; EOT 0.0%	$	7,732	$	7,672	$	7,862	(9)(14)(19)

Dandelion Energy, Inc.	Equipment Financing	June 25, 2024	July 1, 2025	Fixed interest rate 15.9%; EOT 0.0%	$	1,361	$	1,355	$	1,379	(9)(14)

Electric Hydrogen Co.	Equipment Financing	September 12, 2022	April 1, 2026	Fixed interest rate 9.0%; EOT 10.0%	$	644	$	831	$	817	(14)
	Equipment Financing	December 22, 2023	January 1, 2029	Fixed interest rate 12.5%; EOT 15.0%		3,716		3,986		3,965	(9)(14)(19)
	Equipment Financing	June 27, 2024	January 1, 2029	Fixed interest rate 12.6%; EOT 15.0%		3,047		3,170		3,194	(9)(14)(19)
	Equipment Financing	September 19, 2024	October 1, 2028	Fixed interest rate 12.5%; EOT 15.0%		1,862		1,919		1,921	(9)(14)(19)
	Equipment Financing	November 14, 2024	December 1, 2028	Fixed interest rate 11.9%; EOT 15.0%		444		453		452	(9)(14)(19)
Total Electric Hydrogen Co.						9,713		10,359		10,349

Form Energy Inc.	Equipment Financing	October 21, 2024	November 1, 2027	Fixed interest rate 12.7%; EOT 3.0%	$	28,411	$	28,057	$	28,459	(9)(14)(19)
	Equipment Financing	December 12, 2024	January 1, 2028	Fixed interest rate 12.5%; EOT 3.0%		7,508		7,383		7,474	(9)(14)(19)
Total Form Energy Inc.						35,919		35,440		35,933

Hi-Power, LLC	Equipment Financing	September 30, 2022	April 1, 2026	Fixed interest rate 14.7%; EOT 1.0%	$	1,415	$	1,449	$	1,467	(14)

SeaOn Global, LLC	Equipment Financing	June 16, 2022	July 1, 2026	Fixed interest rate 9.3%; EOT 11.0%	$	2,374	$	3,040	$	2,943
	Equipment Financing	August 17, 2022	September 1, 2026	Fixed interest rate 9.3%; EOT 11.0%		1,286		1,595		1,551
Total SeaOn Global, LLC						3,660		4,635		4,494

Footprint International Holding, Inc.	Secured Loan	February 18, 2022	March 1, 2027	Variable interest rate Prime + 7.3% or Floor rate 10.5%; EOT 3.5%	$	14,327	$	14,369	$	13,647	(8)(14)
	Secured Loan	April 20, 2022	March 1, 2027	Variable interest rate Prime + 7.3% or Floor rate 10.5%; EOT 3.5%		14,327		14,343		13,618	(8)(14)
Total Footprint International Holding, Inc.						28,654		28,712		27,265

Mainspring Energy, Inc.	Secured Loan	March 18, 2022	October 1, 2026	Fixed interest rate 11.0%; EOT 3.8%	$	17,055	$	17,976	$	17,806	(14)

Sub-total: Green Technology (16.7%)*					$	137,583	$	139,851	$	139,166


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Healthcare Technology
Moxe Health Corporation	Secured Loan	December 29, 2023	January 1, 2028	Variable interest rate Prime + 5.5% or Floor rate 13.0%; EOT 4.8%	$	12,500	$	12,570	$	12,505	(8)

RXAnte, Inc.	Secured Loan	November 21, 2022	December 1, 2027	Variable interest rate Prime + 4.48% or Floor rate 9.98%+PIK Fixed Interest Rate 1.5%; EOT 3.5%	$	8,548	$	8,654	$	8,708	(8)(9)(14)(15)(19)
	Secured Loan	April 14, 2023	December 1, 2027	Variable interest rate Prime + 4.48% or Floor rate 9.98%+PIK Fixed Interest Rate 1.5%; EOT 3.5%		2,842		2,853		2,943	(8)(9)(14)(15)(19)
	Secured Loan	October 19, 2023	December 1, 2027	Variable interest rate Prime + 4.48% or Floor rate 9.98%+PIK Fixed Interest Rate 1.5%; EOT 3.5%		2,813		2,819		2,887	(8)(9)(14)(15)(19)
	Secured Loan	September 9, 2024	December 1, 2027	Variable interest rate Prime + 4.48% or Floor rate 9.98%+PIK Fixed Interest Rate 1.5%; EOT 3.5%		2,777		2,778		2,846	(8)(9)(14)(15)(19)
Total RXAnte, Inc.						16,980		17,104		17,384

TMRW Life Sciences, Inc.	Secured Loan	April 29, 2022	May 1, 2027	Variable interest rate Prime + 5.0% or Floor rate 8.8%; EOT 4.0%	$	5,000	$	5,138	$	4,865	(8)(14)
	Secured Loan	March 3, 2023	May 1, 2027	Variable interest rate Prime + 5.0% or Floor rate 8.8%; EOT 4.0%		15,000		15,352		15,112	(8)(14)
	Secured Loan	December 8, 2023	May 1, 2027	Variable interest rate Prime + 5.0% or Floor rate 8.8%; EOT 4.0%		10,000		10,172		10,026	(8)(14)
Total TMRW Life Sciences, Inc.						30,000		30,662		30,003

WorkWell Prevention & Care Inc.	Secured Loan	December 31, 2022	January 1, 2027	Variable interest rate Prime + 5.0% or Floor rate 6.0%; EOT 0.0%	$	500	$	500	$	500	(8)(22)

Sub-total: Healthcare Technology (7.2%)*					$	59,980	$	60,836	$	60,392


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Human Resource Technology
Nomad Health, Inc.	Secured Loan	March 29, 2022	December 1, 2026	Variable interest rate Prime + 5.5% or Floor rate 9.3%; EOT 4.0%	$	32,225	$	33,169	$	28,961	(8)(14)(15)
	Secured Loan	June 12, 2024	December 1, 2026	Fixed interest rate 10.0%; EOT 0.0%		500		500		481	(16)
Total Nomad Health, Inc.						32,725		33,669		29,442

Sub-total: Human Resource Technology (3.5%)*					$	32,725	$	33,669	$	29,442

Industrials
3DEO, Inc.	Equipment Financing	February 1, 2025	February 1, 2028	Fixed interest rate 0.1%; EOT 2.2%	$	2,258	$	2,263	$	2,208	(14)

Sub-total: Industrials (0.3%)*					$	2,258	$	2,263	$	2,208

Marketing, Media, and Entertainment
Drone Racing League, Inc.	Secured Loan	October 17, 2022	December 1, 2025	Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 2.5%	$	6,940	$	7,096	$	6,810	(8)

Grabit Interactive Media, Inc.	Secured Loan	April 8, 2022	November 1, 2026	Variable interest rate Prime + 7.5% or Floor rate 10.8%; EOT 2.5%	$	2,758	$	2,843	$	2,795	(8)(14)

Incontext Solutions, Inc.	Secured Loan	January 16, 2020	September 1, 2025	Fixed interest rate 11.8%; EOT 11.4%	$	939	$	2,089	$	1,879

Vox Media Holdings, Inc.	Secured Loan	October 18, 2022	November 1, 2027	Variable interest rate Prime + 6.3% or Floor rate 11.8%; EOT 2.5%	$	10,506	$	10,619	$	10,783	(8)(9)(14)(19)
	Secured Loan	December 29, 2022	January 1, 2028	Variable interest rate Prime + 6.3% or Floor rate 11.8%; EOT 2.5%		5,251		5,297		5,377	(8)(9)(14)(19)
Total Vox Media Holdings, Inc.						15,757		15,916		16,160

Sub-total: Marketing, Media, and Entertainment (3.3%)*					$	26,394	$	27,944	$	27,644


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Medical Devices
Apiject Holdings, Inc.	Equipment Financing	June 24, 2024	July 1, 2028	Fixed interest rate 12.6%; EOT 7.5%	$	16,816	$	16,939	$	17,083	(9)(14)(19)
	Equipment Financing	September 30, 2024	October 1, 2028	Fixed interest rate 12.7%; EOT 7.5%		7,045		7,004		7,038	(9)(14)(19)
Total Apiject Holdings, Inc.						23,861		23,943		24,121

Cagent Vascular, Inc.	Secured Loan	January 24, 2025	February 1, 2030	Variable interest rate PRIME + 4.0% or Floor rate 11.3%; EOT 3.0%	$	4,700	$	4,657	$	4,657	(8)(19)

Convergent Dental, Inc.	Secured Loan	April 21, 2023	May 1, 2027	Variable interest rate Prime + 5.8% or Floor rate 13.5%; EOT 5.5%	$	12,000	$	12,156	$	12,285	(8)(9)(14)
	Secured Loan	February 29, 2024	May 1, 2027	Variable interest rate Prime + 5.8% or Floor rate 13.5%; EOT 5.5%		6,000		6,044		6,168	(8)(9)(14)
Total Convergent Dental, Inc.						18,000		18,200		18,453

Elucent Medical, Inc.	Secured Loan	October 31, 2024	November 30, 2029	Variable interest rate PRIME + 3.8% or Floor rate 11.3%; EOT 3.3%	$	12,150	$	11,944	$	12,116	(8)(9)(19)

Lightforce Orthodontics, Inc.	Secured Loan	August 6, 2024	August 6, 2029	Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 4.0%	$	28,200	$	27,883	$	28,118	(8)(19)
	Secured Loan	September 25, 2024	August 6, 2029	Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 4.0%		4,700		4,646		4,686	(8)(19)
Total Lightforce Orthodontics, Inc.						32,900		32,529		32,804

Neurolens, Inc.	Secured Loan	September 29, 2023	October 1, 2028	Variable interest rate Prime + 3.5% or Floor rate 11.5%; EOT 3.0%	$	20,000	$	20,032	$	20,679	(8)
	Secured Loan	January 21, 2025	October 1, 2028	Variable interest rate Prime + 3.5% or Floor rate 11.5%; EOT 3.0%		15,000		14,872		14,872	(8)
Total Neurolens, Inc.						35,000		34,904		35,551

Neuros Medical, Inc.	Secured Loan	August 10, 2023	September 1, 2027	Variable interest rate Prime + 6.0% or Floor rate 14.3%; EOT 4.5%	$	6,000	$	6,061	$	6,063	(8)(9)(14)
	Secured Loan	August 30, 2024	September 1, 2027	Variable interest rate Prime + 6.0% or Floor rate 14.3%; EOT 4.5%		3,000		2,981		2,951	(8)(9)(14)
Total Neuros Medical, Inc.						9,000		9,042		9,014

Restor3d, Inc.	Secured Loan	June 4, 2024	July 4, 2028	Variable interest rate Prime + 4.8% or Floor rate 12.3%; EOT 3.3%	$	11,985	$	11,925	$	12,034	(8)(9)(14)(19)

Shoulder Innovations, Inc.	Secured Loan	August 7, 2023	September 1, 2028	Variable interest rate Prime + 3.5% or Floor rate 11.5%; EOT 3.0%	$	11,250	$	11,267	$	11,442	(8)(9)(14)

Vital Connect, Inc.	Secured Loan	July 3, 2024	July 3, 2029	Variable interest rate Prime + 4.0% or Floor rate 11.5%; EOT 4.0%	$	27,650	$	27,562	$	27,796	(8)(9)(19)
	Secured Loan	March 21, 2025	July 3, 2029	Variable interest rate Prime + 4.0% or Floor rate 11.5%; EOT 4.0%		7,900		7,823		7,823	(8)(9)(19)
Total Vital Connect, Inc.						35,550		35,385		35,619

Sub-total: Medical Devices (23.5%)*					$	194,396	$	193,796	$	195,811


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Multi-Sector Holdings
Senior Credit Corp 2022 LLC	Secured Loan	January 30, 2023	December 5, 2028	Fixed interest rate 8.5%; EOT 0.0%	$	12,885	$	12,885	$	12,885	(10)(21)

Sub-total: Multi-Sector Holdings (1.5%)*					$	12,885	$	12,885	$	12,885

Other Healthcare Services
Cellares Corporation	Equipment Financing	August 2, 2024	September 1, 2029	Fixed interest rate 12.0%; EOT 4.5%	$	4,285	$	4,313	$	4,384	(14)(19)
	Equipment Financing	January 10, 2025	February 1, 2030	Fixed interest rate 12.2%; EOT 4.5%		5,845		5,835		5,835	(14)(19)
	Equipment Financing	January 29, 2025	February 1, 2030	Fixed interest rate 12.5%; EOT 4.5%		3,569		3,560		3,560	(14)(19)
	Secured Loan	August 2, 2024	February 1, 2027	Variable interest rate Prime + 3.3% or Floor rate 11.8%; EOT 4.0%		47,000		46,683		47,443	(8)(14)(19)
Total Cellares Corporation						60,699		60,391		61,222

Metabolon, Inc.	Secured Loan	March 28, 2024	April 1, 2029	Variable interest rate PRIME + 2.5% or Floor rate 10.0%+PIK Fixed Interest Rate 3.0%; EOT 4.8%	$	43,466	$	42,845	$	43,179	(8)(15)
	Secured Loan	October 1, 2024	April 1, 2029	Variable interest rate PRIME + 2.5% or Floor rate 10.0%+PIK Fixed Interest Rate 3.0%; EOT 4.8%		5,075		5,024		4,978	(8)(15)
	Secured Loan	January 6, 2025	April 1, 2029	Variable interest rate PRIME + 2.5% or Floor rate 10.0%+PIK Fixed Interest Rate 3.0%; EOT 4.8%		2,518		2,476		2,476	(8)(15)
Total Metabolon, Inc.						51,059		50,345		50,633

Upward Health, Inc.	Secured Loan	August 6, 2024	September 1, 2029	Variable interest rate Prime + 4.3% or Floor rate 12.8%; EOT 3.0%	$	5,875	$	5,730	$	5,848	(8)(9)(14)(19)

Velentium, Inc.	Secured Loan	May 24, 2024	May 24, 2029	Variable interest rate Prime + 5.0% or Floor rate 12.5%; EOT 4.0%	$	8,500	$	8,413	$	8,473	(8)(9)(14)

Sub-total: Other Healthcare Services (15.1%)*					$	126,133	$	124,879	$	126,176

Real Estate Technology
Homelight Lending, Inc.	Secured Loan	October 15, 2021	June 1, 2026	Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 4.5%	$	3,312	$	3,537	$	3,447	(8)(14)

Knockaway, Inc.	Secured Loan	September 29, 2023	September 1, 2028	Fixed interest rate 10.2%; EOT 0.0%	$	23,644	$	20,355	$	19,576	(8)(14)(22)

Knockaway Trinity Holdings, LLC	Secured Loan	December 6, 2023	December 27, 2026	Variable interest rate SOFR 30 Day Forward + 9.3% or Floor rate 13.8%; EOT 0.0%	$	23,784	$	23,769	$	23,769	(8)(10)(12)(21)(22)

Maxwell Financial Labs, Inc.	Secured Loan	September 30, 2021	April 1, 2026	Variable interest rate Prime + 6.0% or Floor rate 10.0%; EOT 5.0%	$	15,000	$	15,596	$	15,137	(8)(14)
	Secured Loan	October 2, 2024	October 2, 2026	Fixed interest rate 6.0%; EOT 0.0%		187		187		188	(16)
Total Maxwell Financial Labs, Inc.						15,187		15,783		15,325

Orchard Technologies, Inc.	Secured Loan	January 1, 2024	January 1, 2029	Variable interest rate Prime + 10.0% or Floor rate 17.0%; EOT 4.0%	$	28,540	$	29,549	$	24,787	(8)(14)

Sub-total: Real Estate Technology (10.4%)*					$	94,467	$	92,993	$	86,904


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Software as a Service ("SaaS")
Cpacket Networks, Inc.	Secured Loan	January 29, 2024	February 1, 2029	Variable interest rate PRIME + 4.8% or Floor rate 12.0%+PIK Fixed Interest Rate 1.3%; EOT 3.0%	$	20,542	$	20,430	$	20,640	(8)(9)(14)(15)

Eyelit Technologies, Inc.	Secured Loan	November 4, 2024	November 4, 2029	Variable interest rate SOFR 1 Month Term + 5.8%; EOT 0.0%	$	4,500	$	4,417	$	4,554	(8)(19)(20)
	Secured Loan	December 27, 2024	November 4, 2029	Variable interest rate SOFR 1 Month Term + 5.8%; EOT 0.0%		7,920		7,770		7,960	(8)(19)(20)
Total Eyelit Technologies, Inc.						12,420		12,187		12,514

Hometown Ticketing, Inc.	Secured Loan	November 25, 2024	November 25, 2029	Variable interest rate SOFR 3 Month Term + 7.7%; EOT 0.0%	$	24,848	$	24,385	$	24,995	(8)(19)

ServiceTrade, Inc.	Secured Loan	August 15, 2024	August 15, 2029	Variable interest rate SOFR 3 Month Term + 5.5%; EOT 0.0%	$	23,500	$	23,113	$	23,650	(8)(14)(19)(20)

Silk Technologies, Inc.	Secured Loan	November 4, 2024	December 1, 2029	Variable interest rate Prime + 4.0% or Floor rate 11.3%; EOT 1.5%	$	16,200	$	15,816	$	15,817	(8)(9)(14)(19)

SOCi, Inc.	Secured Loan	October 3, 2024	October 3, 2029	Variable interest rate SOFR 3 Month Term + 7.9%; EOT 0.0%	$	36,009	$	35,276	$	36,037	(8)(14)(19)(20)
	Secured Loan	December 30, 2024	October 3, 2029	Variable interest rate SOFR 3 Month Term + 7.9%; EOT 0.0%		3,282		3,212		3,265	(8)(14)(19)(20)
Total SOCi, Inc.						39,291		38,488		39,302

Steno Agency, Inc.	Secured Loan	June 21, 2024	July 1, 2029	Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 2.5%	$	3,740	$	3,636	$	3,751	(8)(9)(14)(19)
	Secured Loan	January 2, 2025	July 1, 2029	Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 2.5%		3,650		3,638		3,638	(8)(9)(14)(19)
Total Steno Agency, Inc.						7,390		7,274		7,389

Xytech Systems, LLC	Secured Loan	February 26, 2025	February 26, 2030	Variable interest rate SOFR 3 Month Term + 6.0%; EOT 0.0%	$	39,200	$	38,431	$	38,431	(8)(19)(20)

Sub-total: SaaS (21.9%)*					$	183,391	$	180,124	$	182,738

Space Technology
Astranis Space Technology Corporation	Equipment Financing	April 13, 2023	November 1, 2026	Fixed interest rate 12.1%; EOT 5.0%	$	6,669	$	7,215	$	7,293	(9)(14)(19)
	Equipment Financing	September 27, 2024	April 1, 2028	Fixed interest rate 12.4%; EOT 5.5%		10,218		9,854		9,989	(9)(14)(19)
	Equipment Financing	September 27, 2024	October 1, 2027	Fixed interest rate 12.6%; EOT 4.0%		2,485		2,395		2,425	(9)(14)(19)
Total Astranis Space Technology Corporation						19,372		19,464		19,707

Hadrian Automation, Inc.	Equipment Financing	March 2, 2022	September 1, 2025	Fixed interest rate 12.6%; EOT 0.0%	$	86	$	85	$	87	(14)
	Equipment Financing	May 6, 2022	November 1, 2025	Fixed interest rate 12.9%; EOT 0.0%		1,106		1,105		1,129	(14)
	Equipment Financing	July 15, 2022	January 1, 2026	Fixed interest rate 14.3%; EOT 0.0%		933		932		955	(14)
	Equipment Financing	September 30, 2022	March 1, 2026	Fixed interest rate 15.2%; EOT 0.0%		1,866		1,864		1,917	(9)(14)
	Equipment Financing	December 22, 2022	June 1, 2026	Fixed interest rate 16.1%; EOT 0.0%		520		517		537	(9)(14)
	Equipment Financing	December 22, 2022	December 1, 2026	Fixed interest rate 16.4%; EOT 0.0%		244		244		253	(9)(14)(19)
	Equipment Financing	March 29, 2023	March 1, 2027	Fixed interest rate 15.7%; EOT 0.0%		794		792		819	(9)(14)(19)
	Equipment Financing	September 28, 2023	September 1, 2027	Fixed interest rate 17.7%; EOT 0.0%		435		433		451	(9)(14)(19)
	Equipment Financing	June 27, 2024	June 1, 2028	Fixed interest rate 17.6%; EOT 0.0%		1,205		1,201		1,240	(9)(14)(19)
Total Hadrian Automation, Inc.						7,189		7,173		7,388


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Impulse Space, Inc.	Equipment Financing	June 18, 2024	July 1, 2027	Fixed interest rate 12.7%; EOT 3.0%	$	1,044	$	1,043	$	1,061	(9)(14)(19)
	Equipment Financing	September 13, 2024	October 1, 2027	Fixed interest rate 12.5%; EOT 3.0%		831		824		841	(9)(14)(19)
	Equipment Financing	December 27, 2024	January 1, 2028	Fixed interest rate 12.9%; EOT 3.0%		807		793		815	(9)(14)(19)
	Equipment Financing	February 12, 2025	March 1, 2028	Fixed interest rate 12.6%; EOT 3.0%		1,125		1,103		1,103	(14)(19)
Total Impulse Space, Inc.						3,807		3,763		3,820

Kymeta Corporation	Secured Loan	July 3, 2024	August 1, 2029	Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 3.0%	$	7,900	$	7,615	$	7,807	(8)(9)(14)(19)

Rocket Lab USA, Inc.	Equipment Financing	December 29, 2023	January 1, 2029	Fixed interest rate 12.8%; EOT 1.0%	$	43,408	$	42,869	$	44,212	(9)(10)(14)
	Equipment Financing	March 20, 2025	April 1, 2030	Fixed interest rate 12.3%; EOT 1.0%		25,000		24,927		24,927	(10)(14)
Total Rocket Lab USA, Inc.						68,408		67,796		69,139

Slingshot Aerospace, Inc.	Secured Loan	July 12, 2024	August 1, 2029	Variable interest rate Prime + 5.5% or Floor rate 14.0%; EOT 3.0%	$	23,700	$	23,311	$	23,801	(8)(9)(14)(19)
	Secured Loan	August 7, 2024	April 30, 2025	Fixed interest rate 10.0%; EOT 0.0%		500		500		537	(16)
Total Slingshot Aerospace, Inc.						24,200		23,811		24,338

Space Perspective, Inc.	Secured Loan	March 3, 2022	July 1, 2026	Variable interest rate Prime + 7.8% or Floor rate 11.0%; EOT 5.0%	$	2,854	$	3,021	$	1,009	(8)(18)

Sub-total: Space Technology (16.0%)*					$	133,730	$	132,643	$	133,208

Supply Chain Technology
Macrofab, Inc.	Secured Loan	July 21, 2023	August 1, 2027	Variable interest rate Prime + 5.5% or Floor rate 13.3%; EOT 4.5%	$	19,495	$	20,257	$	18,601	(8)(14)

Nucleus RadioPharma, Inc.	Equipment Financing	June 4, 2024	June 1, 2027	Fixed interest rate 11.8%; EOT 4.0%	$	332	$	337	$	342	(9)(14)
	Equipment Financing	December 23, 2024	January 1, 2028	Fixed interest rate 12.3%; EOT 4.0%		1,570		1,564		1,578	(9)(14)
Total Nucleus RadioPharma, Inc.						1,902		1,901		1,920

Sub-total: Supply Chain Technology (2.5%)*					$	21,397	$	22,158	$	20,521


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Transportation Technology
NextCar Holding Company, Inc.	Secured Loan	December 14, 2021	June 30, 2025	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0%	$	2,728	$	2,988	$	754	(8)(18)
	Secured Loan	December 15, 2021	June 30, 2025	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0%		2,274		2,379		631	(8)(18)
	Secured Loan	February 23, 2022	June 30, 2025	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0%		2,843		2,974		789	(8)(18)
	Secured Loan	March 16, 2022	June 30, 2025	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0%		3,411		3,569		946	(8)(18)
	Secured Loan	April 18, 2022	June 30, 2025	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0%		2,843		2,974		789	(8)(18)
	Secured Loan	April 18, 2022	June 30, 2025	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0%		2,843		2,974		789	(8)(18)
	Secured Loan	May 17, 2022	June 30, 2025	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0%		5,685		5,948		1,577	(8)(18)
	Secured Loan	June 22, 2022	June 30, 2025	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0%		2,843		2,974		789	(8)(18)
Total NextCar Holding Company, Inc.						25,470		26,780		7,064

Get Spiffy, Inc.	Secured Loan	July 14, 2023	January 14, 2028	Variable interest rate Prime + 4.5% or Floor rate 12.3%; EOT 6.0%	$	9,046	$	9,222	$	7,713	(8)(9)(14)
	Equipment Financing	July 14, 2023	February 1, 2027	Fixed interest rate 12.1%; EOT 4.0%		259		265		255	(9)(14)
Total Get Spiffy, Inc.						9,305		9,487		7,968

Uveye, Inc.	Equipment Financing	December 26, 2024	January 1, 2028	Fixed interest rate 11.9%; EOT 1.0%	$	18,645	$	18,494	$	18,566	(14)
	Equipment Financing	March 28, 2025	April 1, 2028	Fixed interest rate 11.9%; EOT 1.0%		5,073		5,021		5,021	(14)
Total Uveye, Inc.						23,718		23,515		23,587

Zuum Transportation, Inc.	Secured Loan	December 17, 2021	January 1, 2027	Variable interest rate Prime + 6.0% or Floor rate 10.8%; EOT 2.5%	$	4,955	$	5,029	$	4,648	(8)(14)

Sub-total: Transportation Technology (5.2%)*					$	63,448	$	64,811	$	43,267

Total: Debt Securities- United States (191.3%)*					$	1,630,687	$	1,637,052	$	1,594,200


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- Canada

Construction Technology
Nexii, Inc.	Secured Loan	July 24, 2024	July 1, 2027	Fixed interest rate 10.0%; EOT 0.0%	$	365	$	365	$	375	(10)(22)

Sub-total: Construction Technology (0.0%)*					$	365	$	365	$	375

Supply Chain Technology
GoFor Delivers, Inc.	Secured Loan	June 28, 2024	July 1, 2028	Variable interest rate Prime + 3.5% or Floor rate 12.0%; EOT 2.5%	$	6,000	$	6,037	$	5,803	(8)(10)(22)

Sub-total: Supply Chain Technology (0.7%)*					$	6,000	$	6,037	$	5,803

Total: Debt Securities- Canada (0.7%)*					$	6,365	$	6,402	$	6,178
Debt Securities- Europe

Industrials
Aledia, Inc.	Equipment Financing	June 30, 2022	July 1, 2025	Fixed interest rate 9.7%; EOT 7.0%	$	111	$	193	$	190	(10)(14)
	Equipment Financing	August 5, 2022	September 1, 2025	Fixed interest rate 10.7%; EOT 7.0%		240		344		343	(10)(14)
	Equipment Financing	September 30, 2022	October 1, 2025	Fixed interest rate 12.0%; EOT 7.0%		460		624		624	(10)(14)
Total Aledia, Inc.						811		1,161		1,157

Sub-total: Industrials (0.1%)*					$	811	$	1,161	$	1,157

Medical Devices
CMR Surgical Limited	Secured Loan	March 24, 2025	April 1, 2030	Variable interest rate Prime + 4.0% or Floor rate 11.0%; EOT 4.0%	$	30,000	$	29,585	$	29,585	(8)(10)(19)

Sub-total: Other Healthcare Services (3.5%)*					$	30,000	$	29,585	$	29,585

Other Healthcare Services
Zandivio PLC	Secured Loan	October 30, 2024	May 1, 2029	Variable interest rate PRIME + 5.3% or Floor rate 13.8%; EOT 2.5%	$	28,200	$	27,535	$	27,963	(8)(10)(19)

Sub-total: Other Healthcare Services (3.4%)*					$	28,200	$	27,535	$	27,963

Space Technology
All.Space Networks, Limited.	Secured Loan	August 22, 2022	September 1, 2027	Variable interest rate Prime + 7.0% or Floor rate 11.5%; EOT 2.5%	$	8,219	$	8,353	$	8,022	(8)(10)

Sub-total: Space Technology (1.0%)*					$	8,219	$	8,353	$	8,022

Total: Debt Securities- Europe (8.0%)*					$	67,230	$	66,634	$	66,727

Total: Debt Securities (200.0%)*					$	1,704,282	$	1,710,088	$	1,667,105


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Expiration Date	Series	Shares		Strike Price		Cost		Fair Value (6)		Footnotes
Warrant Investments- United States

Artificial Intelligence & Automation

Ambient Photonics, Inc.	Warrant	July 27, 2022	July 27, 2032	Common Stock		15,976	$	5.50	$	47	$	1

Everalbum, Inc.	Warrant	January 16, 2020	July 29, 2026	Class A Common Stock		851,063	$	0.10	$	25	$	8	(17)

Hologram, Inc.	Warrant	January 31, 2020	January 27, 2030	Common Stock		193,054	$	0.26	$	49	$	136

Presto Automation, Inc.	Warrant	January 16, 2020	April 28, 2027	Preferred Series A		402,679	$	0.37	$	185	$	—	(7)(17)
	Warrant	January 16, 2020	July 28, 2027	Common Stock		170,993	$	5.85		28		—	(7)
Total Presto Automation, Inc.										213		—

Sortera Technologies, Inc.	Warrant	February 11, 2025	February 11, 2035	Common Stock		52,201	$	5.23	$	392	$	368	(19)

Sub-Total: Artificial Intelligence & Automation (0.1%)*									$	726	$	513

Biotechnology

Pendulum Therapeutics, Inc.	Warrant	January 16, 2020	October 9, 2029	Preferred Series B		55,263	$	1.90	$	43	$	49	(17)
	Warrant	June 1, 2020	July 15, 2030	Preferred Series B		36,842	$	1.90		36		33	(17)
	Warrant	December 31, 2021	December 31, 2031	Preferred Series C		322,251	$	3.24		118		216	(17)
	Warrant	February 5, 2024	February 5, 2034	Common Stock		1,143,690	$	1.03		588		1,248
Total Pendulum Therapeutics, Inc.										785		1,546

Sub-Total: Biotechnology (0.2%)*									$	785	$	1,546

Connectivity
Tarana Wireless, Inc.	Warrant	June 30, 2021	June 30, 2031	Common Stock		5,027,629	$	0.19	$	967	$	2,698
	Warrant	September 23, 2024	September 23, 2034	Common Stock		2,094,922	$	0.51		695		760	(9)(19)
Total Tarana Wireless, Inc.										1,662		3,458

Vertical Communications, Inc.	Warrant	January 16, 2020	July 11, 2026	Preferred Series A		828,479	$	1.00	$	—	$	—	(11)(17)(22)

viaPhoton, Inc.	Warrant	March 31, 2022	March 31, 2032	Common Stock		15,839	$	0.60	$	22	$	15

Sub-Total: Connectivity (0.4%)*									$	1,684	$	3,473

Construction Technology
Project Frog, Inc.	Warrant	January 16, 2020	February 28, 2027	Preferred Series AA-1		211,649	$	0.19	$	9	$	—	(17)(22)
	Warrant	January 16, 2020	February 28, 2027	Common Stock		180,340	$	0.19		9		—	(22)
	Warrant	August 3, 2021	December 31, 2031	Preferred Series CC		250,000	$	0.01		20		—	(17)(22)
Total Project Frog, Inc.										38		—

Sub-total: Construction Technology (0.0%)*									$	38	$	—


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Expiration Date	Series	Shares		Strike Price		Cost		Fair Value (6)		Footnotes
Warrant Investments- United States, Continued

Consumer Products & Services
BaubleBar, Inc.	Warrant	January 16, 2020	March 29, 2027	Preferred Series C		531,806	$	1.96	$	638	$	6	(17)
	Warrant	January 16, 2020	April 20, 2028	Preferred Series C		60,000	$	1.96		72		1	(17)
Total BaubleBar, Inc.										710		7

Boosted eCommerce, Inc.	Warrant	December 14, 2020	December 14, 2030	Preferred Series A-1		759,263	$	0.84	$	259	$	—	(17)

Eterneva, Inc.	Warrant	September 30, 2024	September 30, 2034	Common Stock		833,333	$	0.48	$	421	$	383

Happiest Baby, Inc.	Warrant	January 16, 2020	May 16, 2029	Common Stock		182,554	$	0.33	$	193	$	8

Madison Reed, Inc.	Warrant	January 16, 2020	March 23, 2027	Preferred Series C		194,553	$	2.57	$	185	$	231	(17)
	Warrant	January 16, 2020	July 18, 2028	Common Stock		43,158	$	0.99		71		80
	Warrant	January 16, 2020	June 30, 2029	Common Stock		36,585	$	1.23		56		64
Total Madison Reed, Inc.										312		375

Ogee, Inc.	Warrant	February 14, 2023	February 14, 2033	Preferred Series A-3		243,668	$	0.68	$	54	$	213	(17)(19)
	Warrant	September 29, 2023	February 14, 2033	Preferred Series A-3		243,668	$	0.68		49		213	(17)(19)
	Warrant	August 1, 2024	August 1, 2034	Preferred Series A-3		243,668	$	0.68		104		213	(17)(19)
Total Ogee, Inc.										207		639

Portofino Labs, Inc.	Warrant	December 31, 2020	December 31, 2030	Common Stock		99,148	$	1.53	$	160	$	51
	Warrant	April 1, 2021	April 1, 2031	Common Stock		39,912	$	1.46		99		22
Total Portofino Labs, Inc.										259		73

Quip NYC, Inc.	Warrant	March 9, 2021	March 9, 2031	Common Stock		10,833	$	48.46	$	203	$	—

Rinse, Inc.	Warrant	May 10, 2022	May 10, 2032	Preferred Series C		278,761	$	1.13	$	118	$	459	(17)

SI Tickets, Inc.	Warrant	May 11, 2022	May 11, 2032	Common Stock		53,029	$	2.52	$	162	$	4

Super73, Inc.	Warrant	December 31, 2020	December 31, 2030	Common Stock		177,305	$	3.16	$	105	$	49

Trendly, Inc.	Warrant	January 16, 2020	August 10, 2026	Preferred Series A		245,506	$	1.14	$	222	$	21	(17)

VitaCup, Inc.	Warrant	June 23, 2021	June 23, 2031	Preferred Series C		68,996	$	2.79	$	9	$	—	(17)
	Warrant	November 22, 2023	November 22, 2033	Common Stock		51,225	$	0.41		—		—
Total VitaCup, Inc.										9		—

Whoop, Inc.	Warrant	May 17, 2023	May 17, 2033	Common Stock		2,393,845	$	0.43	$	1,099	$	2,702	(9)(19)

Sub-total: Consumer Products & Services (0.6%)*									$	4,279	$	4,720

Education Technology
Edblox, Inc.	Warrant	March 19, 2024	March 19, 2034	Common Stock		111,458	$	1.71	$	152	$	5	(9)

Medical Sales Training Holding Company	Warrant	March 18, 2021	March 18, 2031	Common Stock		130,853	$	7.74	$	108	$	—
	Warrant	April 17, 2024	April 17, 2034	Common Stock		32,493	$	7.74		73		—
	Warrant	December 18, 2024	December 18, 2034	Common Stock		21,444	$	7.74		4		—
Total Medical Sales Training Holding Company										185		—

Yellowbrick Learning, Inc.	Warrant	January 16, 2020	September 30, 2028	Common Stock		222,222	$	0.90	$	120	$	1

Sub-Total: Education Technology (0.0%)*									$	457	$	6


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Expiration Date	Series	Shares		Strike Price		Cost		Fair Value (6)		Footnotes
Warrant Investments- United States, Continued

Finance and Insurance
Beam Technologies, Inc.	Warrant	August 30, 2024	August 30, 2034	Common Stock		47,479	$	17.28	$	631	$	540	(9)(19)

Bestow, Inc.	Warrant	August 1, 2024	August 1, 2034	Preferred Series C-2		349,793	$	0.01	$	1,987	$	1,956	(17)

Busbot, Inc.	Warrant	April 1, 2024	April 1, 2034	Common Stock		44,133	$	0.96	$	85	$	25	(10)(12)

Centivo Corporation	Warrant	July 31, 2024	July 31, 2034	Common Stock		80,578	$	0.76	$	67	$	162	(9)(19)
	Warrant	December 20, 2024	July 31, 2034	Common Stock		80,577	$	0.76		189		162	(9)(19)
	Warrant	February 3, 2025	July 31, 2034	Common Stock		80,578	$	0.76		164		162	(9)(19)
Total Centivo Corporation										420		486

DailyPay, Inc.	Warrant	September 30, 2020	September 30, 2030	Common Stock		89,264	$	3.00	$	151	$	1,604

Empower Financial, Inc.	Warrant	October 13, 2023	October 13, 2033	Common Stock		404,893	$	1.43	$	953	$	1,601	(9)(19)

Eqis Capital Management, Inc.	Warrant	June 15, 2022	June 15, 2032	Preferred Class B		904,000	$	0.01	$	10	$	73	(17)

Gravie, Inc.	Warrant	June 4, 2024	June 4, 2034	Common Stock		123,816	$	2.68	$	293	$	82	(9)(19)

Kafene, Inc.	Warrant	January 5, 2024	January 5, 2034	Common Stock		44,448	$	4.03	$	58	$	549

Mesa Financial, Inc.	Warrant	August 29, 2024	August 29, 2034	Common Stock		62,422	$	0.73	$	28	$	28	(10)(12)

Parafin, Inc.	Warrant	February 16, 2024	February 16, 2034	Common Stock		24,616	$	7.09	$	118	$	328	(10)(12)
	Warrant	July 25, 2024	July 25, 2034	Common Stock		24,641	$	7.09		108		328	(10)(12)
	Warrant	December 23, 2024	December 23, 2034	Common Stock		3,657	$	11.14		49		43	(10)(12)
Total Parafin, Inc.										275		699

PatientFi, Inc.	Warrant	March 14, 2025	March 14, 2035	Preferred Series B		100,586	$	3.10	$	139	$	139	(17)(19)

RealtyMogul, Co.	Warrant	January 16, 2020	December 18, 2027	Preferred Series B		954,979	$	0.95	$	285	$	1,408	(17)

Slope Tech, Inc.	Warrant	September 14, 2022	September 14, 2032	Common Stock		90,971	$	0.88	$	109	$	439	(10)(12)
	Warrant	August 30, 2023	August 30, 2033	Common Stock		21,303	$	0.88		112		103	(10)(12)
Total Slope Tech, Inc.										221		542

Under Technologies, Inc.	Warrant	May 3, 2024	May 3, 2034	Common Stock		76,133	$	2.90	$	210	$	179	(9)(19)

Wisetack, Inc.	Warrant	November 14, 2024	November 14, 2034	Common Stock		111,153	$	1.58	$	102	$	120	(9)(19)

Sub-Total: Finance and Insurance (1.2%)*									$	5,848	$	10,031


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Expiration Date	Series	Shares		Strike Price		Cost		Fair Value (6)		Footnotes
Warrant Investments- United States, Continued

Food and Agriculture Technologies
Athletic Brewing Company, LLC	Warrant	October 28, 2022	October 28, 2032	Preferred Class B		3,741	$	140.21	$	287	$	457	(17)

Bowery Farming, Inc.	Warrant	January 16, 2020	June 10, 2029	Common Stock		68,863	$	5.08	$	410	$	—
	Warrant	December 22, 2020	December 22, 2030	Common Stock		29,925	$	6.24		160		—
	Warrant	September 10, 2021	September 10, 2028	Common Stock		21,577	$	0.01		617		—
	Warrant	December 29, 2023	December 29, 2030	Common Stock		114,725	$	0.01		29		—
Total Bowery Farming, Inc.										1,216		—

Daring Foods, Inc.	Warrant	April 8, 2021	April 8, 2031	Common Stock		68,100	$	0.27	$	106	$	55

DrinkPak, LLC	Warrant	September 13, 2022	September 13, 2032	Common Stock		2,387	$	19.12	$	7	$	48	(9)
	Warrant	February 17, 2023	February 17, 2033	Common Stock		12,010	$	18.89		26		244	(9)(19)
Total DrinkPak, LLC										33		292

Emergy, Inc.	Warrant	October 5, 2022	October 5, 2032	Common Stock		4,051	$	39.60	$	181	$	—	(9)

GrubMarket, Inc.	Warrant	June 15, 2020	June 15, 2030	Common Stock		405,000	$	1.10	$	115	$	7,452

Intelligent Brands, Inc. (f.k.a. PSB Holdings, Inc.)	Warrant	January 16, 2020	October 5, 2027	Common Stock		103,636	$	21.42	$	111	$	—
	Warrant	December 31, 2020	December 29, 2032	Common Stock		33,348	$	3.17		546		—
Total Intelligent Brands, Inc.										657		—

The Fynder Group, Inc.	Warrant	October 14, 2020	October 14, 2030	Common Stock		36,445	$	0.49	$	68	$	21

Zero Acre Farms, Inc.	Warrant	December 23, 2022	December 23, 2032	Class A Common Stock		20,181	$	2.13	$	79	$	3	(17)

Sub-Total: Food and Agriculture Technologies (1.0%)*									$	2,742	$	8,280


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Expiration Date	Series	Shares		Strike Price		Cost		Fair Value (6)		Footnotes
Warrant Investments- United States, Continued

Green Technology
Bolb, Inc.	Warrant	October 12, 2021	October 12, 2031	Common Stock		181,784	$	0.07	$	36	$	—

Edeniq, Inc.	Warrant	January 16, 2020	December 23, 2026	Preferred Series B		2,685,501	$	0.22	$	—	$	528	(11)(17)(21)
	Warrant	January 16, 2020	December 23, 2026	Preferred Series B		2,184,672	$	0.01		—		881	(11)(17)(21)
	Warrant	January 16, 2020	June 29, 2027	Preferred Series C		5,106,972	$	0.44		—		176	(11)(17)(21)
	Warrant	January 16, 2020	November 2, 2028	Preferred Series C		3,850,294	$	0.01		—		1,745	(11)(17)(21)
	Warrant	November 29, 2021	November 29, 2031	Preferred Series D		154,906,320	$	0.01		7		5,325	(17)(21)
Total Edeniq, Inc.										7		8,655

Footprint International Holding, Inc.	Warrant	February 14, 2020	February 14, 2030	Common Stock		38,171	$	0.31	$	9	$	—
	Warrant	February 18, 2022	February 18, 2032	Common Stock		77,524	$	0.01		4,246		—
	Warrant	June 23, 2022	June 23, 2032	Common Stock		14,624	$	0.01		359		—
	Warrant	October 31, 2024	October 31, 2034	Preferred Class F		250	$	25,000.00		—		—	(17)
Total Footprint International Holding, Inc.										4,614		—

Form Energy Inc.	Warrant	October 21, 2024	October 21, 2034	Common Stock		85,556	$	8.03	$	796	$	752	(9)(19)

Mainspring Energy, Inc.	Warrant	January 16, 2020	July 9, 2029	Common Stock		140,186	$	1.15	$	283	$	230
	Warrant	November 20, 2020	November 20, 2030	Common Stock		81,294	$	1.15		226		133
	Warrant	March 18, 2022	March 18, 2032	Common Stock		137,692	$	1.66		344		215
Total Mainspring Energy, Inc.										853		578

RTS Holding, Inc.	Warrant	December 10, 2021	December 10, 2031	Preferred Series C		2,314	$	205.28	$	75	$	68	(9)(17)
	Warrant	October 10, 2022	October 10, 2032	Preferred Series D		917	$	196.50		87		31	(9)(17)
	Warrant	January 19, 2024	January 19, 2034	Preferred Series D-1		2,876	$	203.47		418		97	(9)(17)
Total RTS Holding, Inc.										580		196

Sub-Total: Green Technology (1.2%)*									$	6,886	$	10,181

Healthcare Technology
Dentologie Enterprises, Inc.	Warrant	October 14, 2022	October 14, 2034	Common Stock		51,632	$	0.76	$	66	$	151	(9)

Exer Holdings, LLC	Warrant	November 19, 2021	November 19, 2031	Common Stock		281	$	527.51	$	93	$	11

Hospitalists Now, Inc.	Warrant	January 16, 2020	March 30, 2026	Preferred Series D-2		135,807	$	5.89	$	71	$	25	(17)
	Warrant	January 16, 2020	December 6, 2026	Preferred Series D-2		750,000	$	5.89		391		137	(17)
Total Hospitalists Now, Inc.										462		162

Lark Technologies, Inc.	Warrant	September 30, 2020	September 30, 2030	Common Stock		76,231	$	1.76	$	177	$	4
	Warrant	June 30, 2021	June 30, 2031	Common Stock		79,325	$	1.76		258		4
	Warrant	December 22, 2022	December 22, 2032	Common Stock		97,970	$	2.49		58		4
Total Lark Technologies, Inc.										493		12

Moxe Health Corporation	Warrant	December 29, 2023	December 29, 2033	Preferred Series B		155,438	$	3.62	$	135	$	54	(17)

RXAnte, Inc.	Warrant	November 21, 2022	November 21, 2032	Preferred A		16,517	$	10.00	$	89	$	131	(9)(17)(19)
	Warrant	April 7, 2023	November 21, 2032	Preferred A		5,518	$	10.00		25		44	(9)(17)(19)
	Warrant	October 17, 2023	November 21, 2032	Preferred A		5,506	$	10.00		37		44	(9)(17)(19)
Total RXAnte, Inc.										151		219

TMRW Life Sciences, Inc.	Warrant	April 29, 2022	April 29, 2032	Preferred Class A		268,983	$	2.09	$	80	$	5	(17)
	Warrant	March 3, 2023	April 29, 2032	Preferred Class A		268,983	$	2.09		80		5	(17)
Total TMRW Life Sciences, Inc.										160		10

Sub-Total: Healthcare Technology (0.1%)*									$	1,560	$	619


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Expiration Date	Series	Shares		Strike Price		Cost		Fair Value (6)		Footnotes
Warrant Investments- United States, Continued

Human Resource Technology
BetterLeap, Inc.	Warrant	April 20, 2022	April 20, 2032	Common Stock		88,435	$	2.26	$	38	$	3

Qwick, Inc.	Warrant	December 31, 2021	December 31, 2031	Common Stock		16,964	$	2.79	$	48	$	—
	Warrant	August 8, 2022	August 8, 2032	Common Stock		16,964	$	2.79		48		—
Total Qwick, Inc.										96		—

Sub-Total: Human Resource Technology (0.0%)*									$	134	$	3

Industrials
3DEO, Inc.	Warrant	February 23, 2022	February 23, 2032	Common Stock		37,218	$	1.81	$	93	$	—

Sub-total: Industrials (0.0%)*									$	93	$	—

Marketing, Media, and Entertainment
Drone Racing League, Inc.	Warrant	October 17, 2022	October 17, 2032	Common Stock		253,824	$	6.76	$	375	$	—

Firefly Systems, Inc.	Warrant	January 29, 2020	January 29, 2030	Common Stock		133,147	$	1.14	$	281	$	154

Grabit Interactive Media, Inc.	Warrant	April 8, 2022	April 8, 2034	Preferred Series A		142,828	$	1.00	$	40	$	29	(17)

Incontext Solutions, Inc.	Warrant	January 16, 2020	September 28, 2028	Common Stock		2,219	$	220.82	$	34	$	—

PebblePost, Inc.	Warrant	May 7, 2021	May 7, 2031	Common Stock		657,343	$	0.52	$	68	$	687

Sub-Total: Marketing, Media, and Entertainment (0.1%)*									$	798	$	870

Medical Devices
Apiject Holdings, Inc.	Warrant	June 24, 2024	June 24, 2034	Common Stock		937,604	$	0.99	$	612	$	532	(9)(19)

Convergent Dental, Inc.	Warrant	April 21, 2023	April 21, 2033	Preferred Series D		446,982	$	1.61	$	493	$	130	(9)(17)

Delphinus, Inc.	Warrant	June 27, 2023	June 27, 2033	Preferred Series E		294,288	$	0.69	$	29	$	13	(9)(17)

Elucent Medical, Inc.	Warrant	October 31, 2024	October 31, 2034	Preferred Series C-2		1,628,141	$	0.30	$	144	$	297	(9)(17)(19)

Lightforce Orthodontics, Inc.	Warrant	August 6, 2024	August 6, 2034	Preferred Series D		62,627	$	18.01	$	249	$	187	(17)(19)
	Warrant	September 25, 2024	August 6, 2034	Preferred Series D		10,438	$	18.01		37		31	(17)(19)
Total Lightforce Orthodontics, Inc.										286		218

Neuros Medical, Inc.	Warrant	August 10, 2023	August 10, 2033	Preferred Series C		798,085	$	0.38	$	71	$	67	(9)(17)
	Warrant	August 30, 2024	August 10, 2033	Preferred Series C		399,042	$	0.38		39		34	(9)(17)
Total Neuros Medical, Inc.										110		101

Restor3d, Inc.	Warrant	June 4, 2024	June 4, 2034	Preferred Series A Preferred		95,688	$	5.01	$	51	$	95	(9)(17)(19)

Shoulder Innovations, Inc.	Warrant	August 7, 2023	August 7, 2033	Preferred Series D		623,615	$	0.54	$	120	$	138	(9)(17)

Sub-Total: Medical Devices (0.2%)*									$	1,845	$	1,524

Other Healthcare Services
Cellares Corporation	Warrant	August 2, 2024	August 2, 2034	Common Stock		243,868	$	4.77	$	841	$	840	(19)

Upward Health, Inc.	Warrant	August 6, 2024	August 6, 2034	Preferred Class A Common Stock		763,137	$	0.28	$	251	$	341	(9)(17)(19)

Metabolon, Inc.	Warrant	March 28, 2024	March 28, 2034	Preferred Series 3		2,288,461	$	0.65	$	644	$	264	(17)
	Warrant	October 1, 2024	March 28, 2034	Preferred Series 3		384,615	$	0.65		33		44	(17)
	Warrant	January 6, 2025	March 28, 2034	Preferred Series 3		192,308	$	0.65		23		22	(17)
Total Metabolon, Inc.										700		330

Velentium, Inc.	Warrant	May 24, 2024	May 24, 2034	Preferred Class B		7,958	$	53.40	$	129	$	128	(9)(17)

Sub-Total: Other Healthcare Services (0.2%)*									$	1,921	$	1,639


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Expiration Date	Series	Shares		Strike Price		Cost		Fair Value (6)		Footnotes
Warrant Investments- United States, Continued

Real Estate Technology
Homelight Lending, Inc.	Warrant	June 23, 2022	June 23, 2032	Common Stock		5,434	$	18.40	$	1	$	15

Knockaway, Inc.	Warrant	January 16, 2020	May 24, 2029	Common Stock		880	$	85.27	$	208	$	—	(22)
	Warrant	November 10, 2021	November 10, 2031	Common Stock		16,350	$	2.20		265		—	(22)
	Warrant	September 29, 2023	September 29, 2033	Common Stock		2,804,355	$	0.01		—		1	(22)
	Warrant	December 6, 2023	December 6, 2033	Preferred Series AA		457,778	$	0.01		—		1	(12)(17)(22)
	Warrant	September 16, 2024	September 16, 2034	Preferred Series BB		93,951,849	$	0.00		2,391		851	(17)(22)
	Warrant	September 27, 2023	September 27, 2033	Preferred Series AA-1		5,084,804	$	0.09		—		—	(17)(21)
Total Knockaway, Inc.										2,864		853

Maxwell Financial Labs, Inc.	Warrant	October 8, 2020	October 8, 2030	Common Stock		106,735	$	0.29	$	21	$	8
	Warrant	December 22, 2020	December 22, 2030	Common Stock		110,860	$	0.29		34		9
	Warrant	September 30, 2021	September 30, 2031	Common Stock		79,135	$	1.04		148		4
	Warrant	May 10, 2024	May 10, 2034	Common Stock		303,562	$	0.27		83		24
	Warrant	July 1, 2024	May 10, 2034	Common Stock		303,562	$	0.27		91		24
Total Maxwell Financial Labs, Inc.										377		69

Orchard Technologies, Inc.	Warrant	February 12, 2024	February 12, 2034	Preferred Series 1		228,000	$	0.01	$	—	$	119	(17)
	Warrant	February 12, 2025	February 12, 2034	Preferred Series 1		228,000	$	0.01		126		119	(17)
Total Orchard Technologies, Inc.										126		238

Sub-Total: Real Estate Technology (0.1%)*									$	3,368	$	1,175

SaaS
All Seated, Inc.	Warrant	February 28, 2022	February 28, 2032	Common Stock		5,101	$	15.72	$	20	$	—

Cart.com, Inc.	Warrant	November 17, 2023	November 17, 2033	Common Stock		31,572	$	15.87	$	441	$	636	(9)

Cpacket Networks, Inc.	Warrant	January 29, 2024	January 29, 2034	Class B Common		499,366	$	0.36	$	166	$	104	(9)(17)

Crowdtap, Inc.	Warrant	January 16, 2020	December 16, 2025	Preferred Series B		442,233	$	1.09	$	42	$	790	(17)
	Warrant	January 16, 2020	December 11, 2027	Preferred Series B		100,000	$	1.09		9		179	(17)
Total Crowdtap, Inc.										51		969

Gtxcel, Inc.	Warrant	January 16, 2020	September 24, 2025	Preferred Series C		1,000,000	$	0.21	$	83	$	5	(17)
	Warrant	January 16, 2020	September 24, 2025	Preferred Series D		1,000,000	$	0.21		83		11	(17)
Total Gtxcel, Inc.										166		16

Lucidworks, Inc.	Warrant	January 16, 2020	June 27, 2026	Preferred Series D		619,435	$	0.77	$	806	$	620	(17)

Reciprocity, Inc.	Warrant	September 25, 2020	September 25, 2030	Common Stock		114,678	$	4.17	$	99	$	—
	Warrant	April 29, 2021	April 29, 2031	Common Stock		57,195	$	4.17		54		—
Total Reciprocity, Inc.										153		—

Silk Technologies, Inc.	Warrant	November 4, 2024	November 4, 2034	Common Stock		204,760	$	1.98	$	433	$	304	(9)(19)

Smartly, Inc.	Warrant	May 16, 2022	May 16, 2034	Common Stock		48,097	$	1.10	$	84	$	97

Steno Agency, Inc.	Warrant	June 21, 2024	June 21, 2034	Common Stock		55,818	$	1.98	$	136	$	145	(9)(19)

The Tomorrow Companies, Inc.	Warrant	December 14, 2022	December 14, 2032	Common Stock		26,124	$	1.70	$	49	$	17	(9)

Sub-Total: SaaS (0.3%)*									$	2,505	$	2,908


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Expiration Date	Series	Shares		Strike Price		Cost		Fair Value (6)		Footnotes
Warrant Investments- United States, Continued

Space Technology
Astranis Space Technology Corporation	Warrant	April 13, 2023	April 13, 2033	Common Stock		85,644	$	7.89	$	83	$	253	(9)(19)
	Warrant	September 27, 2024	September 27, 2034	Common Stock		156,677	$	2.27		683		643	(9)(19)
Total Astranis Space Technology Corporation										766		896

Axiom Space, Inc.	Warrant	May 28, 2021	May 28, 2031	Common Stock		1,773	$	169.24	$	121	$	14
	Warrant	May 28, 2021	May 28, 2031	Common Stock		882	$	340.11		39		2
Total Axiom Space, Inc.										160		16

Hermeus Corporation	Warrant	August 9, 2022	August 9, 2032	Common Stock		19,286	$	6.24	$	144	$	96	(9)(19)

Impulse Space, Inc.	Warrant	June 18, 2024	June 18, 2034	Common Stock		60,554	$	1.91	$	244	$	498	(9)(19)

Slingshot Aerospace, Inc.	Warrant	July 12, 2024	July 12, 2034	Common Stock		328,416	$	0.46	$	400	$	304	(9)(19)

Kymeta Corporation	Warrant	July 3, 2024	July 3, 2034	Common Stock		3,995,407	$	0.11	$	331	$	458	(9)(19)

Space Perspective, Inc.	Warrant	March 3, 2022	March 3, 2032	Preferred Series A		221,280	$	2.75	$	256	$	—	(17)

Sub-Total: Space Technology (0.3%)*									$	2,301	$	2,268

Supply Chain Technology
Macrofab, Inc.	Warrant	January 14, 2025	July 21, 2035	Common Stock		311,176	$	0.01	$	166	$	2
	Warrant	January 14, 2025	January 29, 2034	Preferred C-1 Preferred		392,157	$	0.01		254		75	(17)
	Warrant	January 14, 2025	April 11, 2036	Common Stock		161,006	$	0.01		64		1
	Warrant	January 14, 2025	July 21, 2035	Preferred C-1 Preferred		311,177	$	0.01		166		59	(17)
	Warrant	January 14, 2025	April 11, 2036	Preferred C-1 Preferred		161,007	$	0.01		64		31	(17)
	Warrant	January 14, 2025	January 14, 2035	Preferred C-1 Preferred		247,173	$	0.01		151		47	(17)
Total Macrofab, Inc.										865		215

Nucleus RadioPharma, Inc.	Warrant	June 4, 2024	June 4, 2034	Common Stock		43,636	$	1.99	$	69	$	42	(9)

Sub-Total: Supply Chain Technology (0.0%)*									$	934	$	257

Transportation Technology
Get Spiffy, Inc.	Warrant	July 14, 2023	July 14, 2033	Common Stock		874,527	$	0.70	$	408	$	—	(9)

NextCar Holding Company, Inc.	Warrant	December 14, 2021	December 14, 2026	Class A Common		6,211	$	64.42	$	35	$	—	(13)
	Warrant	February 23, 2022	February 23, 2027	Class A Common		486	$	64.42		3		—	(13)
	Warrant	March 16, 2022	March 16, 2027	Class A Common		583	$	64.42		3		—	(13)
	Warrant	April 18, 2022	April 18, 2027	Class A Common		5,336	$	64.42		7		—	(13)
	Warrant	September 29, 2022	September 29, 2027	Preferred Stock		1,224,752	$	0.22		170		—	(13)(17)
Total NextCar Holding Company, Inc.										218		—

Uveye, Inc.	Warrant	December 26, 2024	December 26, 2034	Preferred Ordinary		476,031	$	4.38	$	539	$	417	(17)

Zuum Transportation, Inc.	Warrant	April 30, 2024	April 30, 2034	Common Stock		41,271	$	4.34	$	95	$	61

Sub-Total: Transportation Technology (0.1%)*									$	1,260	$	478

Total: Warrant Investments- United States (6.1%)*									$	40,164	$	50,491


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Expiration Date	Series	Shares		Strike Price		Cost		Fair Value (6)		Footnotes
Warrant Investments- Europe

Industrials
Aledia, Inc.	Warrant	March 31, 2022	March 31, 2032	Ordinary		11,771	€	149.02	$	130	$	438	(10)(17)

Sub-Total: Industrials (0.1%)*									$	130	$	438

Medical Devices
CMR Surgical Limited	Warrant	March 24, 2025	March 24, 2030	Preferred Ordinary		7,680	€	0.01	$	124	$	94	(10)(17)(19)

Sub-Total: Industrials (0.0%)*									$	124	$	94

Other Healthcare Services
Zandivio PLC	Warrant	October 29, 2024	October 29, 2034	Common Stock		132,042	€	0.01	$	771	$	752	(10)(19)

Sub-Total: Other Healthcare Services (0.1%)*									$	771	$	752

Space Technology
All.Space Networks, Limited.	Warrant	August 19, 2022	August 19, 2032	Common Stock		71,203	$	21.79	$	113	$	—	(10)
	Warrant	August 22, 2024	August 22, 2034	Common Stock		20,769	$	8.90		1		1	(10)
Total All.Space Networks, Limited.										114		1

Sub-Total: Space Technology (0.0%)*									$	114	$	1

Total: Warrant Investments- Europe (0.2%)*									$	1,139	$	1,285

Total: Warrant Investments- (6.2%)*									$	41,303	$	51,776


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Shares / Principal		Series	Cost		Fair Value (6)		Footnotes
Equity Investments- United States

Artificial Intelligence & Automation
Cabernet AI, Inc.	Equity	February 27, 2025	$	500	SAFE Note	$	500	$	500

Sub-Total: Artificial Intelligence & Automation (0.1%)*						$	500	$	500

Connectivity
Tarana Wireless, Inc.	Equity	March 16, 2022		611,246	Preferred Series 6	$	500	$	559	(17)

Vertical Communications, Inc.	Equity	January 16, 2020		3,892,485	Preferred Series 1	$	—	$	—	(11)(17)(22)
	Equity	January 16, 2020	$	5,500	Convertible Note		3,966		284	(16)(21)
Total Vertical Communications, Inc.							3,966		284

viaPhoton Inc.	Equity	May 23, 2024	$	740	SAFE Note	$	370	$	370

Sub-Total: Connectivity (0.1%)*						$	4,836	$	1,213

Construction Technology
Project Frog, Inc.	Equity	January 16, 2020		4,383,497	Preferred Series AA-1	$	351	$	—	(17)(22)
	Equity	January 16, 2020		3,401,678	Preferred Series BB		1,333		—	(17)(22)
	Equity	August 3, 2021		6,633,486	Common Stock		1,684		—	(22)
	Equity	August 3, 2021		3,129,887	Preferred Series CC		1,253		—	(17)(22)
Total Project Frog, Inc.							4,621		—

Sub-Total: Construction Technology (0.0%)*						$	4,621	$	-

Consumer Products & Services
Portofino Labs, Inc.	Equity	November 1, 2021		256,291	Preferred Series B-1	$	500	$	468	(17)

Quip NYC, Inc.	Equity	August 17, 2021		3,321	Common Stock	$	500	$	—

Rinse, Inc.	Equity	December 30, 2024		290,242	Preferred Series D	$	500	$	496	(17)

Sub-Total: Consumer Products & Services (0.1%)*						$	1,500	$	964

Finance and Insurance
Busbot, Inc.	Equity	October 18, 2024		539,490	Preferred Series B-1	$	500	$	494.000	(10)(12)(17)

Centivo Corporation	Equity	December 20, 2024		128,393	Preferred Series B-1	$	375	$	338.000	(9)(17)(19)

Dynamics, Inc.	Equity	January 16, 2020		17,726	Preferred Series A	$	390	$	—	(17)

Empower Financial, Inc.	Equity	May 15, 2024		2,810,235	Preferred Series C	$	20,000	$	21,203	(17)
	Equity	May 15, 2024		300,285	Common Stock		4,023		1,486
Total Empower Financial, Inc.							24,023		22,689

Openly Holdings Corp.	Equity	May 9, 2023		44,725	Preferred Series D-1	$	500	$	539	(17)

Slope Tech, Inc.	Equity	June 20, 2023		64,654	Preferred Series A-3	$	500	$	510	(10)(12)(17)

Sub-Total: Finance and Insurance (2.9%)*						$	26,288	$	24,570

Food and Agriculture Technologies
Emergy, Inc.	Equity	June 28, 2021		7,595	Common Stock	$	500	$	—

Athletic Brewing Company, LLC	Equity	August 1, 2024		1,214	Class B	$	283	$	279	(9)(17)(19)

Sub-Total: Food and Agriculture Technologies (0.0%)*						$	783	$	279


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Shares / Principal		Series	Cost		Fair Value (6)		Footnotes
Equity Investments- United States, Continued

Green Technology
Crusoe Energy Systems LLC	Equity	November 6, 2024		11,140	Preferred Series D-1	$	325	$	328	(9)(17)(19)

Edeniq, Inc.	Equity	January 16, 2020		7,807,499	Preferred Series B	$	—	$	3,224	(11)(17)(22)
	Equity	January 16, 2020		3,657,487	Preferred Series C		—		1,693	(11)(17)(22)
	Equity	January 16, 2020		133,766,138	Preferred Series D		—		6,273	(11)(17)(21)
Total Edeniq, Inc.							—		11,190

Electric Hydrogen Co.	Equity	April 6, 2023		87,112	Preferred Series C	$	500	$	312	(17)

Mainspring Energy, Inc.	Equity	March 30, 2022		65,614	Preferred Series E-1	$	500	$	216	(17)

RTS Holding, Inc.	Equity	July 5, 2022		2,035	Preferred Series E-1D	$	334	$	375	(9)(17)
	Equity	February 15, 2023		1,966	Preferred Series E-1D1		405		373	(9)(17)
	Equity	February 7, 2025		2,054	Preferred Series E-1		328		320	(9)(17)
Total RTS Holding, Inc.							1,067		1,068

Sub-Total: Green Technology (1.6%)*						$	2,392	$	13,114

Healthcare Technology
Dentologie Enterprises, Inc.	Equity	August 3, 2023		72,338	Preferred Series B-1	$	300	$	327	(9)(17)

Emerald Cloud Lab, Inc.	Equity	June 3, 2022		499,999	Preferred Series A	$	500	$	169	(17)
	Equity	April 29, 2024		617,890	Preferred Series B-1		129		114	(17)
Total Emerald Cloud Lab, Inc.							629		283

Lark Technologies, Inc.	Equity	August 19, 2021		32,416	Preferred Series D	$	500	$	69	(17)

WorkWell Prevention & Care Inc.	Equity	January 16, 2020		7,000,000	Common Stock	$	51	$	—	(22)
	Equity	January 16, 2020		3,450	Preferred Series P		3,450		—	(17)(22)
	Equity	January 16, 2020	$	3,170	Convertible Note		3,219		—	(16)(21)
Total WorkWell Prevention & Care Inc.							6,720		—

Sub-Total: Healthcare Technology (0.1%)*						$	8,149	$	679


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Shares / Principal		Series	Cost		Fair Value (6)		Footnotes
Equity Investments- United States, Continued

Human Resource Technology
Nomad Health, Inc.	Equity	May 27, 2022		37,920	Common Stock	$	500	$	—

Sub-Total: Human Resource Technology (0.0%)*						$	500	$	—

Industrials
Digilens, Inc.	Equity	July 29, 2023		21,730	Preferred Series A-1	$	13	$	24	(17)
	Equity	September 18, 2024		9,498	Preferred Series A-1		8		11	(17)
	Equity	January 12, 2024		12,205	Preferred Series A-1		7		14	(17)
	Equity	March 24, 2025		4,489	Preferred Series A-1		4		5	(17)
	Equity	October 10, 2023		6,332	Preferred Series A-1		4		7	(17)
	Equity	May 6, 2024		4,117	Preferred Series A-1		4		5	(17)
	Equity	June 9, 2024		2,617	Preferred Series A-1		2		3	(17)
	Equity	May 20, 2024		126,641	Preferred Series A-1		110		144	(17)
	Equity	March 26, 2025		73,873	Preferred Series A-1		65		84	(17)
Total Digilens, Inc.							217		297

Sub-Total: Industrials (0.0%)*						$	217	$	297

Multi-Sector Holdings
Senior Credit Corp 2022 LLC	Equity	January 30, 2023		—	Preferred	$	5,522	$	5,729	(10)(17)(22)

EPT 16 LLC	Equity	June 28, 2024		—	Preferred	$	9,215	$	9,615	(10)(17)(22)

Trinity Capital Adviser, LLC	Equity	June 28, 2024		—	Preferred	$	1	$	7,219	(17)(22)

Sub-Total: Multi-Sector Holdings (2.7%)*						$	14,738	$	22,563

Real Estate Technology
Knockaway, Inc.	Equity	March 30, 2022		30,458	Common Stock	$	500	$	—	(22)
	Equity	September 29, 2023		2,956,224	Preferred Series AA		250		6	(17)(22)
	Equity	September 16, 2024		97,866,510	Preferred Series BB		2,500		896	(17)(22)
	Equity	September 7, 2023		3,409,997	Preferred Series AA-1		—		2	(17)(22)
Total Knockaway Inc.							3,250		904

Orchard Technologies, Inc.	Equity	August 6, 2021		2,938	Preferred Series 2	$	30	$	—	(17)
	Equity	March 16, 2023		97,060	Preferred Series 1		971		50	(17)
	Equity	January 24, 2025		3,009	Preferred Series 1		1		2	(17)
	Equity	January 24, 2025		10,900	SAFE Note		5		5
Total Orchard Technologies, Inc.							1,007		57

Maxwell Financial Labs, Inc	Equity	January 22, 2021		84,998	Preferred Series B	$	313	$	39	(17)
	Equity	May 10, 2024		229,972	Preferred Series B-1		365		158	(17)
	Equity	October 2, 2024		32,839	Preferred Series B-2		121		99	(17)
	Equity	October 2, 2024		17,804	Common Stock		66		2
Total Maxwell Financial Labs, Inc							865		298

Sub-Total: Real Estate Technology (0.2%)*						$	5,122	$	1,259

SaaS
Cart.com, Inc.	Equity	April 17, 2024		11,533	Preferred Series C	$	500	$	533	(9)(17)

Smartly, Inc.	Equity	March 29, 2023		136,388	Preferred Series B	$	500	$	665	(17)

The Tomorrow Companies, Inc.	Equity	July 5, 2023		108,088	Preferred Series E-1	$	325	$	191	(9)(17)

Sub-total: SaaS (0.2%)*						$	1,325	$	1,389


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Shares / Principal		Series	Cost		Fair Value (6)		Footnotes
Equity Investments- United States, Continued

Space Technology
Astranis Space Technology Corporation	Equity	April 5, 2023		13,685	Series C Prime Preferred	$	300	$	130	(9)(17)
	Equity	March 19, 2024		64,223	Preferred Series D		600		573	(9)(17)
Total Astranis Space Technology Corporation							900		703

Axiom Space, Inc.	Equity	August 11, 2021		3,624	Preferred Series C-1	$	521	$	432	(17)

Hadrian Automation, Inc.	Equity	March 29, 2022		53,154	Preferred A-4	$	500	$	441	(17)
	Equity	December 11, 2023		31,831	Preferred B-1		300		265	(9)(17)
Total Hadrian Automation, Inc.							800		706

Impulse Space, Inc.	Equity	August 30, 2024		23,240	Preferred Series B	$	325	$	316	(9)(17)(19)

Sub-total: Space Technology (0.3%)*						$	2,546	$	2,157

Supply Chain Technology
Macrofab, Inc.	Equity	January 30, 2024		247,173	Preferred C-1 Preferred	$	500	$	66	(17)

Sub-total: Supply Chain Technology (0.0%)*						$	500	$	66

Transportation Technology
NextCar Holding Company, Inc.	Equity	April 18, 2023		2,688,971	Preferred Series A-6	$	—	$	—	(17)

Sub-total: Transportation Technology (0.0%)*						$	—	$	—

Total: Equity Investments- United States (8.3%)*						$	74,017	$	69,050


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Shares / Principal		Series	Cost		Fair Value (6)		Footnotes
Equity Investments- Canada

Construction Technology
Nexii, Inc.	Equity	July 24, 2024		6,126	Preferred Series A-1	$	3,049	$	388	(10)(17)(22)
	Equity	July 24, 2024		50,000	Preferred Series A-1		1,370		3,168	(10)(17)(22)
Total Nexii, Inc.							4,419		3,556

Sub-Total: Construction Technology (0.4%)*						$	4,419	$	3,556

Supply Chain Technology
GoFor Delivers, Inc.	Equity	June 28, 2024		194,329	Series 2 Seed	$	660	$	1,202	(10)(22)

Sub-total: Supply Chain Technology (0.1%)*						$	660	$	1,202

Total: Equity Investments- Canada (0.6%)*						$	5,079	$	4,758

Total: Equity Investments (8.9%)*						$	79,096	$	73,808

Total Investment in Securities (215.1%)*						$	1,830,487	$	1,792,689

Cash and Cash Equivalents
Goldman Sachs Financial Square Government Institutional Fund						$	3,262	$	3,262
Other cash accounts							5,124		5,124
Cash and Cash Equivalents (1.0%)*							8,386		8,386

Total Portfolio Investments and Cash and Cash Equivalents (216.1%) of net assets)						$	1,838,873	$	1,801,075

* Value as a percent of net assets

(1)

All portfolio companies are located in North America or Europe. As of March 31, 2025, Trinity Capital Inc. (the "Company") had six foreign domiciled portfolio companies, two of which are based in Canada and four of which are based in Europe. In total, these foreign domiciled portfolio investments represent 9.5% of total net asset value based on fair value. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale and may be deemed to be “restricted securities” under the Securities Act.

(2)

All debt investments are income producing unless otherwise noted. All equity and warrant investments are non-income producing unless otherwise noted. Equipment financed under our equipment financing investments relates to operational equipment essential to revenue production for the portfolio company in the industry noted.

(3)

Investment date represents the date of initial investment date, either purchases or funding, not adjusted for modifications. For assets purchased from the Legacy Funds as part of the Formation Transactions (both terms as defined in "Note 1 – Organization and Basis of Presentation"), the investment date is January 16, 2020, the date of the Formation Transactions.

(4)

Interest rate is the fixed or variable rate of the debt investments and does not include any original issue discount, end-of-term (“EOT”) payment, or additional fees related to such investments, such as deferred interest, commitment fees, prepayment fees or exit fees. EOT payments are contractual payments due in cash at the maturity date of the loan, including upon prepayment, and are a fixed rate determined at the inception of the loan. At the end of the term of certain equipment financings, the borrower has the option to purchase the underlying assets at fair value, generally subject to a cap, or return the equipment and pay a restocking fee. The fair values of the financed assets have been estimated as a percentage of original cost for purpose of the EOT payment value. The EOT payment is amortized and recognized as non-cash income over the term of the loan or equipment financing prior to its payment and is included as a component of the cost basis of the Company’s current debt securities.

(5)

Principal is net of repayments, if any, as per the terms of the debt instrument’s contract.

(6)

Except as noted, all investments were valued at fair value as determined in good faith by the Company’s Board of Directors (the “Board”) using Level 3 inputs.

(7)

Asset is valued at fair value as determined in good faith by the Company's Board using Level 1 and Level 2 inputs.

(8)

The interest rate on variable interest rate investments represents a benchmark rate plus spread. The benchmark interest rate is subject to an interest rate floor. As of March 31, 2025, the U.S. Prime Rate (“Prime”) was 7.50% and the Secured Overnight Financing Rate (“SOFR”) 30 Day Forward Rate and 3-Month Term Rate were 4.32% and 4.28%, respectively.

(9)

Senior Credit Corp 2022 LLC owns an additional portion of this security. See “Note 12 – Related Party Transactions” for further discussion.

(10)

Indicates a “non-qualifying asset” under section 55(a) of the Investment Company Act of 1940, as amended (the “1940 Act”). The Company’s percentage of non-qualifying assets at fair value represents 16.1% of the Company’s total assets as of March 31, 2025. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets.

(11)

Investment has zero cost basis as it was purchased at a fair value of zero as part of the Formation Transactions (as defined in "Note 1 – Organization and Basis of Presentation").

(12)

Investment is a secured loan warehouse facility collateralized by interest in specific assets that meet the eligibility requirements under the facility during the warehouse period. Repayment of the facility will occur over the amortizing period unless otherwise prepaid.

(13)

Company has been issued warrants with pricing and number of shares dependent upon a future round of equity issuance by the portfolio company.

(14)

Investment is pledged as collateral supporting amounts outstanding under the Company's credit facility with KeyBank, National Association (the “KeyBank Credit Facility”). See “Note 5 – Borrowings” for more information.

(15)

Interest on this loan includes a payment-in-kind (“PIK”) provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally collected through amortization, is recorded on an accrual basis to the extent such amounts are expected to be collected.

(16)

Convertible notes represent investments through which the Company will participate in future equity rounds at preferential rates. There are no principal or interest payments made against the note unless conversion does not occur.

(17)

Preferred stock represents investments through which the Company will have preference in liquidation rights and do not contain any cumulative preferred dividends.

(18)

Investment is on non-accrual status as of March 31, 2025 and is therefore considered non-income producing.

(19)

EPT 16 LLC owns an additional portion of this security. See “Note 12 – Related Party Transactions” for further discussion.

(20)

Investment has an unfunded commitment as of March 31, 2025 (see “Note 6 – Commitments and Contingencies”). The fair value of the investment includes the impact of the fair value of any unfunded commitments.

(21)

Borrower is a wholly owned, special purpose vehicle subsidiary of named portfolio company.

(22)

This investment is deemed to be a “Control Investment” or an “Affiliate Investment.” The Company classifies its investment portfolio in accordance with the requirements of the 1940 Act. The 1940 Act defines Control Investments as investments in companies in which the Company owns beneficially, either directly or indirectly, more than 25% of the voting securities, or maintains greater than 50% of the board representation. Affiliate Investments are defined by the 1940 Act as investments in companies in which the Company owns beneficially, either directly or indirectly, between 5% and 25% (inclusive) of the voting securities and does not have rights to maintain greater than 50% of the board representation. Fair value as of March 31, 2025, along with transactions during the three months ended March 31, 2025 in these control and affiliate investments are as follows:


										Net change in
										Unrealized
	Fair Value at		Gross		Gross			Realized		(Depreciation)/			Fair Value at		Interest and
	December 31, 2024		Additions (1)		Reductions (2)			Gain/(Loss)		Appreciation			March 31, 2025		Dividend Income
For the Three Months Ended March 31, 2025
Control Investments
Edeniq, Inc.	$	18,105	$	—	$	—		$	—	$	1,742		$	19,847	$	—
Project Frog, Inc.		44		—		—			—		(44	)		—		—
Vertical Communications, Inc.		16,608		1,559		(13	)		—		(803	)		17,351		431
WorkWell Prevention and Care Inc.		500		—		—			—		—			500		15
Knockaway, Inc.		49,141		4,221		(5,000	)		—		(3,261	)		45,101		1,882
Trinity Capital Adviser, LLC		4,851		—		—			—		2,368			7,219		—
Total Control Investments	$	89,249	$	5,780	$	(5,013	)	$	—	$	2		$	90,018	$	2,328

Affiliate Investments
EPT 16 LLC	$	9,215	$	—	$	—		$	—	$	400		$	9,615	$	—
GoFor Delivers, Inc.		6,441		9		—			—		554			7,005		189
Nexii, Inc.		3,997		—		—			—		(67	)		3,930		9
Senior Credit Corp 2022 LLC		19,071		—		—			—		(457	)		18,614		1,074
Total Affiliate Investments	$	38,724	$	9	$	—		$	—	$	430		$	39,164	$	1,272

Total Control and Affiliate Investments	$	127,973	$	5,789	$	(5,013	)	$	—	$	432		$	129,182	$	3,600

(1)

Gross additions may include increases in the cost basis of investments resulting from new portfolio investments, PIK interest, the accretion of discounts, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company into this category from a different category.

(2)

Gross reductions may include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category.

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2024

(In thousands, except share and per share data)


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States

Artificial Intelligence & Automation
Ambient Photonics, Inc.	Secured Loan	July 28, 2022	July 1, 2025	Variable interest rate Prime + 6.0% or Floor rate 9.5%; EOT 4.0%	$	1,003	$	1,175	$	1,184	(8)
	Secured Loan	November 17, 2022	May 1, 2025	Variable interest rate Prime + 6.0% or Floor rate 9.5%; EOT 4.0%		947		1,131		939	(8)
	Secured Loan	December 20, 2022	June 1, 2025	Variable interest rate Prime + 6.0% or Floor rate 9.5%; EOT 4.0%		175		204		177	(8)
Total Ambient Photonics, Inc.						2,125		2,510		2,300

Applied Digital Corporation	Equipment Financing	March 13, 2024	October 1, 2025	Fixed interest rate 19.0%; EOT 0.0%	$	4,190	$	4,191	$	4,270	(9)(10)(14)
	Equipment Financing	March 25, 2024	March 1, 2026	Fixed interest rate 19.0%; EOT 0.0%		6,975		6,978		7,162	(9)(10)(14)(19)
	Equipment Financing	April 24, 2024	April 1, 2026	Fixed interest rate 19.0%; EOT 0.0%		3,711		3,714		3,814	(9)(10)(14)(19)
	Equipment Financing	May 28, 2024	May 1, 2026	Fixed interest rate 16.0%; EOT 0.0%		1,657		1,657		1,700	(9)(10)(14)
	Equipment Financing	June 21, 2024	April 1, 2026	Fixed interest rate 19.0%; EOT 0.0%		6,011		6,016		6,178	(9)(10)(14)(19)
Total Applied Digital Corporation						22,544		22,556		23,124

Augmented Reality Concepts, Inc.	Secured Loan	June 17, 2024	June 18, 2029	Variable interest rate SOFR 3 Month Term + 7.3%; EOT 0.0%	$	19,270	$	18,894	$	19,404	(8)(19)

Cirrascale Cloud Services, LLC	Equipment Financing	June 27, 2024	September 1, 2026	Fixed interest rate 12.7%; EOT 4.0%	$	18,771	$	19,170	$	19,371	(9)(19)
	Equipment Financing	October 22, 2024	April 1, 2027	Fixed interest rate 10.2%; EOT 5.0%		19,838		20,041		20,041	(19)
Total Cirrascale Cloud Services, LLC						38,609		39,211		39,412

Sub-total: Artificial Intelligence & Automation (10.2%)*					$	82,548	$	83,171	$	84,240

Biotechnology
Pendulum Therapeutics, Inc.	Secured Loan	December 31, 2021	July 1, 2026	Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0%	$	4,292	$	4,468	$	4,453	(8)(14)
	Secured Loan	February 28, 2022	July 1, 2026	Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0%		4,581		4,757		4,747	(8)(14)
	Secured Loan	March 30, 2022	July 1, 2026	Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0%		4,722		4,899		4,891	(8)(14)
	Secured Loan	May 6, 2022	July 1, 2026	Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0%		5,000		5,177		5,173	(8)(14)
	Secured Loan	June 17, 2022	July 1, 2026	Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0%		5,000		5,177		5,173	(8)(14)
	Secured Loan	February 1, 2024	July 1, 2026	Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 4.0%		1,405		1,089		1,053	(8)(14)
Total Pendulum Therapeutics, Inc.						25,000		25,567		25,490

Taysha Gene Therapies, Inc.	Secured Loan	November 13, 2023	December 1, 2028	Variable interest rate Prime + 4.5% or Floor rate 12.8%; EOT 5.0%	$	30,000	$	30,195	$	30,949	(8)(9)(14)

Sub-total: Biotechnology (6.9%)*					$	55,000	$	55,762	$	56,439


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Connectivity
Tarana Wireless, Inc.	Secured Loan	September 23, 2024	October 1, 2029	Variable interest rate Prime + 4.5% or Floor rate 12.5%; EOT 4.0%	$	14,800	$	14,058	$	14,283	(8)(9)(19)

Vertical Communications, Inc.	Secured Loan	August 23, 2021	March 1, 2026	Variable interest rate Prime + 4.0% or Floor rate 11.0%; EOT 23.8%	$	12,600	$	15,521	$	15,521	(8)(21)

Sub-total: Connectivity (3.6%)*					$	27,400	$	29,579	$	29,804

Consumer Products & Services
Eterneva, Inc.	Equipment Financing	November 24, 2021	June 1, 2026	Fixed interest rate 7.8%; EOT 11.5%	$	227	$	250	$	223
	Equipment Financing	March 16, 2022	October 1, 2026	Fixed interest rate 8.1%; EOT 11.5%		376		392		353	(14)
	Equipment Financing	June 17, 2022	January 1, 2027	Fixed interest rate 11.9%; EOT 11.5%		1,139		1,141		1,014	(14)
Total Eterneva, Inc.						1,742		1,783		1,590

Molekule Group, Inc.	Equipment Financing	June 19, 2020	March 31, 2025	Fixed interest rate 8.8%; EOT 10.0%	$	312	$	595	$	218	(18)
	Equipment Financing	September 29, 2020	March 31, 2025	Fixed interest rate 12.3%; EOT 10.0%		273		347		191	(18)
	Equipment Financing	December 18, 2020	March 31, 2025	Fixed interest rate 11.9%; EOT 10.0%		473		584		331	(18)
	Equipment Financing	August 25, 2021	March 31, 2025	Fixed interest rate 11.3%; EOT 10.0%		385		454		270	(18)
Total Molekule Group, Inc.						1,443		1,980		1,010

Ogee, Inc.	Secured Loan	February 14, 2023	March 1, 2027	Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8%	$	4,700	$	4,752	$	4,736	(8)(14)(19)
	Secured Loan	September 29, 2023	March 1, 2027	Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8%		4,700		4,722		4,751	(8)(14)(19)
	Secured Loan	August 1, 2024	March 1, 2027	Variable interest rate Prime + 5.8% or Floor rate 12.0%; EOT 3.8%		4,700		4,612		4,620	(8)(14)(19)
Total Ogee, Inc.						14,100		14,086		14,107

Portofino Labs, Inc.	Secured Loan	April 1, 2021	November 1, 2025	Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 6.0%	$	1,064	$	1,150	$	1,176	(8)(14)

Quip NYC, Inc.	Secured Loan	March 9, 2021	April 1, 2026	Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.0%	$	7,778	$	8,237	$	8,264	(8)(14)
	Secured Loan	February 10, 2022	April 1, 2026	Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.0%		1,111		1,179		1,185	(8)(14)
Total Quip NYC, Inc.						8,889		9,416		9,449

Rinse, Inc.	Secured Loan	May 10, 2022	June 1, 2027	Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.8%	$	3,849	$	3,954	$	3,984	(8)(14)
	Secured Loan	September 22, 2023	October 1, 2028	Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.8%		4,000		3,997		4,068	(8)(14)
Total Rinse, Inc.						7,849		7,951		8,052

SI Tickets, Inc.	Secured Loan	May 11, 2022	September 1, 2026	Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 3.0%	$	1,928	$	1,986	$	1,939	(8)(14)

UnTuckIt, Inc.	Secured Loan	January 16, 2020	December 1, 2025	Fixed interest rate 12.0%; EOT 5.0%	$	5,051	$	5,951	$	5,859

VitaCup, Inc.	Secured Loan	June 23, 2021	January 1, 2026	Variable interest rate Prime + 7.5% or Floor rate 11.5%; EOT 5.0%	$	6,000	$	6,128	$	5,842	(8)(14)

Sub-total: Consumer Products & Services (6.0%)*					$	48,066	$	50,431	$	49,024


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Digital Assets Technology and Services
Cleanspark, Inc.	Equipment Financing	April 22, 2022	May 1, 2025	Fixed interest rate 10.3%; EOT 5.0%	$	2,522	$	3,511	$	3,493	(10)(14)

Sub-total: Digital Assets Technology and Services (0.4%)*					$	2,522	$	3,511	$	3,493

Education Technology
Edblox, Inc.	Secured Loan	March 19, 2024	April 1, 2029	Variable interest rate Prime + 4.5% or Floor rate 11.8%; EOT 2.5%	$	15,000	$	14,848	$	13,712	(8)(9)(14)

Medical Sales Training Holding Company	Secured Loan	March 18, 2021	April 1, 2025	Variable interest rate Prime + 8.8% or Floor rate 12.0%; EOT 6.3%	$	5,175	$	5,531	$	5,300	(8)
	Secured Loan	July 21, 2021	August 1, 2025	Variable interest rate Prime + 8.8% or Floor rate 12.0%; EOT 6.3%		1,825		1,938		1,759	(8)
Total Medical Sales Training Holding Company						7,000		7,469		7,059

Yellowbrick Learning, Inc.	Secured Loan	February 1, 2021	March 1, 2026	Fixed interest rate 2.0%; EOT 5.0%	$	7,500	$	7,876	$	6,683
	Secured Loan	August 10, 2021	March 1, 2026	Fixed interest rate 2.0%; EOT 5.0%		2,500		2,625		2,229
Total Yellowbrick Learning, Inc.						10,000		10,501		8,912

Sub-total: Education Technology (3.6%)*					$	32,000	$	32,818	$	29,683


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Finance and Insurance
Beam Technologies, Inc.	Secured Loan	August 30, 2024	April 1, 2027	Variable interest rate PRIME + 2.8% or Floor rate 11.0%+PIK Fixed Interest Rate 1.5%; EOT 2.0%	$	34,956	$	34,130	$	34,579	(8)(15)(19)

Bestow, Inc.	Secured Loan	August 1, 2024	December 1, 2027	Variable interest rate Prime + 6.0% or Floor rate 13.0%; EOT 1.5%	$	40,000	$	38,342	$	38,122	(8)(14)

Busbot, Inc.	Secured Loan	April 1, 2024	October 1, 2026	Variable interest rate SOFR 30 Day Forward + 11.5% or Floor rate 13.5%; EOT 0.0%	$	8,630	$	8,482	$	8,482	(8)(10)(12)

Centivo Corporation	Secured Loan	July 31, 2024	August 1, 2029	Variable interest rate PRIME + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0%	$	3,765	$	3,677	$	3,735	(8)(9)(15)(19)
	Secured Loan	December 20, 2024	August 1, 2029	Variable interest rate PRIME + 4.5% or Floor rate 11.3%+PIK Fixed Interest Rate 1.0%; EOT 2.0%		3,751		3,528		3,528	(8)(9)(15)(19)
Total Centivo Corporation						7,516		7,205		7,263

Cherry Technologies, Inc.	Secured Loan	March 29, 2024	April 1, 2029	Variable interest rate PRIME + 4.5% or Floor rate 12.0%+PIK Fixed Interest Rate 1.0%; EOT 2.0%	$	14,577	$	14,504	$	15,000	(8)(9)(14)(15)(19)
	Secured Loan	July 31, 2024	April 1, 2029	Variable interest rate PRIME + 4.5% or Floor rate 12.0%+PIK Fixed Interest Rate 1.0%; EOT 2.0%		14,530		14,437		14,924	(8)(9)(14)(15)(19)
Total Cherry Technologies, Inc.						29,107		28,941		29,924

Empower Financial, Inc.	Secured Loan	October 13, 2023	May 1, 2028	Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8%	$	11,622	$	11,514	$	11,663	(8)(9)(14)(19)
	Secured Loan	January 5, 2024	May 1, 2028	Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8%		2,902		2,809		2,856	(8)(9)(14)(19)
	Secured Loan	February 8, 2024	May 1, 2028	Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8%		4,353		4,210		4,281	(8)(9)(14)(19)
	Secured Loan	April 9, 2024	May 1, 2028	Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8%		4,348		4,078		4,142	(8)(9)(14)(19)
	Secured Loan	May 15, 2024	May 1, 2028	Variable interest rate Prime + 4.8% or Floor rate 11.5%; EOT 3.8%		14,495		14,591		14,895	(8)(14)(19)
Total Empower Financial, Inc.						37,720		37,202		37,837


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Eqis Capital Management, Inc.	Secured Loan	June 15, 2022	July 1, 2026	Variable interest rate Prime + 7.5% or Floor rate 10.8%; EOT 3.0%	$	6,809	$	7,019	$	6,610	(8)(14)

Gravie, Inc.	Secured Loan	June 4, 2024	July 1, 2029	Variable interest rate Prime + 4.5% or Floor rate 13.0%; EOT 2.5%	$	15,980	$	15,662	$	15,796	(8)(9)(14)(19)

Kafene, Inc.	Secured Loan	January 5, 2024	February 1, 2029	Variable interest rate Prime + 4.0% or Floor rate 12.0%; EOT 1.0%	$	12,500	$	12,403	$	12,582	(8)(14)

Mesa Financial, Inc.	Secured Loan	August 29, 2024	February 28, 2027	Variable interest rate SOFR 30 Day Forward + 10.3% or Floor rate 12.3%; EOT 0.0%	$	9,861	$	9,665	$	9,665	(8)(10)(12)

Pagaya Structured Products LLC	Secured Loan	August 23, 2024	August 23, 2025	Fixed interest rate 20.0%; EOT 0.0%	$	13,814	$	13,712	$	13,712	(10)

Parafin SPV 2, LLC	Secured Loan	February 22, 2024	December 21, 2026	Variable interest rate SOFR 1 Month Term + 10.8% or Floor rate 12.8%; EOT 0.0%	$	24,600	$	24,252	$	24,252	(8)(10)(12)

Parafin SPV 3, LLC	Secured Loan	July 25, 2024	January 25, 2027	Variable interest rate SOFR 1 Month Term + 10.8% or Floor rate 13.8%; EOT 0.0%	$	16,452	$	16,220	$	16,220	(8)(10)(12)

Slope Tech, Inc.	Secured Loan	October 5, 2022	February 27, 2026	Variable interest rate SOFR 1 Month Term + 11.8% or Floor rate 11.8%; EOT 0.0%	$	1,823	$	1,742	$	1,742	(8)(10)(12)

Under Technologies, Inc.	Secured Loan	September 13, 2024	June 1, 2029	Variable interest rate PRIME + 3.8% or Floor rate 12.0%; EOT 4.3%	$	9,400	$	9,223	$	9,369	(8)(19)
	Secured Loan	November 27, 2024	June 1, 2029	Variable interest rate PRIME + 3.8% or Floor rate 12.0%; EOT 4.3%		9,400		9,191		9,191	(8)(19)
Total Under Technologies, Inc.						18,800		18,414		18,560

Wisetack, Inc.	Secured Loan	November 14, 2024	December 1, 2029	Variable interest rate Prime + 5.0% or Floor rate 12.5%; EOT 2.5%	$	14,100	$	13,862	$	13,862	(8)(19)

Sub-total: Finance and Insurance (35.1%)*					$	292,668	$	287,253	$	289,208


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Food and Agriculture Technologies
Bowery Farming, Inc.	Secured Loan	September 10, 2021	September 10, 2026	Variable interest rate SOFR 1 Month Term + 10.0% or Floor rate 1.0%; EOT 0.0%	$	7,652	$	6,938	$	57	(8)(18)

Daring Foods, Inc.	Equipment Financing	March 8, 2022	April 1, 2025	Fixed interest rate 9.5%; EOT 7.5%	$	215	$	385	$	381	(14)
	Equipment Financing	April 29, 2022	May 1, 2025	Fixed interest rate 10.2%; EOT 7.5%		126		201		199	(14)
	Equipment Financing	July 6, 2022	August 1, 2025	Fixed interest rate 10.9%; EOT 7.5%		99		132		131	(14)
	Equipment Financing	August 25, 2022	September 1, 2025	Fixed interest rate 12.1%; EOT 7.5%		267		342		341	(14)
Total Daring Foods, Inc.						707		1,060		1,052

DrinkPak, LLC	Equipment Financing	February 17, 2023	September 1, 2026	Fixed interest rate 12.9%; EOT 7.0%	$	7,274	$	8,033	$	8,074	(9)(14)(19)

Emergy, Inc.	Equipment Financing	December 15, 2021	July 1, 2026	Fixed interest rate 11.2%; EOT 11.5%	$	3,711	$	4,520	$	3,668	(14)
	Equipment Financing	December 13, 2022	July 1, 2027	Fixed interest rate 8.8%; EOT 11.5%		6,744		7,531		5,930	(9)(14)
Total Emergy, Inc.						10,455		12,051		9,598

Sub-total: Food and Agriculture Technologies (2.3%)*					$	26,088	$	28,082	$	18,781


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Green Technology
Commonwealth Fusion Systems, LLC	Equipment Financing	June 16, 2023	July 1, 2030	Fixed interest rate 13.0%; EOT 10.0%	$	3,450	$	3,565	$	3,665	(9)(14)(19)
	Equipment Financing	June 27, 2024	July 1, 2030	Fixed interest rate 13.2%; EOT 10.0%		9,979		10,021		10,333	(9)(14)(19)
Total Commonwealth Fusion Systems, LLC						13,429		13,586		13,998

Crusoe Energy Systems LLC	Equipment Financing	March 1, 2024	March 1, 2029	Fixed interest rate 12.7%; EOT 0.0%	$	8,098	$	8,034	$	8,237	(9)(14)(19)

Dandelion Energy, Inc.	Equipment Financing	June 25, 2024	July 1, 2025	Fixed interest rate 15.9%; EOT 0.0%	$	1,361	$	1,349	$	1,378	(9)(14)

Electric Hydrogen Co.	Equipment Financing	September 12, 2022	April 1, 2026	Fixed interest rate 9.0%; EOT 10.0%	$	797	$	974	$	956	(14)
	Equipment Financing	December 22, 2023	January 1, 2029	Fixed interest rate 12.5%; EOT 15.0%		3,908		4,125		4,125	(9)(14)(19)
	Equipment Financing	June 27, 2024	January 1, 2029	Fixed interest rate 12.6%; EOT 15.0%		3,203		3,276		3,321	(9)(14)(19)
	Equipment Financing	September 19, 2024	October 1, 2028	Fixed interest rate 12.5%; EOT 15.0%		1,967		1,989		2,004	(9)(14)(19)
	Equipment Financing	November 14, 2024	December 1, 2028	Fixed interest rate 11.9%; EOT 15.0%		870		874		874	(14)(19)
Total Electric Hydrogen Co.						10,745		11,238		11,280

Form Energy Inc.	Equipment Financing	October 21, 2024	November 1, 2027	Fixed interest rate 12.7%; EOT 3.0%	$	35,626	$	34,946	$	34,946	(19)
	Equipment Financing	December 12, 2024	January 1, 2028	Fixed interest rate 12.5%; EOT 3.0%		9,400		9,185		9,185	(19)
Total Form Energy Inc.						45,026		44,131		44,131

Hi-Power, LLC	Equipment Financing	September 30, 2021	April 1, 2025	Fixed interest rate 12.4%; EOT 1.0%	$	601	$	670	$	680	(14)
	Equipment Financing	September 30, 2022	April 1, 2026	Fixed interest rate 14.7%; EOT 1.0%		1,737		1,769		1,779	(14)
Total Hi-Power, LLC						2,338		2,439		2,459

SeaOn Global, LLC	Equipment Financing	June 16, 2022	July 1, 2026	Fixed interest rate 9.3%; EOT 11.0%	$	2,817	$	3,450	$	3,332
	Equipment Financing	August 17, 2022	September 1, 2026	Fixed interest rate 9.3%; EOT 11.0%		1,496		1,788		1,737
Total SeaOn Global, LLC						4,313		5,238		5,069

Footprint International Holding, Inc.	Secured Loan	February 18, 2022	March 1, 2027	Variable interest rate Prime + 7.3% or Floor rate 10.5%; EOT 3.5%	$	15,838	$	15,722	$	15,382	(8)(14)
	Secured Loan	April 20, 2022	March 1, 2027	Variable interest rate Prime + 7.3% or Floor rate 10.5%; EOT 3.5%		15,838		15,689		15,345	(8)(14)
Total Footprint International Holding, Inc.						31,676		31,411		30,727

Mainspring Energy, Inc.	Secured Loan	March 18, 2022	October 1, 2026	Fixed interest rate 11.0%; EOT 3.8%	$	19,488	$	20,347	$	20,126	(14)

Sub-total: Green Technology (16.7%)*					$	136,474	$	137,773	$	137,405


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Healthcare Technology
Lark Technologies, Inc.	Secured Loan	September 30, 2020	April 1, 2025	Variable interest rate Prime + 8.3% or Floor rate 11.5% or ceiling rate of 13.5%; EOT 4.0%	$	659	$	856	$	853	(8)(14)
	Secured Loan	June 30, 2021	January 1, 2026	Variable interest rate Prime + 8.3% or Floor rate 11.5% or ceiling rate of 13.5%; EOT 4.0%		2,041		2,212		2,187	(14)
	Secured Loan	July 7, 2023	January 1, 2028	Variable interest rate Prime + 8.3% or Floor rate 11.5% or ceiling rate of 13.5%; EOT 4.0%		5,000		5,039		5,094	(8)(14)
Total Lark Technologies, Inc.						7,700		8,107		8,134

Moxe Health Corporation	Secured Loan	December 29, 2023	January 1, 2028	Variable interest rate Prime + 5.5% or Floor rate 13.0%; EOT 4.8%	$	12,500	$	12,512	$	12,439	(8)

RXAnte, Inc.	Secured Loan	November 21, 2022	December 1, 2027	Variable interest rate Prime + 4.48% or Floor rate 9.98%+PIK Fixed Interest Rate 1.5%; EOT 3.5%	$	8,516	$	8,601	$	8,658	(8)(9)(14)(15)(19)
	Secured Loan	April 14, 2023	December 1, 2027	Variable interest rate Prime + 4.48% or Floor rate 9.98%+PIK Fixed Interest Rate 1.5%; EOT 3.5%		2,831		2,832		2,932	(8)(9)(14)(15)(19)
	Secured Loan	October 19, 2023	December 1, 2027	Variable interest rate Prime + 4.48% or Floor rate 9.98%+PIK Fixed Interest Rate 1.5%; EOT 3.5%		2,803		2,797		2,873	(8)(9)(14)(15)(19)
	Secured Loan	September 9, 2024	December 1, 2027	Variable interest rate Prime + 4.48% or Floor rate 9.98%+PIK Fixed Interest Rate 1.5%; EOT 3.5%		2,767		2,756		2,830	(8)(9)(14)(15)(19)
Total RXAnte, Inc.						16,917		16,986		17,293

TMRW Life Sciences, Inc.	Secured Loan	April 29, 2022	May 1, 2027	Variable interest rate Prime + 5.0% or Floor rate 8.8%; EOT 4.0%	$	5,000	$	5,127	$	4,799	(8)(14)
	Secured Loan	March 3, 2023	May 1, 2027	Variable interest rate Prime + 5.0% or Floor rate 8.8%; EOT 4.0%		15,000		15,309		15,007	(8)(14)
	Secured Loan	December 8, 2023	May 1, 2027	Variable interest rate Prime + 5.0% or Floor rate 8.8%; EOT 4.0%		10,000		10,131		10,129	(8)(14)
Total TMRW Life Sciences, Inc.						30,000		30,567		29,935

WorkWell Prevention & Care Inc.	Secured Loan	December 31, 2022	January 1, 2027	Variable interest rate Prime + 5.0% or Floor rate 6.0%; EOT 0.0%	$	500	$	500	$	500	(8)(21)

Sub-total: Healthcare Technology (8.3%)*					$	67,617	$	68,672	$	68,301


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Human Resource Technology
Nomad Health, Inc.	Secured Loan	March 29, 2022	December 1, 2026	Variable interest rate Prime + 5.5% or Floor rate 9.3%; EOT 4.0%	$	31,416	$	32,287	$	28,390	(8)(14)(15)
	Secured Loan	June 12, 2024	December 1, 2026	Fixed interest rate 10.0%; EOT 0.0%		500		500		478
Total Nomad Health, Inc.						31,916		32,787		28,868

Sub-total: Human Resource Technology (3.5%)*					$	31,916	$	32,787	$	28,868

Industrials
3DEO, Inc.	Equipment Financing	February 23, 2022	February 1, 2025	Fixed interest rate 0.0%; EOT 9.0%	$	1,256	$	1,567	$	1,517	(14)
	Equipment Financing	April 12, 2022	February 1, 2025	Fixed interest rate 0.0%; EOT 9.0%		675		816		796	(14)
Total 3DEO, Inc.						1,931		2,383		2,313

Formlogic Corporation	Equipment Financing	December 28, 2023	January 1, 2028	Fixed interest rate 12.1%; EOT 1.5%	$	4,017	$	4,014	$	1,718	(9)(14)(18)
	Equipment Financing	April 25, 2024	May 1, 2028	Fixed interest rate 12.1%; EOT 1.5%		350		347		149	(9)(14)(18)
Total Formlogic Corporation						4,367		4,361		1,867

Sub-total: Industrials (0.5%)*					$	6,298	$	6,744	$	4,180

Marketing, Media, and Entertainment
Drone Racing League, Inc.	Secured Loan	October 17, 2022	December 1, 2025	Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 2.5%	$	8,360	$	8,449	$	8,123	(8)

Grabit Interactive Media, Inc.	Secured Loan	April 8, 2022	November 1, 2026	Variable interest rate Prime + 7.5% or Floor rate 10.8%; EOT 2.5%	$	3,115	$	3,193	$	3,130	(8)(14)

Incontext Solutions, Inc.	Secured Loan	January 16, 2020	September 1, 2025	Fixed interest rate 11.8%; EOT 11.4%	$	1,388	$	2,538	$	2,332

PebblePost, Inc.	Secured Loan	May 7, 2021	June 1, 2026	Variable interest rate Prime + 8.8% or Floor rate 11.5%; EOT 3.8%	$	7,478	$	7,886	$	7,871	(8)(14)

Vox Media Holdings, Inc.	Secured Loan	October 18, 2022	November 1, 2027	Variable interest rate Prime + 6.3% or Floor rate 11.8%; EOT 2.5%	$	10,506	$	10,599	$	10,768	(8)(9)(14)(19)
	Secured Loan	December 29, 2022	January 1, 2028	Variable interest rate Prime + 6.3% or Floor rate 11.8%; EOT 2.5%		5,251		5,286		5,371	(8)(9)(14)(19)
Total Vox Media Holdings, Inc.						15,757		15,885		16,139

Sub-total: Marketing, Media, and Entertainment (4.6%)*					$	36,098	$	37,951	$	37,595


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Medical Devices
Apiject Holdings, Inc.	Equipment Financing	June 24, 2024	July 1, 2028	Fixed interest rate 12.6%; EOT 7.5%	$	17,847	$	17,773	$	17,982	(9)(14)(19)
	Equipment Financing	September 30, 2024	October 1, 2028	Fixed interest rate 12.7%; EOT 7.5%		7,438		7,314		7,371	(9)(14)(19)
Total Apiject Holdings, Inc.						25,285		25,087		25,353

Convergent Dental, Inc.	Secured Loan	April 21, 2023	May 1, 2027	Variable interest rate Prime + 5.8% or Floor rate 13.5%; EOT 5.5%	$	12,000	$	12,074	$	12,215	(8)(9)(14)
	Secured Loan	February 29, 2024	May 1, 2027	Variable interest rate Prime + 5.8% or Floor rate 13.5%; EOT 5.5%		6,000		5,997		6,137	(8)(9)(14)
Total Convergent Dental, Inc.						18,000		18,071		18,352

Elucent Medical, Inc.	Secured Loan	October 31, 2024	November 30, 2029	Variable interest rate PRIME + 3.8% or Floor rate 11.3%; EOT 3.3%	$	14,100	$	13,822	$	13,822	(8)(19)

Lightforce Orthodontics, Inc.	Secured Loan	August 6, 2024	August 6, 2029	Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 4.0%	$	28,200	$	27,803	$	28,052	(8)(19)
	Secured Loan	September 25, 2024	August 6, 2029	Variable interest rate Prime + 4.3% or Floor rate 11.8%; EOT 4.0%		4,700		4,633		4,675	(8)(19)
Total Lightforce Orthodontics, Inc.						32,900		32,436		32,727

Neurolens, Inc.	Secured Loan	September 29, 2023	October 1, 2028	Variable interest rate Prime + 3.5% or Floor rate 11.5%; EOT 3.0%	$	20,000	$	20,000	$	20,706	(8)

Neuros Medical, Inc.	Secured Loan	August 10, 2023	September 1, 2027	Variable interest rate Prime + 6.0% or Floor rate 14.3%; EOT 4.5%	$	6,000	$	6,034	$	6,032	(8)(9)(14)
	Secured Loan	August 30, 2024	September 1, 2027	Variable interest rate Prime + 6.0% or Floor rate 14.3%; EOT 4.5%		3,000		2,961		2,926	(8)(9)(14)
Total Neuros Medical, Inc.						9,000		8,995		8,958

Restor3d, Inc.	Secured Loan	June 4, 2024	July 4, 2028	Variable interest rate Prime + 4.8% or Floor rate 12.3%; EOT 3.3%	$	11,985	$	11,895	$	12,006	(8)(9)(19)

Shoulder Innovations, Inc.	Secured Loan	August 7, 2023	September 1, 2028	Variable interest rate Prime + 3.5% or Floor rate 11.5%; EOT 3.0%	$	11,250	$	11,245	$	11,426	(8)(9)(14)

Vital Connect, Inc.	Secured Loan	July 3, 2024	July 3, 2029	Variable interest rate Prime + 4.0% or Floor rate 11.5%; EOT 4.0%	$	27,650	$	27,504	$	27,745	(8)(9)(19)

Sub-total: Medical Devices (20.8%)*					$	170,170	$	169,055	$	171,095


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Multi-Sector Holdings
Senior Credit Corp 2022 LLC	Secured Loan	January 30, 2023	December 5, 2028	Fixed interest rate 8.5%; EOT 0.0%	$	12,885	$	12,885	$	12,885	(10)(14)(21)

Sub-total: Multi-Sector Holdings (1.6%)*					$	12,885	$	12,885	$	12,885

Other Healthcare Services
Cellares Corporation	Equipment Financing	August 2, 2024	September 1, 2029	Fixed interest rate 12.0%; EOT 4.5%	$	4,467	$	4,477	$	4,555	(19)
	Secured Loan	August 2, 2024	February 1, 2027	Variable interest rate Prime + 3.3% or Floor rate 11.8%; EOT 4.0%		47,000		46,411		47,219	(8)(19)
Total Cellares Corporation						51,467		50,888		51,774

Metabolon, Inc.	Secured Loan	March 28, 2024	April 1, 2029	Variable interest rate PRIME + 2.5% or Floor rate 10.0%+PIK Fixed Interest Rate 3.0%; EOT 4.8%	$	43,141	$	42,389	$	42,382	(8)(15)
	Secured Loan	October 1, 2024	April 1, 2029	Variable interest rate PRIME + 2.5% or Floor rate 10.0%+PIK Fixed Interest Rate 3.0%; EOT 4.8%		5,038		4,972		4,972	(8)(15)
Total Metabolon, Inc.						48,179		47,361		47,354

Upward Health, Inc.	Secured Loan	August 6, 2024	September 1, 2029	Variable interest rate Prime + 4.3% or Floor rate 12.8%; EOT 3.0%	$	5,875	$	5,707	$	5,833	(8)(9)(19)

Velentium, Inc.	Secured Loan	May 24, 2024	May 24, 2029	Variable interest rate Prime + 5.0% or Floor rate 12.5%; EOT 4.0%	$	8,500	$	8,379	$	8,445	(8)(9)(14)

Sub-total: Other Healthcare Services (13.8%)*					$	114,021	$	112,335	$	113,406

Real Estate Technology
Homelight Lending, Inc.	Secured Loan	October 15, 2021	June 1, 2026	Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 4.5%	$	3,900	$	4,129	$	3,999	(8)(14)

Knockaway, Inc.	Secured Loan	September 29, 2023	September 1, 2028	Fixed interest rate 10.2%; EOT 0.0%	$	23,644	$	19,920	$	19,159	(8)(14)(21)

Knockaway Trinity Holdings, LLC	Secured Loan	December 6, 2023	December 27, 2026	Variable interest rate SOFR 30 Day Forward + 9.0% or Floor rate 13.5%; EOT 0.0%	$	25,000	$	24,981	$	24,981	(8)(10)(12)(21)

Maxwell Financial Labs, Inc.	Secured Loan	September 30, 2021	April 1, 2026	Variable interest rate Prime + 6.0% or Floor rate 10.0%; EOT 5.0%	$	15,000	$	15,486	$	15,052	(8)(14)
	Secured Loan	October 2, 2024	October 2, 2026	Fixed interest rate 6.0%; EOT 0.0%		187		187		187
Total Maxwell Financial Labs, Inc.						15,187		15,673		15,239

Orchard Technologies, Inc.	Secured Loan	January 1, 2024	January 1, 2029	Variable interest rate Prime + 8.0% or Floor rate 15.0%; EOT 3.0%	$	28,540	$	28,765	$	24,662	(8)(14)

Sub-total: Real Estate Technology (10.7%)*					$	96,271	$	93,468	$	88,040


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Software as a Service ("SaaS")
BackBlaze, Inc.	Equipment Financing	March 29, 2021	April 1, 2025	Fixed interest rate 7.5%; EOT 11.5%	$	198	$	518	$	510	(14)

Cpacket Networks, Inc.	Secured Loan	January 29, 2024	February 1, 2029	Variable interest rate PRIME + 4.8% or Floor rate 12.0%+PIK Fixed Interest Rate 1.3%; EOT 3.0%	$	20,478	$	20,316	$	20,532	(8)(9)(14)(15)

Eyelit Technologies, Inc.	Secured Loan	November 4, 2024	November 4, 2029	Variable interest rate SOFR 1 Month Term + 5.8%; EOT 0.0%	$	4,500	$	4,413	$	4,413	(8)(19)(20)
	Secured Loan	December 27, 2024	November 4, 2029	Variable interest rate SOFR 1 Month Term + 5.8%; EOT 0.0%		7,920		7,764		7,764	(8)(19)(20)
Total Eyelit Technologies, Inc.						12,420		12,177		12,177

Hometown Ticketing, Inc.	Secured Loan	November 25, 2024	November 25, 2029	Variable interest rate SOFR 3 Month Term + 7.7%; EOT 0.0%	$	24,910	$	24,422	$	24,422	(8)(19)

ServiceTrade, Inc.	Secured Loan	August 15, 2024	August 15, 2029	Variable interest rate SOFR 3 Month Term + 5.5%; EOT 0.0%	$	23,500	$	23,091	$	23,720	(8)(19)(20)

Silk Technologies, Inc.	Secured Loan	November 4, 2024	December 1, 2029	Variable interest rate Prime + 4.0% or Floor rate 11.3%; EOT 1.5%	$	18,800	$	18,309	$	18,309	(8)(19)

SOCi, Inc.	Secured Loan	October 3, 2024	October 3, 2029	Variable interest rate SOFR 3 Month Term + 7.9%; EOT 0.0%	$	36,100	$	35,326	$	35,326	(8)(19)
	Secured Loan	December 30, 2024	October 3, 2029	Variable interest rate SOFR 3 Month Term + 7.9%; EOT 0.0%		3,290		3,216		3,216	(8)(19)
Total SOCi, Inc.						39,390		38,542		38,542

Steno Agency, Inc.	Secured Loan	June 21, 2024	July 1, 2029	Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 2.5%	$	3,740	$	3,621	$	3,744	(8)(9)(14)(19)

Sub-total: SaaS (17.2%)*					$	143,436	$	140,996	$	141,956

Space Technology
Astranis Space Technology Corporation	Equipment Financing	April 13, 2023	November 1, 2026	Fixed interest rate 12.1%; EOT 5.0%	$	7,611	$	8,099	$	8,201	(9)(14)(19)
	Equipment Financing	September 27, 2024	April 1, 2028	Fixed interest rate 12.4%; EOT 5.5%		10,911		10,388		10,557	(9)(14)(19)
	Equipment Financing	September 27, 2024	October 1, 2027	Fixed interest rate 12.6%; EOT 4.0%		2,693		2,563		2,603	(9)(14)(19)
Total Astranis Space Technology Corporation						21,215		21,050		21,361

Axiom Space, Inc.	Secured Loan	May 28, 2021	June 1, 2026	Variable interest rate Prime + 6.0% or Floor rate 9.3%; EOT 2.5%	$	15,000	$	15,641	$	15,530	(8)(14)

Hadrian Automation, Inc.	Equipment Financing	March 2, 2022	September 1, 2025	Fixed interest rate 12.6%; EOT 0.0%	$	126	$	126	$	129	(14)
	Equipment Financing	May 6, 2022	November 1, 2025	Fixed interest rate 12.9%; EOT 0.0%		1,497		1,495		1,522	(14)
	Equipment Financing	July 15, 2022	January 1, 2026	Fixed interest rate 14.3%; EOT 0.0%		1,192		1,191		1,215	(14)
	Equipment Financing	September 30, 2022	March 1, 2026	Fixed interest rate 15.2%; EOT 0.0%		2,290		2,289		2,347	(9)(14)
	Equipment Financing	December 22, 2022	June 1, 2026	Fixed interest rate 16.1%; EOT 0.0%		612		608		632	(9)(14)
	Equipment Financing	December 22, 2022	December 1, 2026	Fixed interest rate 16.4%; EOT 0.0%		274		273		284	(9)(14)(19)
	Equipment Financing	March 29, 2023	March 1, 2027	Fixed interest rate 15.7%; EOT 0.0%		877		875		903	(9)(14)(19)
	Equipment Financing	September 28, 2023	September 1, 2027	Fixed interest rate 17.7%; EOT 0.0%		468		467		485	(9)(14)(19)
	Equipment Financing	June 27, 2024	June 1, 2028	Fixed interest rate 17.6%; EOT 0.0%		1,273		1,268		1,307	(9)(14)(19)
Total Hadrian Automation, Inc.						8,609		8,592		8,824


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Impulse Space, Inc.	Equipment Financing	June 18, 2024	July 1, 2027	Fixed interest rate 12.7%; EOT 3.0%	$	1,143	$	1,133	$	1,155	(9)(14)(19)
	Equipment Financing	September 13, 2024	October 1, 2027	Fixed interest rate 12.5%; EOT 3.0%		901		887		907	(9)(14)(19)
	Equipment Financing	December 27, 2024	January 1, 2028	Fixed interest rate 12.9%; EOT 3.0%		1,077		1,051		1,051	(14)(19)
Total Impulse Space, Inc.						3,121		3,071		3,113

Kymeta Corporation	Secured Loan	July 3, 2024	August 1, 2029	Variable interest rate Prime + 4.0% or Floor rate 12.5%; EOT 3.0%	$	7,900	$	7,575	$	7,783	(8)(9)(19)

Rocket Lab USA, Inc.	Equipment Financing	December 29, 2023	January 1, 2029	Fixed interest rate 12.8%; EOT 1.0%	$	45,649	$	44,992	$	46,466	(9)(10)(14)

Slingshot Aerospace, Inc.	Secured Loan	July 12, 2024	August 1, 2029	Variable interest rate Prime + 5.5% or Floor rate 14.0%; EOT 3.0%	$	23,700	$	23,233	$	23,750	(8)(9)(19)
	Secured Loan	August 7, 2024	April 30, 2025	Fixed interest rate 10.0%; EOT 0.0%		500		500		524
Total Slingshot Aerospace, Inc.					$	24,200	$	23,733	$	24,274

Space Perspective, Inc.	Secured Loan	March 3, 2022	July 1, 2026	Variable interest rate Prime + 7.8% or Floor rate 11.0%; EOT 5.0%	$	2,936	$	3,021	$	1,637	(8)(14)(18)

Sub-total: Space Technology (15.7%)*					$	128,630	$	127,675	$	128,988

Supply Chain Technology
Macrofab, Inc.	Secured Loan	July 21, 2023	August 1, 2027	Variable interest rate Prime + 5.5% or Floor rate 13.3%; EOT 4.0%	$	19,495	$	19,448	$	19,220	(8)(14)

Nucleus RadioPharma, Inc.	Equipment Financing	June 4, 2024	June 1, 2027	Fixed interest rate 11.8%; EOT 4.0%	$	364	$	366	$	373	(9)(14)
	Equipment Financing	December 23, 2024	January 1, 2028	Fixed interest rate 12.3%; EOT 4.0%		2,000		1,980		1,980
Total Nucleus RadioPharma, Inc.					$	2,364	$	2,346	$	2,353


Sub-total: Supply Chain Technology (2.6%)*					$	21,859	$	21,794	$	21,573


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- United States, Continued

Transportation Technology
NextCar Holding Company, Inc.	Secured Loan	December 14, 2021	March 31, 2025	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0%	$	2,927	$	3,188	$	926	(8)
	Secured Loan	December 15, 2021	March 31, 2025	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0%		2,274		2,379		720	(8)(18)
	Secured Loan	February 23, 2022	March 31, 2025	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0%		2,843		2,974		900	(8)(18)
	Secured Loan	March 16, 2022	March 31, 2025	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0%		3,411		3,569		1,080	(8)(18)
	Secured Loan	April 18, 2022	March 31, 2025	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0%		2,843		2,974		900	(8)(18)
	Secured Loan	April 18, 2022	March 31, 2025	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0%		2,843		2,974		900	(8)(18)
	Secured Loan	May 17, 2022	March 31, 2025	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0%		5,685		5,948		1,800	(8)(18)
	Secured Loan	June 22, 2022	March 31, 2025	Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0%		2,843		2,974		900	(8)(18)
Total NextCar Holding Company, Inc.						25,669		26,980		8,126

Get Spiffy, Inc.	Secured Loan	July 14, 2023	January 14, 2028	Variable interest rate Prime + 4.5% or Floor rate 12.3%; EOT 6.0%	$	9,000	$	9,127	$	7,763	(8)(9)(14)
	Equipment Financing	July 14, 2023	February 1, 2027	Fixed interest rate 12.1%; EOT 4.0%		291		292		274	(9)(14)
Total Get Spiffy, Inc.						9,291		9,419		8,037

Uveye, Inc.	Equipment Financing	December 26, 2024	January 1, 2028	Fixed interest rate 11.9%; EOT 1.0%	$	20,217	$	20,011	$	20,011

Zuum Transportation, Inc.	Secured Loan	December 17, 2021	January 1, 2027	Variable interest rate Prime + 6.0% or Floor rate 10.8%; EOT 2.5%	$	5,000	$	5,065	$	4,737	(8)(14)

Sub-total: Transportation Technology (5.0%)*					$	60,177	$	61,475	$	40,911

Total: Debt Securities- United States (189.1%)*					$	1,592,144	$	1,594,217	$	1,555,875


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Maturity Date	Interest Rate (4)	Principal Amount (5)		Cost		Fair Value (6)		Footnotes
Debt Securities- Canada

Construction Technology
Nexii, Inc.	Secured Loan	July 24, 2024	July 1, 2027	Fixed interest rate 10.0%; EOT 0.0%	$	365	$	365	$	375	(10)

Sub-total: Construction Technology (0.0%)*					$	365	$	365	$	375

Supply Chain Technology
GoFor Delivers, Inc.	Secured Loan	June 28, 2024	July 1, 2028	Variable interest rate Prime + 3.5% or Floor rate 12.0%; EOT 2.5%	$	6,000	$	6,027	$	5,769	(8)(10)(21)

Sub-total: Supply Chain Technology (0.7%)*					$	6,000	$	6,027	$	5,769

Total: Debt Securities- Canada (0.7%)*					$	6,365	$	6,392	$	6,144
Debt Securities- Europe

Industrials
Aledia, Inc.	Equipment Financing	March 31, 2022	April 1, 2025	Fixed interest rate 9.0%; EOT 7.0%	$	1,701	$	2,971	$	2,947	(10)(14)
	Equipment Financing	June 30, 2022	July 1, 2025	Fixed interest rate 9.7%; EOT 7.0%		218		298		297	(10)(14)
	Equipment Financing	August 5, 2022	September 1, 2025	Fixed interest rate 10.7%; EOT 7.0%		379		480		478	(10)(14)
	Equipment Financing	September 30, 2022	October 1, 2025	Fixed interest rate 12.0%; EOT 7.0%		680		838		838	(10)(14)
Total Aledia, Inc.						2,978		4,587		4,560

Sub-total: Industrials (0.6%)*					$	2,978	$	4,587	$	4,560

Other Healthcare Services
Zandivio PLC	Secured Loan	October 30, 2024	May 1, 2029	Variable interest rate PRIME + 5.3% or Floor rate 13.8%; EOT 2.5%	$	28,200	$	27,426	$	27,426	(8)(10)(19)

Sub-total: Other Healthcare Services (3.3%)*					$	28,200	$	27,426	$	27,426

Space Technology
All.Space Networks, Limited.	Secured Loan	August 22, 2022	September 1, 2027	Variable interest rate Prime + 7.0% or Floor rate 11.5%; EOT 2.5%	$	8,219	$	8,339	$	8,126	(8)(10)

Sub-total: Space Technology (1.0%)*					$	8,219	$	8,339	$	8,126

Total: Debt Securities- Europe (4.9%)*					$	39,397	$	40,352	$	40,112

Total: Debt Securities (194.7%)*					$	1,637,906	$	1,640,961	$	1,602,131


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Expiration Date	Series	Shares		Strike Price		Cost		Fair Value (6)		Footnotes
Warrant Investments- United States

Artificial Intelligence & Automation

Ambient Photonics, Inc.	Warrant	July 27, 2022	July 27, 2032	Common Stock		15,976	$	5.50	$	47	$	1

Everalbum, Inc.	Warrant	January 16, 2020	July 29, 2026	Preferred Class A Common Stock		851,063	$	0.10	$	25	$	19	(17)

Hologram, Inc.	Warrant	January 31, 2020	January 27, 2030	Common Stock		193,054	$	0.26	$	49	$	188

Presto Automation, Inc.	Warrant	January 16, 2020	April 28, 2027	Preferred Series A		402,679	$	0.37	$	185	$	—	(7)(17)
	Warrant	January 16, 2020	July 28, 2027	Common Stock		170,993	$	5.85		28		—	(7)
Total Presto Automation, Inc.										213		—

Sub-Total: Artificial Intelligence & Automation (0.0%)*									$	334	$	208

Biotechnology

Pendulum Therapeutics, Inc.	Warrant	January 16, 2020	October 9, 2029	Preferred Series B		55,263	$	1.90	$	43	$	44	(17)
	Warrant	June 1, 2020	July 15, 2030	Preferred Series B		36,842	$	1.90		36		30	(17)
	Warrant	December 31, 2021	December 31, 2031	Preferred Series C		322,251	$	3.24		118		194	(17)
	Warrant	February 5, 2024	February 5, 2034	Common Stock		1,143,690	$	1.03		588		1,129
Total Pendulum Therapeutics, Inc.										785		1,397

Sub-Total: Biotechnology (0.2%)*									$	785	$	1,397

Connectivity
Tarana Wireless, Inc.	Warrant	June 30, 2021	June 30, 2031	Common Stock		5,027,629	$	0.19	$	967	$	2,701
	Warrant	September 23, 2024	September 23, 2034	Common Stock		2,094,922	$	0.51		695		722	(9)(19)
Total Tarana Wireless, Inc.										1,662		3,423

Vertical Communications, Inc.	Warrant	January 16, 2020	July 11, 2026	Preferred Series A		828,479	$	1.00	$	—	$	—	(11)(17)(21)

viaPhoton, Inc.	Warrant	March 31, 2022	March 31, 2032	Common Stock		15,839	$	0.60	$	22	$	1

Sub-Total: Connectivity (0.4%)*									$	1,684	$	3,424

Construction Technology
Project Frog, Inc.	Warrant	January 16, 2020	February 28, 2027	Preferred Series AA-1		211,649	$	0.19	$	9	$	—	(17)(21)
	Warrant	January 16, 2020	February 28, 2027	Common Stock		180,340	$	0.19		9		—	(21)
	Warrant	August 3, 2021	December 31, 2031	Preferred Series CC		250,000	$	0.01		20		2	(17)(21)
Total Project Frog, Inc.										38		2

Sub-total: Construction Technology (0.0%)*									$	38	$	2


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Expiration Date	Series	Shares		Strike Price		Cost		Fair Value (6)		Footnotes
Warrant Investments- United States, Continued

Consumer Products & Services
BaubleBar, Inc.	Warrant	January 16, 2020	March 29, 2027	Preferred Series C		531,806	$	1.96	$	638	$	33	(17)
	Warrant	January 16, 2020	April 20, 2028	Preferred Series C		60,000	$	1.96		72		4	(17)
Total BaubleBar, Inc.										710		37

Boosted eCommerce, Inc.	Warrant	December 14, 2020	December 14, 2030	Preferred Series A-1		759,263	$	0.84	$	259	$	—	(17)

Eterneva, Inc.	Warrant	September 30, 2024	September 30, 2034	Common Stock		833,333	$	0.48	$	421	$	477

Happiest Baby, Inc.	Warrant	January 16, 2020	May 16, 2029	Common Stock		182,554	$	0.33	$	193	$	35

Madison Reed, Inc.	Warrant	January 16, 2020	March 23, 2027	Preferred Series C		194,553	$	2.57	$	185	$	169	(17)
	Warrant	January 16, 2020	July 18, 2028	Common Stock		43,158	$	0.99		71		59
	Warrant	January 16, 2020	June 30, 2029	Common Stock		36,585	$	1.23		56		47
Total Madison Reed, Inc.										312		275

Ogee, Inc.	Warrant	February 14, 2023	February 14, 2033	Preferred Series A-3		243,668	$	0.68	$	54	$	303	(17)(19)
	Warrant	September 29, 2023	September 29, 2033	Preferred Series A-3		243,668	$	0.68		49		303	(17)(19)
	Warrant	August 1, 2024	August 1, 2034	Preferred Series A-3		243,668	$	0.68		104		303	(17)(19)
Total Ogee, Inc.										207		909

Portofino Labs, Inc.	Warrant	December 31, 2020	December 31, 2030	Common Stock		99,148	$	1.53	$	160	$	62
	Warrant	April 1, 2021	April 1, 2031	Common Stock		39,912	$	1.46		99		26
Total Portofino Labs, Inc.										259		88

Quip NYC, Inc.	Warrant	March 9, 2021	March 9, 2031	Common Stock		10,833	$	48.46	$	203	$	—

Rinse, Inc.	Warrant	May 10, 2022	May 10, 2032	Preferred Series C		278,761	$	1.13	$	118	$	454	(17)

SI Tickets, Inc.	Warrant	May 11, 2022	May 11, 2032	Common Stock		53,029	$	2.52	$	162	$	—

Super73, Inc.	Warrant	December 31, 2020	December 31, 2030	Common Stock		177,305	$	3.16	$	105	$	58

Trendly, Inc.	Warrant	January 16, 2020	August 10, 2026	Preferred Series A		245,506	$	1.14	$	222	$	1	(17)

VitaCup, Inc.	Warrant	June 23, 2021	June 23, 2031	Preferred Series C		68,996	$	2.79	$	9	$	—	(17)
	Warrant	November 22, 2023	November 22, 2033	Common Stock		51,225	$	0.41		—		—
Total VitaCup, Inc.										9		—

Whoop, Inc.	Warrant	May 17, 2023	May 17, 2033	Common Stock		2,393,845	$	0.43	$	1,099	$	2,275	(9)(19)

Sub-total: Consumer Products & Services (0.6%)*									$	4,279	$	4,609

Education Technology
Edblox, Inc.	Warrant	March 19, 2024	March 19, 2034	Common Stock		111,458	$	1.71	$	152	$	24

Medical Sales Training Holding Company	Warrant	March 18, 2021	March 18, 2031	Common Stock		130,853	$	7.74	$	108	$	23
	Warrant	April 17, 2024	April 17, 2034	Common Stock		32,493	$	7.74		73		6
	Warrant	December 18, 2024	December 18, 2034	Common Stock		21,444	$	7.74		4		4
Total Medical Sales Training Holding Company										185		33

Yellowbrick Learning, Inc.	Warrant	January 16, 2020	September 30, 2028	Common Stock		222,222	$	0.90	$	120	$	—

Sub-Total: Education Technology (0.0%)*									$	457	$	57


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Expiration Date	Series	Shares		Strike Price		Cost		Fair Value (6)		Footnotes
Warrant Investments- United States, Continued

Finance and Insurance
Beam Technologies, Inc.	Warrant	August 30, 2024	August 30, 2034	Common Stock		56,494	$	17.28	$	749	$	702	(19)

Bestow, Inc.	Warrant	August 1, 2024	August 1, 2034	Preferred Series C-2		349,793	$	0.01	$	1,987	$	1,624	(17)

Busbot, Inc.	Warrant	April 1, 2024	April 1, 2034	Common Stock		44,133	$	0.96	$	85	$	31

Centivo Corporation	Warrant	July 31, 2024	July 31, 2034	Common Stock		161,155	$	0.76	$	256	$	369	(9)(19)

DailyPay, Inc.	Warrant	September 30, 2020	September 30, 2030	Common Stock		89,264	$	3.00	$	151	$	1,516

Empower Financial, Inc.	Warrant	October 13, 2023	October 13, 2033	Common Stock		404,893	$	1.43	$	953	$	1,534	(9)(19)

Eqis Capital Management, Inc.	Warrant	June 15, 2022	June 15, 2032	Preferred Class B		904,000	$	0.01	$	10	$	87	(17)

Gravie, Inc.	Warrant	June 4, 2024	June 4, 2034	Common Stock		123,816	$	2.68	$	293	$	257	(9)(19)

Kafene, Inc.	Warrant	January 5, 2024	January 5, 2034	Common Stock		44,448	$	4.03	$	58	$	429

Mesa Financial, Inc.	Warrant	August 29, 2024	August 29, 2034	Common Stock		62,422	$	0.73	$	28	$	27	(10)

Parafin, Inc.	Warrant	February 16, 2024	February 16, 2034	Common Stock		24,616	$	7.09	$	118	$	321	(10)
	Warrant	July 25, 2024	July 25, 2034	Common Stock		24,641	$	7.09		108		321	(10)
	Warrant	December 23, 2024	December 23, 2034	Common Stock		3,657	$	11.14		49		43	(10)
Total Parafin, Inc.										275		685

RealtyMogul, Co.	Warrant	January 16, 2020	December 18, 2027	Preferred Series B		954,979	$	0.95	$	285	$	1,386	(17)

Slope Tech, Inc.	Warrant	September 14, 2022	September 14, 2032	Common Stock		90,971	$	0.88	$	109	$	476	(10)
	Warrant	August 30, 2023	August 30, 2033	Common Stock		21,303	$	0.88		112		112	(10)
Total Slope Tech, Inc.										221		588

Under Technologies, Inc.	Warrant	May 3, 2024	May 3, 2034	Common Stock		96,710	$	2.90	$	267	$	243	(19)

Wisetack, Inc.	Warrant	November 14, 2024	November 14, 2034	Common Stock		128,992	$	1.58	$	119	$	118	(19)

Sub-Total: Finance and Insurance (1.2%)*									$	5,737	$	9,596


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Expiration Date	Series	Shares		Strike Price		Cost		Fair Value (6)		Footnotes
Warrant Investments- United States, Continued

Food and Agriculture Technologies
Athletic Brewing Company, LLC	Warrant	October 28, 2022	October 28, 2032	Preferred Class B		3,741	$	140.21	$	287	$	490	(17)

Bowery Farming, Inc.	Warrant	January 16, 2020	June 10, 2029	Common Stock		68,863	$	5.08	$	410	$	—
	Warrant	December 22, 2020	December 22, 2030	Common Stock		29,925	$	6.24		160		—
	Warrant	September 10, 2021	September 10, 2028	Common Stock		21,577	$	0.01		617		—
	Warrant	December 29, 2023	December 29, 2030	Common Stock		114,725	$	0.01		29		—
Total Bowery Farming, Inc.										1,216	$	—

Daring Foods, Inc.	Warrant	April 8, 2021	April 8, 2031	Common Stock		68,100	$	0.27	$	106	$	55

DrinkPak, LLC	Warrant	September 13, 2022	September 13, 2032	Common Stock		2,387	$	19.12	$	7	$	59	(9)
	Warrant	February 17, 2023	February 17, 2033	Common Stock		12,010	$	18.89		26		296	(9)(19)
Total DrinkPak, LLC										33		355

Emergy, Inc.	Warrant	October 5, 2022	October 5, 2032	Common Stock		4,051	$	39.60	$	181	$	—	(9)

GrubMarket, Inc.	Warrant	June 15, 2020	June 15, 2030	Common Stock		405,000	$	1.10	$	115	$	4,256

Intelligent Brands, Inc. (f.k.a. PSB Holdings, Inc.)	Warrant	January 16, 2020	October 5, 2027	Common Stock		103,636	$	14.47	$	111	$	—
	Warrant	December 31, 2020	December 29, 2032	Common Stock		33,348	$	3.17		546		—
Total Intelligent Brands, Inc.										657		—

The Fynder Group, Inc.	Warrant	October 14, 2020	October 14, 2030	Common Stock		36,445	$	0.49	$	68	$	23

Zero Acre Farms, Inc.	Warrant	December 23, 2022	December 23, 2032	Class A Common Stock		20,181	$	2.13	$	79	$	8	(17)

Sub-Total: Food and Agriculture Technologies (0.6%)*									$	2,742	$	5,187


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Expiration Date	Series	Shares		Strike Price		Cost		Fair Value (6)		Footnotes
Warrant Investments- United States, Continued

Green Technology
Bolb, Inc.	Warrant	October 12, 2021	October 12, 2031	Common Stock		181,784	$	0.07	$	35	$	—

Edeniq, Inc.	Warrant	January 16, 2020	December 23, 2026	Preferred Series B		2,685,501	$	0.22	$	—	$	506	(11)(17)(21)
	Warrant	January 16, 2020	December 23, 2026	Preferred Series B		2,184,672	$	0.01		—		855	(11)(17)(21)
	Warrant	January 16, 2020	June 29, 2027	Preferred Series C		5,106,972	$	0.44		—		149	(11)(17)(21)
	Warrant	January 16, 2020	November 2, 2028	Preferred Series C		3,850,294	$	0.01		—		1,709	(11)(17)(21)
	Warrant	November 29, 2021	November 29, 2031	Preferred Series D		154,906,320	$	0.01		7		4,529	(17)(21)
Total Edeniq, Inc.										7		7,748

Footprint International Holding, Inc.	Warrant	February 14, 2020	February 14, 2030	Common Stock		38,171	$	0.31	$	9	$	—
	Warrant	February 18, 2022	February 18, 2032	Common Stock		77,524	$	0.01		4,246		—
	Warrant	June 23, 2022	June 23, 2032	Common Stock		14,624	$	0.01		359		—
	Warrant	October 31, 2024	October 31, 2034	Preferred Class F		250	$	25,000.00		—		—	(17)
Total Footprint International Holding, Inc.										4,614		—

Form Energy Inc.	Warrant	October 21, 2024	October 21, 2034	Common Stock		99,287	$	8.03	$	925	$	891	(19)

Mainspring Energy, Inc.	Warrant	January 16, 2020	July 9, 2029	Common Stock		140,186	$	1.15	$	283	$	224
	Warrant	November 20, 2020	November 20, 2030	Common Stock		81,294	$	1.15		226		130
	Warrant	March 18, 2022	March 18, 2032	Common Stock		137,692	$	1.66		344		210
Total Mainspring Energy, Inc.										853		564

RTS Holding, Inc.	Warrant	December 10, 2021	December 10, 2031	Preferred Series C		2,314	$	205.28	$	75	$	99	(9)(17)
	Warrant	October 10, 2022	October 10, 2032	Preferred Series D		917	$	196.50		87		44	(9)(17)
	Warrant	January 19, 2024	January 19, 2034	Preferred Series D-1		2,876	$	203.47		418		137	(9)(17)
Total RTS Holding, Inc.										580		280

Sub-Total: Green Technology (1.2%)*									$	7,014	$	9,483

Healthcare Technology
Dentologie Enterprises, Inc.	Warrant	October 14, 2022	October 14, 2034	Common Stock		51,632	$	0.76	$	66	$	147	(9)

Exer Holdings, LLC	Warrant	November 19, 2021	November 19, 2031	Common Stock		281	$	527.51	$	93	$	14

Hospitalists Now, Inc.	Warrant	January 16, 2020	March 30, 2026	Preferred Series D-2		135,807	$	5.89	$	71	$	390	(17)
	Warrant	January 16, 2020	December 6, 2026	Preferred Series D-2		750,000	$	5.89		391		2,152	(17)
Total Hospitalists Now, Inc.										462		2,542

Lark Technologies, Inc.	Warrant	September 30, 2020	September 30, 2030	Common Stock		76,231	$	1.76	$	177	$	4
	Warrant	June 30, 2021	June 30, 2031	Common Stock		79,325	$	1.76		258		4
	Warrant	December 22, 2022	December 22, 2032	Common Stock		97,970	$	2.49		58		4
Total Lark Technologies, Inc.										493		12

Moxe Health Corporation	Warrant	December 29, 2023	December 29, 2033	Preferred Series B		155,438	$	3.62	$	135	$	48	(17)

RXAnte, Inc.	Warrant	November 21, 2022	November 21, 2032	Preferred A		16,517	$	10.00	$	89	$	121	(9)(17)(19)
	Warrant	April 7, 2023	November 21, 2032	Preferred A		5,518	$	10.00		25		41	(9)(17)(19)
	Warrant	October 17, 2023	November 21, 2032	Preferred A		5,506	$	10.00		37		40	(9)(17)(19)
Total RXAnte, Inc.										151		202

TMRW Life Sciences, Inc.	Warrant	April 29, 2022	April 29, 2032	Preferred Class A		268,983	$	2.09	$	80	$	6	(17)
	Warrant	March 3, 2023	April 29, 2032	Preferred Class A		268,983	$	2.09		80		6	(17)
Total TMRW Life Sciences, Inc.										160		12

Sub-Total: Healthcare Technology (0.4%)*									$	1,560	$	2,977


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Expiration Date	Series	Shares		Strike Price		Cost		Fair Value (6)		Footnotes
Warrant Investments- United States, Continued

Human Resource Technology
BetterLeap, Inc.	Warrant	April 20, 2022	April 20, 2032	Common Stock		88,435	$	2.26	$	38	$	6

Qwick, Inc.	Warrant	December 31, 2021	December 31, 2031	Common Stock		16,964	$	2.79	$	48	$	9
	Warrant	August 8, 2022	August 8, 2032	Common Stock		16,964	$	2.79		48		8
Total Qwick, Inc.										96		17

Sub-Total: Human Resource Technology (0.0%)*									$	134	$	23

Industrials
3DEO, Inc.	Warrant	February 23, 2022	February 23, 2032	Common Stock		37,218	$	1.81	$	93	$	—

Digilens, Inc.	Warrant	January 16, 2020	March 24, 2025	Preferred Series A-1		12,155	$	0.70	$	4	$	12	(17)
	Warrant	January 16, 2020	March 26, 2025	Preferred Series A-1		200,000	$	0.70		65		204	(17)
Total Digilens, Inc.										69		216

Sub-total: Industrials (0.0%)*									$	162	$	216

Marketing, Media, and Entertainment
Drone Racing League, Inc.	Warrant	October 17, 2022	October 17, 2032	Common Stock		253,824	$	6.76	$	375	$	—

Firefly Systems, Inc.	Warrant	January 31, 2020	January 29, 2030	Common Stock		133,147	$	1.14	$	281	$	121

Grabit Interactive Media, Inc.	Warrant	April 8, 2022	April 8, 2034	Preferred Series A		142,828	$	1.00	$	40	$	28	(17)

Incontext Solutions, Inc.	Warrant	January 16, 2020	September 28, 2028	Common Stock		2,219	$	220.82	$	34	$	—

PebblePost, Inc.	Warrant	May 7, 2021	May 7, 2031	Common Stock		657,343	$	0.52	$	68	$	735

Sub-Total: Marketing, Media, and Entertainment (0.1%)*									$	798	$	884

Medical Devices
Apiject Holdings, Inc.	Warrant	June 24, 2024	June 24, 2034	Common Stock		937,604	$	0.99	$	612	$	352	(9)(19)

Convergent Dental, Inc.	Warrant	April 21, 2023	April 21, 2033	Preferred Series D		446,982	$	1.61	$	493	$	103	(9)(17)

Delphinus, Inc.	Warrant	June 27, 2023	June 27, 2033	Preferred Series E		294,289	$	0.69	$	29	$	19	(9)(17)

Elucent Medical, Inc.	Warrant	October 31, 2024	October 31, 2034	Preferred Series C-2		1,889,448	$	0.30	$	167	$	210	(17)(19)

Lightforce Orthodontics, Inc.	Warrant	August 6, 2024	August 6, 2034	Preferred Series D		73,065	$	18.01	$	286	$	285	(17)(19)

Neuros Medical, Inc.	Warrant	August 10, 2023	August 10, 2033	Preferred Series C		1,197,127	$	0.38	$	110	$	100	(9)(17)

Restor3d, Inc.	Warrant	June 4, 2024	June 4, 2034	Preferred Series A		95,688	$	5.01	$	51	$	77	(9)(17)(19)

Shoulder Innovations, Inc.	Warrant	August 7, 2023	August 7, 2033	Preferred Series D		623,615	$	0.54	$	120	$	154	(9)(17)

Sub-Total: Medical Devices (0.2%)*									$	1,868	$	1,300

Other Healthcare Services
Cellares Corporation	Warrant	August 2, 2024	August 2, 2034	Common Stock		243,868	$	4.77	$	841	$	809	(19)

Upward Health, Inc.	Warrant	August 6, 2024	August 6, 2034	Preferred Class A Common Stock		763,137	$	0.28	$	251	$	260	(9)(17)(19)

Metabolon, Inc.	Warrant	March 28, 2024	March 28, 2034	Preferred Series 3		2,288,461	$	0.65	$	644	$	245	(17)
	Warrant	October 1, 2024	March 28, 2034	Preferred Series 3		384,615	$	0.65		33		41	(17)
Total Metabolon, Inc.										677		286

Velentium, Inc.	Warrant	May 24, 2024	May 24, 2034	Preferred Class B		7,958	$	53.40	$	129	$	154	(9)(17)

Sub-Total: Other Healthcare Services (0.2%)*									$	1,898	$	1,509


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Expiration Date	Series	Shares		Strike Price		Cost		Fair Value (6)		Footnotes
Warrant Investments- United States, Continued

Real Estate Technology
Homelight Lending, Inc.	Warrant	June 23, 2022	June 23, 2032	Common Stock		5,434	$	18.40	$	1	$	16

Knockaway, Inc.	Warrant	January 16, 2020	May 24, 2029	Common Stock		880	$	85.27	$	209	$	—	(21)
	Warrant	November 10, 2021	November 10, 2031	Common Stock		16,350	$	2.20		265		—	(21)
	Warrant	September 29, 2023	September 29, 2033	Common Stock		2,804,355	$	0.01		—		18	(21)
	Warrant	December 6, 2023	December 6, 2033	Preferred Series AA		457,778	$	0.01		—		6	(17)(21)
	Warrant	September 16, 2024	September 16, 2034	Preferred Series BB		93,951,849	$	0.00		2,391		2,401	(17)(21)
	Warrant	September 23, 2023	September 23, 2033	Preferred Series AA-1		5,084,804	$	0.09		—		—	(17)(21)
Total Knockaway, Inc.										2,865		2,425

Maxwell Financial Labs, Inc.	Warrant	October 7, 2020	October 7, 2030	Common Stock		106,735	$	0.29	$	20	$	9
	Warrant	December 22, 2020	December 22, 2030	Common Stock		110,860	$	0.29		34		9
	Warrant	September 30, 2021	September 30, 2031	Common Stock		79,135	$	1.04		148		5
	Warrant	May 10, 2024	May 10, 2034	Common Stock		303,562	$	0.27		83		26
	Warrant	July 1, 2024	May 10, 2034	Common Stock		303,562	$	0.27		91		26
Total Maxwell Financial Labs, Inc.										376		75

Orchard Technologies, Inc.	Warrant	February 12, 2024	February 12, 2034	Preferred Series 1		228,000	$	0.01	$	—	$	111	(17)

Sub-Total: Real Estate Technology (0.3%)*									$	3,242	$	2,627

SaaS
All Seated, Inc.	Warrant	February 28, 2022	February 28, 2032	Common Stock		5,101	$	15.72	$	20	$	—

Cart.com, Inc.	Warrant	November 17, 2023	November 17, 2033	Common Stock		31,572	$	15.87	$	441	$	697	(9)

Cpacket Networks, Inc.	Warrant	January 29, 2024	January 29, 2034	Preferred Class B Common		499,366	$	0.36	$	166	$	133	(9)(17)

Crowdtap, Inc.	Warrant	January 16, 2020	December 16, 2025	Preferred Series B		442,233	$	1.09	$	42	$	860	(17)
	Warrant	January 16, 2020	December 11, 2027	Preferred Series B		100,000	$	1.09		9		194	(17)
Total Crowdtap, Inc.										51		1,054

Gtxcel, Inc.	Warrant	January 16, 2020	September 24, 2025	Preferred Series C		1,000,000	$	0.21	$	83	$	16	(17)
	Warrant	January 16, 2020	September 24, 2025	Preferred Series D		1,000,000	$	0.21		83		22	(17)
Total Gtxcel, Inc.										166		38

Lucidworks, Inc.	Warrant	January 16, 2020	June 27, 2026	Preferred Series D		619,435	$	0.77	$	806	$	686	(17)

Reciprocity, Inc.	Warrant	September 25, 2020	September 25, 2030	Common Stock		114,678	$	4.17	$	99	$	—
	Warrant	April 29, 2021	April 29, 2031	Common Stock		57,195	$	4.17		54		—
Total Reciprocity, Inc.										153		—

Silk Technologies, Inc.	Warrant	November 4, 2024	November 4, 2034	Common Stock		237,623	$	1.98	$	503	$	491	(19)

Smartly, Inc.	Warrant	May 16, 2022	May 16, 2034	Common Stock		48,097	$	1.10	$	84	$	90

Steno Agency, Inc.	Warrant	June 21, 2024	June 21, 2034	Common Stock		55,818	$	1.98	$	136	$	147	(9)(19)

The Tomorrow Companies, Inc.	Warrant	December 14, 2022	December 14, 2032	Common Stock		26,124	$	1.70	$	49	$	25	(9)

Sub-Total: SaaS (0.4%)*									$	2,575	$	3,361


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Expiration Date	Series	Shares		Strike Price		Cost		Fair Value (6)		Footnotes
Warrant Investments- United States, Continued

Space Technology
Astranis Space Technology Corporation	Warrant	April 13, 2023	April 13, 2033	Common Stock		85,644	$	7.89	$	83	$	279	(9)(19)
	Warrant	September 27, 2024	September 27, 2034	Common Stock		156,677	$	2.27		683		683	(9)(19)
Total Astranis Space Technology Corporation										766		962

Axiom Space, Inc.	Warrant	May 28, 2021	May 28, 2031	Common Stock		1,773	$	169.24	$	121	$	23
	Warrant	May 28, 2021	May 28, 2031	Common Stock		882	$	340.11		39		4
Total Axiom Space, Inc.										160		27

Hermeus Corporation	Warrant	August 9, 2022	August 9, 2032	Common Stock		19,286	$	6.24	$	144	$	47	(9)(19)

Impulse Space, Inc.	Warrant	June 18, 2024	June 18, 2034	Common Stock		64,087	$	1.91	$	258	$	564	(9)(19)

Slingshot Aerospace, Inc.	Warrant	July 12, 2024	July 12, 2034	Common Stock		328,416	$	0.46	$	400	$	389	(9)(19)

Kymeta Corporation	Warrant	July 3, 2024	July 3, 2034	Common Stock		3,995,407	$	0.11	$	331	$	354	(9)(19)

Space Perspective, Inc.	Warrant	March 3, 2022	March 3, 2032	Preferred Series A		221,280	$	2.75	$	256	$	—	(17)

Sub-Total: Space Technology (0.3%)*									$	2,315	$	2,343

Supply Chain Technology
Macrofab, Inc.	Warrant	July 21, 2023	July 21, 2033	Common Stock		622,353	$	2.02	$	332	$	67
	Warrant	April 11, 2024	April 11, 2034	Common Stock		392,157	$	0.01		254		107
	Warrant	January 29, 2024	January 29, 2034	Common Stock		322,013	$	2.02		128		35
Total Macrofab, Inc.										714		209

Nucleus RadioPharma, Inc.	Warrant	June 4, 2024	June 4, 2034	Common Stock		44,303	$	1.99	$	70	$	63	(9)

Sub-Total: Supply Chain Technology (0.0%)*									$	784	$	272

Transportation Technology
Get Spiffy, Inc.	Warrant	July 14, 2023	July 14, 2033	Common Stock		874,527	$	0.70	$	408	$	2	(9)

NextCar Holding Company, Inc.	Warrant	December 14, 2021	December 14, 2026	Class A Common		6,211	$	64.42	$	35	$	—	(13)
	Warrant	February 23, 2022	February 23, 2027	Class A Common		486	$	64.42		3		—	(13)
	Warrant	March 16, 2022	March 16, 2027	Class A Common		583	$	64.42		3		—	(13)
	Warrant	April 18, 2022	April 18, 2027	Class A Common		5,336	$	64.42		7		—	(13)
	Warrant	September 29, 2022	September 29, 2027	Preferred Stock		1,224,752	$	0.22		170		—	(13)(17)
Total NextCar Holding Company, Inc.										218		—

Uveye, Inc.	Warrant	December 26, 2024	December 26, 2034	Preferred Ordinary		476,031	$	2.36	$	539	$	523	(17)

Zuum Transportation, Inc.	Warrant	April 30, 2024	April 30, 2034	Common Stock		41,271	$	4.34	$	95	$	111

Sub-Total: Transportation Technology (0.1%)*									$	1,260	$	636

Total: Warrant Investments- United States (6.1%)*									$	39,666	$	50,111


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Expiration Date	Series	Shares		Strike Price		Cost		Fair Value (6)		Footnotes
Warrant Investments- Europe

Industrials
Aledia, Inc.	Warrant	March 31, 2022	March 31, 2032	Preferred Ordinary		11,771	€	149.02	$	130	$	498	(17)

Sub-Total: Industrials (0.1%)*									$	130	$	498

Other Healthcare Services
Zandivio PLC	Warrant	October 29, 2024	October 29, 2034	Common Stock		132,042	€	0.01	$	771	$	845	(19)

Sub-Total: Other Healthcare Services (0.1%)*									$	771	$	845

Space Technology
All.Space Networks, Limited.	Warrant	August 22, 2022	August 22, 2032	Common Stock		71,203	$	21.79	$	113	$	—

Sub-Total: Space Technology (0.0%)*									$	113	$	—

Total: Warrant Investments- Europe (0.2%)*									$	1,014	$	1,343

Total: Warrant Investments- (6.3%)*									$	40,680	$	51,454


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Shares / Principal		Series	Cost		Fair Value (6)		Footnotes
Equity Investments- United States

Connectivity
Tarana Wireless, Inc.	Equity	March 16, 2022		611,246	Preferred Series 6	$	500	$	564	(17)

Vertical Communications, Inc.	Equity	January 16, 2020		3,892,485	Preferred Series 1	$	—	$	—	(11)(17)(21)
	Equity	January 16, 2020	$	5,500	Convertible Note		3,966		1,087	(16)(21)
Total Vertical Communications, Inc.							3,966		1,087

viaPhoton Inc.	Equity	May 23, 2024	$	740,000	SAFE Note	$	370	$	370

Sub-Total: Connectivity (0.2%)*						$	4,836	$	2,021

Construction Technology
Project Frog, Inc.	Equity	January 16, 2020		4,383,497	Preferred Series AA-1	$	351	$	—	(17)(21)
	Equity	January 16, 2020		3,401,678	Preferred Series BB		1,333		—	(17)(21)
	Equity	August 3, 2021		6,633,486	Common Stock		1,684		—	(21)
	Equity	August 3, 2021		3,129,887	Preferred Series CC		1,253		43	(17)(21)
Total Project Frog, Inc.							4,621		43

Sub-Total: Construction Technology (0.0%)*						$	4,621	$	43

Consumer Products & Services
Portofino Labs, Inc.	Equity	November 1, 2021		256,291	Preferred Series B-1	$	500	$	477	(17)

Quip NYC, Inc.	Equity	August 17, 2021		3,321	Common Stock	$	500	$	1

Rinse, Inc.	Equity	December 30, 2024		290,242	Preferred Series D	$	500	$	496	(17)

Sub-Total: Consumer Products & Services (0.1%)*						$	1,500	$	974

Finance and Insurance
Busbot, Inc.	Equity	October 18, 2024		539,490	Preferred Series B-1	$	500	$	501.000	(10)(17)

Centivo Corporation	Equity	December 20, 2024		128,393	Preferred Series B-1	$	375	$	368.000	(9)(17)(19)

Dynamics, Inc.	Equity	January 16, 2020		17,726	Preferred Series A	$	390	$	—	(17)

Empower Financial, Inc.	Equity	May 15, 2024		2,810,235	Preferred Series C Preferred	$	20,000	$	20,549
	Equity	May 15, 2024		300,285	Common Stock		4,023		1,424
Total Empower Financial, Inc.							24,023		21,973

Openly Holdings Corp.	Equity	May 9, 2023		44,725	Preferred Series D-1	$	500	$	569	(17)

Slope Tech, Inc.	Equity	June 20, 2023		64,654	Preferred Series A-3	$	500	$	520	(10)(17)

Sub-Total: Finance and Insurance (2.9%)*						$	26,288	$	23,931

Food and Agriculture Technologies
Emergy, Inc.	Equity	June 28, 2021		7,595	Common Stock	$	500	$	—

Athletic Brewing Company, LLC	Equity	August 1, 2024		2,144	Preferred Class B	$	500	$	501	(17)

Sub-Total: Food and Agriculture Technologies (0.1%)*						$	1,000	$	501


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Shares / Principal		Series	Cost		Fair Value (6)		Footnotes
Equity Investments- United States, Continued

Green Technology
Crusoe Energy Systems LLC	Equity	November 6, 2024		11,140	Preferred Series D-1	$	325	$	326	(9)(17)(19)

Edeniq, Inc.	Equity	January 16, 2020		7,807,499	Preferred Series B	$	—	$	3,129	(11)(17)(21)
	Equity	January 16, 2020		3,657,487	Preferred Series C		—		1,658	(11)(17)(21)
	Equity	January 16, 2020		133,766,138	Preferred Series D		—		5,569	(11)(17)(21)
Total Edeniq, Inc.							—		10,356

Electric Hydrogen Co.	Equity	April 6, 2023		87,112	Preferred Series C	$	500	$	304	(17)

Mainspring Energy, Inc.	Equity	March 30, 2022		65,614	Preferred Series E-1	$	500	$	291	(17)

RTS Holding, Inc.	Equity	July 5, 2022		2,035	Preferred Series D	$	334	$	345	(9)(17)
	Equity	February 15, 2023		1,966	Preferred Series D-1		405		342	(9)(17)
Total RTS Holding, Inc.							739		687

Sub-Total: Green Technology (1.5%)*						$	2,064	$	11,964

Healthcare Technology
Dentologie Enterprises, Inc.	Equity	August 3, 2023		72,338	Preferred Series B-1	$	300	$	302	(9)(17)

Emerald Cloud Lab, Inc.	Equity	June 3, 2022		499,999	Preferred Series A	$	500	$	103	(17)
	Equity	April 29, 2024		617,890	Preferred Series B-1		129		116	(17)
Total Emerald Cloud Lab, Inc.							629		219

Lark Technologies, Inc.	Equity	August 19, 2021		32,416	Preferred Series D	$	500	$	54	(17)

WorkWell Prevention & Care Inc.	Equity	January 16, 2020		7,000,000	Common Stock	$	51	$	—	(21)
	Equity	January 16, 2020		3,450	Preferred Series P		3,450		—	(17)(21)
	Equity	January 16, 2020	$	3,170	Convertible Note		3,219		—	(16)(21)
Total WorkWell Prevention & Care Inc.							6,720		—

Sub-Total: Healthcare Technology (0.1%)*						$	8,149	$	575


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Shares / Principal		Series	Cost		Fair Value (6)		Footnotes
Equity Investments- United States, Continued

Human Resource Technology
Nomad Health, Inc.	Equity	May 27, 2022		37,920	Common Stock	$	500	$	—

Sub-Total: Human Resource Technology (0.0%)*						$	500	$	—

Industrials
Digilens, Inc.	Equity	July 29, 2023		21,730	Preferred Series A-1	$	14	$	26	(17)
	Equity	September 18, 2024		9,498	Preferred Series A-1		8		12	(17)
	Equity	October 10, 2023		6,332	Preferred Series A-1		4		8	(17)
	Equity	January 12, 2024		12,205	Preferred Series A-1		7		15	(17)
	Equity	May 6, 2024		4,117	Preferred Series A-1		4		5	(17)
	Equity	June 9, 2024		2,617	Preferred Series A-1		2		3	(17)
	Equity	May 20, 2024		126,641	Preferred Series A-1		110		154	(17)
Total Digilens, Inc.							149		223

Sub-Total: Industrials (0.0%)*						$	149	$	223

Multi-Sector Holdings
Senior Credit Corp 2022 LLC	Equity	January 30, 2023		—	Preferred	$	5,522	$	6,186	(7)(10)(21)

EPT 16 LLC	Equity	June 28, 2024		—	Preferred	$	9,215	$	9,215	(7)(10)(17)(21)

Trinity Capital Adviser, LLC	Equity	June 28, 2024		—	Preferred	$	1	$	4,851	(10)(17)(21)

Sub-Total: Multi-Sector Holdings (2.5%)*						$	14,738	$	20,252

Real Estate Technology
Knockaway, Inc.	Equity	March 30, 2022		30,458	Common Stock	$	500	$	—	(21)
	Equity	September 29, 2023		2,956,224	Preferred Series AA		250		45	(17)(21)
	Equity	September 16, 2024		97,866,510	Preferred Series BB		2,500		2,510	(17)(21)
	Equity	September 7, 2023		3,409,997	Preferred Series AA-1		—		19	(17)(21)
Total Knockaway Inc.							3,250		2,574

Orchard Technologies, Inc.	Equity	August 6, 2021		2,938	Preferred Series 2	$	29	$	—	(17)
	Equity	March 16, 2023		97,060	Preferred Series 1		971		50	(17)
Total Orchard Technologies, Inc.							1,000		50

Maxwell Financial Labs, Inc	Equity	January 22, 2021		84,998	Preferred Series B	$	313	$	38	(17)
	Equity	May 10, 2024		229,972	Preferred Series B-1		365		155	(17)
	Equity	October 2, 2024		32,839	Preferred Series B-2		121		101	(17)
	Equity	October 2, 2024		17,804	Common Stock		66		2
Total Maxwell Financial Labs, Inc							865		296

Sub-Total: Real Estate Technology (0.4%)*						$	5,115	$	2,920

SaaS
Cart.com, Inc.	Equity	April 17, 2024		11,533	Preferred Series C	$	500	$	541	(9)(17)

Smartly, Inc.	Equity	March 29, 2023		136,388	Preferred Series B	$	500	$	689	(17)

The Tomorrow Companies, Inc.	Equity	July 5, 2023		108,088	Preferred Series E-1	$	325	$	231	(9)(17)

Sub-total: SaaS (0.2%)*						$	1,325	$	1,461


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Shares / Principal		Series	Cost		Fair Value (6)		Footnotes
Equity Investments- United States, Continued

Space Technology
Astranis Space Technology Corporation	Equity	April 5, 2023		13,685	Series C Prime Preferred	$	300	$	133	(9)(17)
	Equity	March 19, 2024		64,223	Preferred Series D		600		592	(9)(17)
Total Astranis Space Technology Corporation							900		725

Axiom Space, Inc.	Equity	August 11, 2021		3,624	Preferred Series C-1	$	521	$	449

Hadrian Automation, Inc.	Equity	March 29, 2022		53,154	Preferred A-4	$	500	$	570	(17)
	Equity	December 11, 2023		31,831	Preferred B-1		300		341	(9)(17)
Total Hadrian Automation, Inc.							800		911

Impulse Space, Inc.	Equity	August 30, 2024		35,754	Preferred Series B	$	500	$	492	(17)

Sub-total: Space Technology (0.3%)*						$	2,721	$	2,577

Supply Chain Technology
Macrofab, Inc.	Equity	January 30, 2024		247,173	Preferred C-1 Preferred	$	500	$	248	(17)

Sub-total: Supply Chain Technology (0.0%)*						$	500	$	248

Transportation Technology
NextCar Holding Company, Inc.	Equity	April 18, 2023		2,688,971	Preferred Series A-6	$	—	$	—	(17)

Sub-total: Transportation Technology (0.0%)*						$	—	$	—

Total: Equity Investments- United States (8.2%)*						$	73,506	$	67,690


Portfolio Company (1)	Type of Investment (2)	Investment Date (3)	Shares / Principal		Series	Cost		Fair Value (6)		Footnotes
Equity Investments- Canada

Construction Technology
Nexii, Inc.	Equity	July 24, 2024		250	Preferred Series A	$	3,049	$	2,614	(10)(17)
	Equity	July 24, 2024		50,000	Common Stock		1,370		1,008	(10)
Total Nexii, Inc.							4,419		3,622

Sub-Total: Construction Technology (0.4%)*						$	4,419	$	3,622

Supply Chain Technology
GoFor Delivers, Inc.	Equity	June 28, 2024		194,329	Series 2 Seed	$	660	$	673	(10)(21)

Sub-total: Supply Chain Technology (0.1%)*						$	660	$	673

Total: Equity Investments- Canada (0.5%)*						$	5,079	$	4,295

Total: Equity Investments (8.7%)*						$	78,585	$	71,985

Total Investment in Securities (209.7%)*						$	1,760,226	$	1,725,570

Cash and Cash Equivalents
Goldman Sachs Financial Square Government Institutional Fund						$	3,750	$	3,750
Other cash accounts							5,877		5,877
Cash and Cash Equivalents (1.2%)*							9,627		9,627

Total Portfolio Investments and Cash and Cash Equivalents (210.8%) of net assets)						$	1,769,853	$	1,735,197

* Value as a percent of net assets

(1)

All portfolio companies are located in North America or Europe. As of December 31, 2024, Trinity Capital Inc. (the “Company”) had five foreign domiciled portfolio companies, two of which are based in Canada and three of which are based in Europe. In total, these foreign domiciled portfolio investments represent 6.3% of total net asset value based on fair value. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale and may be deemed to be “restricted securities” under the Securities Act.

(2)

(3)

Investment date represents the date of initial investment date, either purchases or funding, not adjusted for modifications. For assets purchased from the Legacy Funds as part of the Formation Transactions (both terms as defined in “Note 1 – Organization and Basis of Presentation”), the investment date is January 16, 2020, the date of the Formation Transactions.

(4)

(5)

Principal is net of repayments, if any, as per the terms of the debt instrument’s contract.

(6)

Except as noted, all investments were valued at fair value as determined in good faith by the Company’s Board of Directors (the “Board”) using Level 3 inputs.

(7)

Asset is valued at fair value as determined in good faith by the Company's Board using Level 1 and Level 2 inputs.

(8)

The interest rate on variable interest rate investments represents a benchmark rate plus spread. The benchmark interest rate is subject to an interest rate floor. As of December 31, 2024, the U.S. Prime Rate (“Prime”) was 7.50% and the Secured Overnight Financing Rate (“SOFR”) 30 Day Forward Rate and 3-Month Term Rate were 4.33% and 4.31%, respectively.

(9)

Senior Credit Corp 2022 LLC owns an additional portion of this security. See “Note 12 – Related Party Transactions” for further discussion.

(10)

Indicates a “non-qualifying asset” under section 55(a) of the Investment Company Act of 1940, as amended (the “1940 Act”). The Company’s percentage of non-qualifying assets at fair value represents 14.6% of the Company’s total assets as of December 31, 2024. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets.

(11)

Investment has zero cost basis as it was purchased at a fair value of zero as part of the Formation Transactions (as defined in “Note 1 – Organization and Basis of Presentation”).

(12)

(13)

Company has been issued warrants with pricing and number of shares dependent upon a future round of equity issuance by the portfolio company.

(14)

(15)

(16)

(17)

Preferred stock represents investments through which the Company will have preference in liquidation rights and do not contain any cumulative preferred dividends.

(18)

Investment is on non-accrual status as of December 31, 2024, and is therefore considered non-income producing.

(19)

EPT 16 LLC owns an additional portion of this security. See “Note 12 – Related Party Transactions” for further discussion.

(20)

Investment has an unfunded commitment as of December 31, 2024 (see “Note 6 – Commitments and Contingencies”). The fair value of the investment includes the impact of the fair value of any unfunded commitments.

(21)

This investment is deemed to be a “Control Investment” or an “Affiliate Investment.” The Company classifies its investment portfolio in accordance with the requirements of the 1940 Act. The 1940 Act defines Control Investments as investments in companies in which the Company owns beneficially, either directly or indirectly, more than 25% of the voting securities, or maintains greater than 50% of the board representation. Affiliate Investments are defined by the 1940 Act as investments in companies in which the Company owns beneficially, either directly or indirectly, between 5% and 25% (inclusive) of the voting securities and does not have rights to maintain greater than 50% of the board representation. Fair value as of December 31, 2024, along with transactions during the year ended December 31, 2024 in these control and affiliate investments are as follows:


											Net change in
											Unrealized
	Fair Value at		Gross		Gross			Realized			(Depreciation)/			Fair Value at		Interest and
	December 31, 2023		Additions (1)		Reductions (2)			Gain/(Loss)			Appreciation			December 31, 2024		Dividend Income
For the Year Ended December 31, 2024
Control Investments
Edeniq, Inc.	$	11,386	$	873	$	(3,036	)	$	—		$	8,882		$	18,105	$	1,075
3Q GoFor Holdings, LP		4,222		988		(7,148	)		(4,226	)		6,164			—		—
Project Frog, Inc.		8		—		—			—			36			44		—
Vertical Communications, Inc.		16,745		264		(150	)		—			(251	)		16,608		1,819
WorkWell Prevention and Care Inc.		500		—		—			—			—			500		67
Knockaway, Inc.		22,989		29,252		(2,416	)		—			(684	)		49,141		5,803
Trinity Capital Adviser, LLC		—		1		—			—			4,850			4,851		—
Total Control Investments	$	55,850	$	31,378	$	(12,750	)	$	(4,226	)	$	18,997		$	89,249	$	8,764

Affiliate Investments
EPT 16 LLC	$	—	$	9,215	$	—		$	—		$	—		$	9,215	$	—
GoFor Delivers, Inc.		—		6,687		—			—			(246	)		6,441		393
Senior Credit Corp 2022 LLC		11,335		7,401		—			—			335			19,071		2,510
Total Affiliate Investments	$	11,335	$	23,303	$	—		$	—		$	89		$	34,727	$	2,903

Total Control and Affiliate Investments	$	67,185	$	54,681	$	(12,750	)	$	(4,226	)	$	19,086		$	123,976	$	11,667

(1)

(2)

TRINITY CAPITAL INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Note 1. Organization and Basis of Presentation

Trinity Capital Inc. (“Trinity Capital” and, together with its subsidiaries, the “Company”) is a specialty lending company focused on providing debt, including loans, equipment financings and asset based lending, to growth-oriented companies, including institutional investor-backed companies. Trinity Capital was formed on August 12, 2019 as a Maryland corporation and commenced operations on January 16, 2020. Prior to January 16, 2020, Trinity Capital had no operations, except for matters relating to its formation and organization as a business development company (“BDC”).

Trinity Capital is an internally managed, closed-end, non-diversified management investment company that has elected to be regulated as a BDC under the Investment Company Act of 1940, as amended (the “1940 Act”). Trinity Capital has elected to be treated, currently qualifies, and intends to continue to qualify annually as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”), for U.S. federal income tax purposes.

On September 27, 2019, Trinity Capital was initially capitalized with the issuance of 10 shares of its common stock for $150 to its sole stockholder.

On January 16, 2020, Trinity Capital completed a private offering of shares of its common stock (the “Private Common Stock Offering”) pursuant to which it issued and sold 8,333,333 shares of its common stock for total aggregate gross proceeds of approximately $125.0 million, inclusive of an over-allotment option that was exercised in full on January 29, 2020.

Concurrent with the initial closing of the Private Common Stock Offering, the Company completed a private debt offering (the “144A Note Offering” and together with the Private Common Stock Offering, the “Private Offerings”), pursuant to which it issued and sold $125.0 million in aggregate principal amount of the Company’s unsecured 7.00% Notes due 2025 (the “2025 Notes”), inclusive of the over-allotment option that was exercised in full on January 29, 2020.

On January 16, 2020, Trinity Capital completed a series of transactions, the Private Offerings, and the acquisition of Trinity Capital Investment, LLC, Trinity Capital Fund II, L.P. (“Fund II”), Trinity Capital Fund III, L.P., Trinity Capital Fund IV, L.P., and Trinity Sidecar Income Fund, L.P. (collectively, the “Legacy Funds”) through mergers of the Legacy Funds with and into Trinity Capital as well as Trinity Capital’s acquisition of Trinity Capital Holdings, LLC (“Trinity Capital Holdings”) (collectively, the “Formation Transactions”).

Trinity Capital’s common stock began trading on the Nasdaq Global Select Market on January 29, 2021, under the symbol “TRIN” in connection with its initial public offering of shares of its common stock (“IPO”).

On December 5, 2022, the Company entered into a joint venture agreement with certain funds and accounts managed by a specialty credit manager to co-manage Senior Credit Corp 2022 LLC (the “JV”), a Delaware limited liability company. The JV invests in secured loans and equipment financings to growth-oriented companies that have been originated by the Company. Refer to “Note 12 – Related Party Transactions” for additional information.

On March 16, 2023, the Company formed an unconsolidated wholly owned subsidiary, Trinity Capital Adviser LLC (“Adviser Sub”), a Delaware limited liability company. The Company was granted exemptive relief by the SEC that permits the Company to organize, acquire, wholly own and operate the Adviser Sub as an investment adviser registered under the Investment Advisers Act of 1940, as amended (the “Adviser Act”). The Adviser Sub may provide investment advisory and related services to one or more investment vehicles (the “Adviser Funds”) with ownership by one or more unrelated third-party investors and receive fee income for such services. Refer to “Note 12 – Related Party Transactions” for additional information.

On June 28, 2024, the Company and a specialty credit manager funded a portion of their respective capital commitments to commence operations of a credit fund, EPT 16 LLC (“EPT 16”), a Delaware limited liability company. EPT 16 has acquired and intends to acquire, hold and, as applicable, dispose of investments that have been originated by the Company. Refer to “Note 12 – Related Party Transactions” for additional information.

Basis of Presentation

The Company’s interim consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Articles 6, 10 and 12 of Regulation S-X. Accordingly, certain disclosures accompanying annual financial statements prepared in accordance with GAAP are omitted. In the opinion of management, the unaudited financial results included herein contain all adjustments, consisting solely of normal accruals, considered necessary for the fair statement of the results for the interim period included herein. The current period’s consolidated results of operations are not necessarily indicative of results that may be achieved for the year. The interim consolidated financial statements and notes thereto should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the Securities and Exchange Commission (“SEC”) on February 26, 2025. As an investment company, the Company follows accounting and reporting guidance determined by the Financial Accounting Standards Board (“FASB”), in Accounting Standards Codification, as amended (“ASC”) 946, Financial Services – Investment Companies (“ASC 946”).

Principles of Consolidation

Under ASC 946, the Company is precluded from consolidating portfolio company investments, including those in which it has a controlling interest, unless the portfolio company is another investment company. An exception to this general principle occurs if the Company holds a controlling interest in an operating company that provides all or substantially all of its services directly to the Company or to its portfolio companies. None of the portfolio investments made by the Company qualify for this exception. Therefore, the Company’s investment portfolio is carried on the Consolidated Statements of Assets and Liabilities at fair value, as discussed further in “Note 3 - Investments,” with any adjustments to fair value recognized as “Net change in unrealized appreciation/(depreciation) from investments” on the Consolidated Statements of Operations.

The Company’s consolidated operations include the activities of its wholly owned subsidiaries, Trinity Funding 1, LLC (“TF1”), and TrinCap Funding, LLC (“TCF”). TF1 was formed on August 14, 2019, as a Delaware limited liability company with Fund II as its sole equity member. On January 16, 2020, in connection with the Formation Transactions, Trinity Capital acquired TF1 through Fund II and became a party to, and assumed, a credit agreement with Credit Suisse AG (the “Credit Suisse Credit Facility”) through TF1 which matured on January 8, 2022 in accordance with its terms. TCF was formed on August 5, 2021, as a Delaware limited liability company with Trinity Capital as its sole equity member for purposes of securing lending in conjunction with a credit agreement with KeyBank National Association (“KeyBank”) (such credit facility, as amended, the “KeyBank Credit Facility”). TF1 and TCF are special purpose bankruptcy-remote entities and are separate legal entities from Trinity Capital. Any assets conveyed to TF1 or TCF are not available to creditors of the Company or any other entity other than TF1’s or TCF’s respective lenders. TF1 and TCF are consolidated for financial reporting purposes and in accordance with GAAP, and the portfolio investments held by these subsidiaries, if any, are included in the Company’s consolidated financial statements and recorded at fair value. All intercompany balances and transactions have been eliminated. As part of the Formation Transactions, Trinity Capital acquired 100% of the equity interests of Trinity Capital Holdings. There has been no activity in Trinity Capital Holdings since acquisition.

As permitted under Regulation S-X and consistent with the guidance in ASC 946-810-45-3, the Company will generally not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Company. The Company does not consolidate the Adviser Sub because it is not an investment company as defined in ASC 946 and provides investment advisory services exclusively to the Adviser Funds with ownership by one or more unrelated third-party investors ("External Parties"). The Company does not consolidate the JV or EPT 16 as the Company does not hold a majority of the ownership or economic interests of such entities, and the Company's representatives do not comprise the majority of the board of managers of the JV. Pursuant to ASC 946, the Adviser Sub, JV, and EPT 16 are each accounted for as a portfolio investment of the Company held at fair value and are not included as a consolidated subsidiary in the Company's financial statements. Refer to “Note 12 – Related Party Transactions” for additional information.

In accordance with Rule 10-01(b)(1) of Regulation S-X, as amended, the Company must determine which of its unconsolidated controlled subsidiaries, if any, are considered “significant subsidiaries.” In evaluating these unconsolidated controlled subsidiaries, there are two significance tests utilized per Rule 1-02(w) of Regulation S-X to determine if any of the Company’s investments or unconsolidated controlled subsidiaries are considered significant: the investment test and the income test. As of March 31, 2025 and December 31, 2024, none of the Company’s investments or unconsolidated controlled subsidiaries met either of these two significance tests.

Note 2. Summary of Significant Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ materially from these estimates.

Investment Transactions

Loan originations are recorded on the date of the legally binding commitment. Realized gains or losses are recorded using the specific identification method as the difference between the net proceeds received, excluding prepayment fees, if any, and the amortized cost basis of the investment without regard to unrealized gains or losses previously recognized, and include investments written off during the period, net of recoveries. The net change in unrealized gains or losses primarily reflects the change in investment fair values as of the last business day of the reporting period and also includes the reversal of previously recorded unrealized gains or losses with respect to investments realized during the period.

Valuation of Investments

The Company’s investments are carried at fair value in accordance with the 1940 Act and ASC 946 and measured in accordance with ASC 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the observability of inputs used to measure fair value, and provides disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that each of the portfolio investments is sold in a hypothetical transaction in the principal or, as applicable, most advantageous market using market participant assumptions as of the measurement date. Market participants are defined as buyers and sellers in the principal market that are independent, knowledgeable and willing and able to transact. The Company values its investments at fair value as determined in good faith pursuant to a consistent valuation policy by the Company’s Board of Directors (the “Board”) in accordance with the provisions of ASC 820 and the 1940 Act.

The SEC adopted Rule 2a-5 under the 1940 Act (“Rule 2a-5”), which establishes a framework for determining fair value in good faith for purposes of the 1940 Act. As adopted, Rule 2a-5 permits boards of directors to designate certain parties to perform fair value determinations, subject to board oversight and certain other conditions. The SEC also adopted Rule 31a-4 under the 1940 Act (“Rule 31a-4”), which provides the recordkeeping requirements associated with fair value determinations. While the Company's Board has not elected to designate a valuation designee, the Company has adopted certain revisions to its valuation policies and procedures to comply with the applicable requirements of Rule 2a-5 and Rule 31a-4.

While the Board is ultimately and solely responsible for determining the fair value of the Company’s investments, the Company has engaged independent valuation firms, on a discretionary basis, to provide the Company with valuation assistance with respect to its investments. Specifically, on a quarterly basis, the Company identifies portfolio investments with respect to which an independent valuation firm assists in valuing such investments. The Company selects these portfolio investments based on a number of factors, including, but not limited to, the potential for material fluctuations in valuation results, size, credit quality and the time lapse since the last valuation of the portfolio investment by an independent valuation firm.

Investments recorded on the Company’s Consolidated Statements of Assets and Liabilities are categorized based on the inputs to the valuation techniques as follows:

Level 1 — Investments whose values are based on unadjusted quoted prices for identical assets in an active market that the Company has the ability to access (examples include investments in active exchange-traded equity securities and investments in most U.S. government and agency securities).

Level 2 — Investments whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the investment.

Level 3 — Investments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement (for example, investments in illiquid securities issued by privately held companies). These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the investment.

Given the nature of lending to venture capital-backed growth-oriented companies, 99.1%, based on fair value, of the Company’s investments in these portfolio companies are considered Level 3 assets under ASC 820 because there is no known or accessible market or market index for these investment securities to be traded or exchanged. Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. The Company uses an internally developed portfolio investment rating system in connection with its investment oversight, portfolio management and analysis, and investment valuation procedures. This system takes into account both quantitative and qualitative factors of the portfolio companies. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material.

Debt Securities

The debt securities identified on the Consolidated Schedule of Investments are secured loans and equipment financings made to growth-oriented companies. For portfolio investments in debt securities for which the Company has determined that third-party quotes or other independent pricing are not available, the Company generally estimates the fair value based on the assumptions that hypothetical market participants would use to value the investment in a current hypothetical sale using an income approach.

In its application of the income approach to determine the fair value of debt securities, the Company bases its assessment of fair value on projections of the discounted future free cash flows that the security will likely generate, including analyzing the discounted cash flows of interest and principal amounts for the security, as set forth in the associated loan and equipment financing agreements, as well as market yields and the financial position and credit risk of the portfolio company (the “Hypothetical Market Yield Method”). The discount rate applied to the future cash flows of the security is based on the calibrated yield implied by the terms of the Company’s investment adjusted for changes in market yields and performance of the subject company. The Company’s estimate of the expected repayment date of its loans and equipment financings securities is either the maturity date of the instrument or the anticipated pre-payment date, depending on the facts and circumstances. The Hypothetical Market Yield Method also considers changes in leverage levels, credit quality, portfolio company performance, market yield movements, and other factors. If there is deterioration in credit quality or if a security is in workout status, the Company may consider other factors in determining the fair value of the security, including, but not limited to, the value attributable to the security from the enterprise value of the portfolio company or the proceeds that would most likely be received in a liquidation analysis.

Equity Securities and Warrants

Often the Company is issued warrants by issuers as yield enhancements. These warrants are recorded as assets at estimated fair value on the grant date. The Company determines the cost basis of the warrants or other equity securities received based upon their respective fair values on the date of receipt in proportion to the total fair value of the debt and warrants or other equity securities received. Depending on the facts and circumstances, the Company generally utilizes a combination of one or several forms of the market approach and contingent claim analyses (a form of option analysis) to estimate the fair value of the securities as of the measurement date and determines the cost basis using a relative fair value methodology. As part of its application of the market approach, the Company estimates the enterprise value of a portfolio company utilizing customary pricing multiples, based on the development stage of the underlying issuers, or other appropriate valuation methods, such as considering recent transactions in the equity securities of the portfolio company or third-party valuations that are assessed to be indicative of fair value of the respective portfolio company. If appropriate, based on the facts and circumstances, the Company performs an allocation of the enterprise value to the equity securities utilizing a contingent claim analysis and/or other waterfall calculation by which it allocates the enterprise value across the portfolio company’s securities in order of their preference relative to one another.

Fair value estimates are made at discrete points in time based on relevant information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amounts of the Company’s financial instruments, consisting of cash, investments, receivables, payables, and other liabilities, approximate the fair values of such items due to the short-term nature of these instruments. Refer to “Note 4 – Fair Value of Financial Instruments” for further discussion.

Cash and Cash Equivalents

Cash, cash equivalents and restricted cash consist of funds deposited with financial institutions and short-term (original maturity of three months or less) liquid investments in money market deposit accounts. Cash equivalents are classified as Level 1 assets and are valued using the net asset value (“NAV”) per share of the money market fund. As of March 31, 2025 and December 31, 2024, cash and cash equivalents consisted of $8.4 million and $9.6 million, respectively, of which $3.3 million and $3.8 million, respectively, was held in the Goldman Sachs Financial Square Government Institutional Fund with a yield between 3% - 6%. Cash held in demand deposit accounts may exceed the Federal Deposit Insurance Corporation (“FDIC”) insured limit and therefore is subject to credit risk. All of the Company’s cash deposits are held at large, established, high credit quality financial institutions, and management believes that the risk of loss associated with any uninsured balances is remote. As of March 31, 2025 and December 31, 2024, the Company did not have any restricted cash.

Other Assets

Other assets generally consist of fixed assets net of accumulated depreciation, leasehold improvements net of accumulated depreciation, right-of-use assets, prepaid expenses, deferred offering costs, unsettled receivables, and security deposits for operating leases.

Equity Offering Costs

Equity offering costs consist of fees and costs incurred in connection with the sale of the Company’s common stock, including legal, accounting and printing fees. These costs are deferred at the time of incurrence and are subsequently charged as a reduction to capital when the offering takes place or as shares are issued. Equity offering costs are periodically reviewed and expensed if the related registration is no longer active.

Security Deposits

Security deposits are collected upon funding equipment financings and are applied in lieu of regular payments at the end of the term.

Debt Financing Costs

The Company records costs related to the issuance of debt obligations as deferred debt financing costs. These costs are deferred and amortized using the straight-line method over the stated maturity life of the obligations. Debt financing costs related to secured or unsecured notes are netted with the outstanding principal balance on the Company’s Consolidated Statements of Assets and Liabilities. Debt financing costs related to the KeyBank Credit Facility are recorded as deferred credit facility costs on the Company’s Consolidated Statements of Assets and Liabilities.

Income Recognition

Interest and Dividend Income

The Company recognizes interest income on an accrual basis and recognizes it as earned in accordance with the contractual terms of the loan agreement to the extent that such amounts are expected to be collected. Original issue discount (“OID”) initially includes the estimated fair value of detachable warrants obtained in conjunction with the origination of debt securities and is accreted into interest income over the term of the loan as a yield enhancement based on the effective yield method. In addition, the Company may also be entitled to an end-of-term (“EOT”) payment. EOT payments to be paid at the termination of the debt agreements are accreted into interest income over the contractual life of the debt based on the effective yield method. When a portfolio company pre-pays their indebtedness prior to the scheduled maturity date, the acceleration of the unaccreted OID and EOT payment is recognized as interest income.

The Company has a limited number of debt investments in its portfolio that contain a payment-in-kind (“PIK”) provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. The Company will generally cease accruing PIK interest if there is insufficient value to support the accrual or management does not expect the portfolio company to be able to pay all principal and interest due. During the three months ended March 31, 2025 and 2024, the Company recorded $1.5 million and $4.1 million, respectively, in PIK interest income.

Income related to application or origination payments, including facility commitment fees, net of related expenses and generally collected in advance, is amortized into interest income over the contractual life of the loan. The Company recognizes nonrecurring fees and additional OID and EOT payment received in consideration for contract modifications commencing in the quarter relating to the specific modification.

The Company records dividend income on an accrual basis to the extent amounts are expected to be collected. Dividend income is recorded when dividends are declared by the portfolio company or at such other time that an obligation exists for the portfolio company to make a distribution. During the three months ended March 31, 2025 and 2024, the Company recorded $0.8 million and $0.2 million in dividend income, respectively.

Fee and Other Income

The Company recognizes one-time fee income, including, but not limited to, structuring fees, prepayment penalties, and exit fees related to a change in ownership of the portfolio company, as other income when earned. These fees are generally earned when the portfolio company enters into an equipment financing arrangement or pays off their outstanding indebtedness prior to the scheduled maturity. In addition, fee income may include fees for originations and administrative agent services rendered by the Company to the JV. Such fees are earned in the period that the services are rendered.

Non-Accrual Policy

When a debt security becomes 90 days or more past due, or if management otherwise does not expect that principal, interest, and other obligations due will be collected in full, the Company will generally place the debt security on non-accrual status and cease recognizing interest income on that debt security until all principal and interest due has been paid or the Company believes the borrower has demonstrated the ability to repay its current and future contractual obligations. Any uncollected interest is reversed from income in the period that collection of the interest receivable is determined to be doubtful. However, the Company may make exceptions to this policy if the investment has sufficient collateral value and is in the process of collection.

As of March 31, 2025, loans to three portfolio companies and equipment financings to two portfolio company were on non-accrual status, with a total cost of approximately $49.7 million, and a total fair value of approximately $15.2 million, or 0.9%, of the fair value of the Company’s debt investment portfolio. As of December 31, 2024, loans to three portfolio companies and equipment financings to two portfolio companies were on non-accrual status, with a total cost of approximately $43.3 million, and a total fair value of approximately $12.7 million, or 0.8%, of the fair value of the Company’s debt investment portfolio.

Net Realized Gains / (Losses)

Realized gains / (losses) are measured by the difference between the net proceeds from the sale or redemption of an investment or a financial instrument and the cost basis of the investment or financial instrument, without regard to unrealized appreciation or depreciation previously recognized, and includes investments written off during the period net of recoveries and realized gains or losses from in-kind redemptions. Net proceeds exclude any prepayment penalties, exit fees, and OID and EOT acceleration. Prepayment penalties and exit fees received at the time of sale or redemption are included in fee income on the Consolidated Statements of Operations. OID and EOT acceleration is included in interest income on the Consolidated Statements of Operations.

Net Change in Unrealized Appreciation / (Depreciation)

Net change in unrealized appreciation / (depreciation) reflects the net change in the fair value of the investment portfolio and financial instruments and the reclassification of any prior period unrealized appreciation or depreciation on exited investments and financial instruments to realized gains or losses.

Stock-Based Compensation

The Company has issued and may, from time to time, issue restricted stock, incentive stock options and non-statutory stock options to its officers and employees under the 2019 Trinity Capital Inc. Long Term Incentive Plan, as amended, and to its non-employee directors under the Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan, as amended. The Company accounts for its stock-based compensation plans using the fair value method, as prescribed by ASC 718, Compensation – Stock Compensation. Accordingly, for restricted stock awards, the Company measures the grant date fair value based upon the market price of its common stock on the date of the grant. For stock option awards, the Company estimates fair value using the Monte Carlo model, which requires the use of subjective assumptions such as expected stock price volatility, expected term of the option, risk-free interest rate, and expected dividend yield. The Company does not estimate forfeitures, and reverses all unvested costs associated with the stock option awards in the period they are forfeited. The Company amortizes the fair value of the awards as stock-based compensation expense over the requisite service period, which is generally the vesting term.

The Company has also adopted Accounting Standards Update (“ASU”) 2016-09, Compensation—Stock Compensation: Improvements to Employee Share-Based Payment Accounting, which requires that all excess tax benefits and tax deficiencies (including tax benefits of dividends on stock-based payment awards) be recognized as income tax expense or benefit in the income statement and not delay recognition of a tax benefit until the tax benefit is realized through a reduction to taxes payable. Accordingly, the tax effects of exercised or vested awards are treated as discrete items in the reporting period in which they occur. Additionally, the Company has elected to account for forfeitures as they occur.

Earnings Per Share

The Company's earnings per share (“EPS”) amounts have been computed based on the weighted-average number of shares of common stock outstanding for the period. Basic earnings per share is computed by dividing net increase (decrease) in net assets resulting from operations by the weighted-average number of common shares outstanding for the period. In accordance with ASC 260, Earnings Per Share, the unvested shares of restricted stock awarded pursuant to Trinity Capital’s equity compensation plans are participating securities and, therefore, are included in the basic earnings per share calculation. Diluted EPS is computed by dividing net increase (decrease) in net assets resulting from operations by the weighted average number of shares of common stock assuming all potential shares had been issued and the additional shares of common stock were dilutive. Diluted EPS, if any, during the fiscal year ending December 31, 2025 will reflect the dilutive effect of common stock deliverable pursuant to stock options which are subject to certain time-based and market-based vesting conditions before the delivery of the underlying common stock. Diluted EPS, if any, during the fiscal year ending December 31, 2024 reflects the potential dilution from the assumed conversion of the Company’s 6.00% Convertible Notes due 2025 (the “Convertible Notes”).

Income Taxes

The Company has elected to be treated, currently qualifies, and intends to continue to qualify annually, as a RIC under Subchapter M of the Code for U.S. federal tax purposes. In order to maintain its treatment as a RIC, the Company is generally required to distribute at least annually to its stockholders at least the sum of 90% of its investment company taxable income (which generally includes its net ordinary taxable income and realized net short-term capital gains in excess of realized net long-term capital losses) and 90% of its net tax-exempt income (if any). The Company generally will not be subject to U.S. federal income tax on these distributed amounts but will pay U.S. federal income tax at corporate rates on any retained amounts.

The Company evaluates tax positions taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority in accordance with ASC 740, Income Taxes (“ASC 740”), as modified by ASC 946. Tax benefits of positions not deemed to meet the more-likely-than-not threshold, or uncertain tax positions, would be recorded as tax expense in the current year. It is the Company’s policy to recognize accrued interest and penalties related to uncertain tax benefits in income tax expense. The Company has no material uncertain tax positions as of March 31, 2025 and December 31, 2024. All the Company’s tax returns remain subject to examination by U.S. federal and state tax authorities.

Based on federal excise distribution requirements applicable to RICs, the Company will be subject to a 4% nondeductible federal excise tax on undistributed taxable income and gains unless the Company distributes in a timely manner an amount at least equal to the sum of (1) 98% of its ordinary income for each calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ending October 31 in that calendar year and (3) any income or gain realized, but not distributed, in the preceding years. For this purpose, however, any ordinary income or capital gain net income retained by the Company and on which the Company paid corporate income tax is considered to have been distributed. The Company, at its discretion, may determine to carry forward taxable income or gain and pay a 4% excise tax on the amount by which it falls short of this calendar-year distribution requirement. If the Company chooses to do so, this generally will increase expenses and reduce the amount available to be distributed to stockholders. The Company will accrue excise tax on estimated undistributed taxable income and capital gains as required on an annual basis.

Distributions

Distributions to common stockholders are recorded on the record date. The amount of taxable income to be paid out as a distribution is determined by the Board each quarter and is generally based upon the earnings estimated by management. Capital gains, if any, are distributed at least annually, although the Company may decide to retain all or some of those capital gains for investment and pay U.S. federal income tax at corporate rates on those retained amounts. If the Company chooses to do so, this generally will increase expenses and reduce the amount available to be distributed to stockholders.

Note 3. Investments

The Company provides debt, including loans, equipment financings and asset based lending to growth-oriented companies, including institutional investor-backed companies, primarily in the United States. The Company’s investment strategy includes making investments consisting primarily of term loans and equipment financings, and, to a lesser extent, working capital loans, equity, and equity-related investments. In addition, the Company may obtain warrants or contingent exit fees at funding from many of its portfolio companies.

Debt Securities

The Company’s debt securities primarily consist of direct investments in interest-bearing secured loans and equipment financings to privately held companies based in the United States. Secured loans are generally secured by a blanket first lien or a blanket second lien on the assets of the portfolio company. Equipment financings typically include a specific asset lien on mission-critical assets as well as a second lien on the assets of the portfolio company. These debt securities typically have a term of between three and five years from the original investment date. Certain of the debt securities are “covenant-lite” loans, which generally are loans that do not have a complete set of financial maintenance covenants and have covenants that are incurrence-based, meaning they are only tested and can only be breached following an affirmative action of the borrower rather than by a deterioration in the borrower’s financial condition. The equipment financings in the investment portfolio generally have fixed interest rates. The secured loans in the investment portfolio generally have floating interest rates subject to interest rate floors. Both equipment financings and secured loans generally include an EOT payment.

The specific terms of each debt security vary depending on the creditworthiness of the portfolio company and the projected value of the financed assets. Companies with stronger creditworthiness may receive an initial period of lower financing factor, which is analogous to an interest-only period on a traditional term loan. Equipment financings may include upfront interim payments and security deposits. Equipment financing arrangements have various structural protections, including customary default penalties, information and reporting rights, material adverse change or investor abandonment provisions, consent rights for any additions or changes to senior debt, and, as needed, intercreditor agreements with cross-default provisions to protect the Company’s second lien positions.

Warrant Investments

In connection with the Company’s debt investments, the Company may receive warrants in the portfolio company. Warrants received in connection with a debt investment typically include a potentially discounted contract price to exercise, and thus, as a portfolio company appreciates in value, the Company may achieve additional investment return from this equity interest. The warrants typically contain provisions that protect the Company as a minority-interest holder, as well as secured or unsecured put rights, or rights to sell such securities back to the portfolio company, upon the occurrence of specified events. In certain cases, the Company may also obtain follow-up rights in connection with these equity interests, which allow the Company to participate in future financing rounds.

Equity Investments

In specific circumstances, the Company may seek to make direct equity investments in situations where it is appropriate to align the interests of the Company with key management and stockholders of the portfolio company, and to allow for participation in the appreciation in the equity values of the portfolio company. These equity investments are generally made in connection with debt investments. The Company seeks to maintain fully diluted equity positions in its portfolio companies of 5% to 50% and may have controlling equity interests in some instances.

Portfolio Composition

The Company’s portfolio investments are in companies conducting business in a variety of industries. Industry classifications have been updated to a preferred presentation and the prior year has been amended to conform with the new preferred presentation. The following table summarizes the composition of the Company’s portfolio investments by industry at cost and fair value and as a percentage of the total portfolio as of March 31, 2025 and December 31, 2024 (dollars in thousands):


	March 31, 2025										December 31, 2024
	Cost					Fair Value					Cost					Fair Value
Industry	Amount		%			Amount		%			Amount		%			Amount		%
Finance and Insurance	$	310,142		16.9	%	$	313,212		17.6	%	$	319,278		18.1	%	$	322,735		18.7	%
Medical Devices		225,350		12.3	%		227,014		12.7	%		170,923		9.7	%		172,395		10.0	%
SaaS		183,954		10.0	%		187,035		10.4	%		144,896		8.2	%		146,778		8.5	%
Green Technology		149,129		8.1	%		162,461		9.1	%		146,851		8.3	%		158,852		9.2	%
Other Healthcare Services		155,106		8.5	%		156,530		8.7	%		142,430		8.1	%		143,186		8.3	%
Space Technology		145,957		8.0	%		145,656		8.1	%		141,163		8.0	%		142,034		8.2	%
Real Estate Technology		101,483		5.5	%		89,338		5.0	%		101,825		5.8	%		93,587		5.4	%
Artificial Intelligence & Automation		77,285		4.2	%		78,127		4.4	%		83,505		4.7	%		84,448		4.9	%
Healthcare Technology		70,545		3.9	%		61,690		3.4	%		78,381		4.5	%		71,853		4.2	%
Biotechnology		56,767		3.1	%		58,225		3.2	%		56,547		3.2	%		57,836		3.4	%
Consumer Products & Services		52,723		2.9	%		51,808		2.9	%		56,210		3.2	%		54,607		3.2	%
Transportation Technology		66,071		3.6	%		43,745		2.4	%		62,735		3.6	%		41,547		2.4	%
Connectivity		37,737		2.1	%		36,104		2.0	%		36,099		2.1	%		35,249		2.0	%
Multi-Sector Holdings (1)		27,623		1.5	%		35,448		2.0	%		27,623		1.6	%		33,137		1.9	%
Human Resource Technology		34,303		1.9	%		29,445		1.6	%		33,421		1.9	%		28,891		1.7	%
Education Technology		33,339		1.8	%		29,374		1.6	%		33,275		1.9	%		29,740		1.7	%
Marketing, Media, and Entertainment		28,742		1.6	%		28,514		1.6	%		38,749		2.2	%		38,479		2.2	%
Supply Chain Technology		30,289		1.7	%		27,849		1.6	%		29,765		1.7	%		28,535		1.7	%
Food and Agriculture Technologies		28,997		1.6	%		21,453		1.2	%		31,824		1.8	%		24,469		1.4	%
Industrials		3,864		0.2	%		4,100		0.2	%		11,772		0.7	%		9,677		0.6	%
Construction Technology		9,443		0.5	%		3,931		0.2	%		9,443		0.5	%		4,042		0.2	%
Digital Assets Technology and Services		1,638		0.1	%		1,630		0.1	%		3,511		0.2	%		3,493		0.2	%
Total	$	1,830,487		100.0	%	$	1,792,689		100.0	%	$	1,760,226		100.0	%	$	1,725,570		100.0	%

(1)

Multi-Sector Holdings consist of the Company's investments in Senior Credit Corp 2022 LLC, Trinity Capital Adviser LLC and EPT 16 LLC. These entities invest or manage investments in secured loans and equipment financings to growth-oriented companies that have been originated by the Company. The portfolio companies held by the Multi-Sector Holdings represent a diverse set of industry classifications, which are similar to those in which the Company invests directly. See “Note 12 – Related Party Transactions” in the notes to the consolidated financial statements included in this Quarterly Report on Form 10-Q for further discussion.

The geographic composition of the Company's investment portfolio is determined by the location of the corporate headquarters of the portfolio company. The following table summarizes the composition of the Company’s portfolio investments by geographic region of the United States and other countries at cost and fair value and as a percentage of the total portfolio as of March 31, 2025 and December 31, 2024 (dollars in thousands):


	March 31, 2025										December 31, 2024
	Cost					Fair Value					Cost					Fair Value
Geographic Region	Amount		%			Amount		%			Amount		%			Amount		%
United States:
West	$	595,153		32.5	%	$	597,966		33.3	%	$	543,501		30.7	%	$	543,102		31.5	%
Northeast		491,907		26.9	%		476,062		26.6	%		494,131		28.1	%		475,944		27.6	%
Mountain		187,904		10.3	%		173,465		9.7	%		191,244		10.9	%		180,644		10.5	%
Southeast		181,170		9.9	%		172,704		9.6	%		184,636		10.5	%		180,002		10.4	%
South		158,315		8.6	%		156,716		8.7	%		162,180		9.2	%		164,654		9.5	%
Midwest		109,163		6.0	%		101,381		5.7	%		104,074		5.9	%		96,193		5.6	%
Multi-Sector Holdings (1)		27,623		1.5	%		35,448		2.0	%		27,623		1.6	%		33,137		1.9	%
International:
Western Europe		67,772		3.7	%		68,012		3.8	%		41,366		2.4	%		41,455		2.4	%
Canada		11,480		0.6	%		10,935		0.6	%		11,471		0.7	%		10,439		0.6	%
Total	$	1,830,487		100.0	%	$	1,792,689		100.0	%	$	1,760,226		100.0	%	$	1,725,570		100.0	%

(1)

Multi-Sector Holdings consist of the Company's investments in Senior Credit Corp 2022 LLC, Trinity Capital Adviser LLC and EPT 16 LLC. These entities invest or manage investments in secured loans and equipment financings to growth-oriented companies that have been originated by the Company. The portfolio companies held by the Multi-Sector Holdings represent a diverse set of geographical classifications, which are similar to those in which the Company invests directly. See “Note 12 – Related Party Transactions” in the notes to the consolidated financial statements included in this Quarterly Report on Form 10-Q for further discussion.

The following table summarizes the composition of the Company’s portfolio investments by investment type at cost and fair value and as a percentage of the total portfolio as of March 31, 2025 and December 31, 2024 (dollars in thousands):


	March 31, 2025										December 31, 2024
	Cost					Fair Value					Cost					Fair Value
Investment	Amount		%			Amount		%			Amount		%			Amount		%
Secured Loans	$	1,371,035		74.9	%	$	1,330,377		74.2	%	$	1,322,999		75.1	%	$	1,286,668		74.5	%
Equipment Financings		339,053		18.5	%		336,728		18.8	%		317,962		18.1	%		315,463		18.3	%
Equity		79,096		4.3	%		73,808		4.1	%		78,585		4.5	%		71,985		4.2	%
Warrants		41,303		2.3	%		51,776		2.9	%		40,680		2.3	%		51,454		3.0	%
Total	$	1,830,487		100.0	%	$	1,792,689		100.0	%	$	1,760,226		100.0	%	$	1,725,570		100.0	%

Certain Risk Factors

In the ordinary course of business, the Company manages a variety of risks, including market risk, credit risk and liquidity risk. The Company identifies, measures and monitors risk through various control mechanisms, including investment limits and diversifying exposures and activities across a variety of instruments, markets and counterparties.

Market risk is the risk of potential adverse changes to the value of financial instruments because of changes in market conditions, including as a result of changes in the credit quality of a particular issuer, credit spreads, interest rates, and other movements and volatility in security prices or commodities. In particular, the Company may invest in issuers that are experiencing or have experienced financial or business difficulties (including difficulties resulting from the initiation or prospect of significant litigation or bankruptcy proceedings), which involves significant risks. The Company manages its exposure to market risk through the use of risk management strategies and various analytical monitoring techniques.

The Company’s investments are generally comprised of securities and other financial instruments or obligations that are illiquid or thinly traded, making purchase or sale of such securities and financial instruments at desired prices or in desired quantities difficult. Furthermore, the sale of any such investments may be possible only at substantial discounts, and it may be extremely difficult to value any such investments accurately.

The Company’s investments consist of growth-oriented companies, many of which have relatively limited operating histories and may experience variation in operating results. Many of these companies conduct business in regulated industries and could be affected by changes in government regulations. Most of the Company’s borrowers will need additional capital to satisfy their continuing working capital needs and other requirements, and in many instances, to service the interest and principal payments on the debt.

Note 4. Fair Value of Financial Instruments

ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the observability of inputs used to measure fair value, and provides disclosure requirements for fair value measurements. The Company accounts for its investments at fair value in accordance with ASC 820. As of March 31, 2025 and December 31, 2024, the Company’s portfolio investments consisted primarily of investments in secured loans and equipment financings. The fair value amounts have been measured as of the reporting date and have not been reevaluated or updated for purposes of these financial statements subsequent to that date. As such, the fair values of these financial instruments subsequent to the reporting date may be different than amounts reported.

In accordance with ASC 820, the Company has categorized its investments based on the priority of the inputs to the valuation technique into a three-level fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical investments (Level 1) and the lowest priority to unobservable inputs (Level 3). See “Note 2 – Summary of Significant Accounting Policies.”

As required by ASC 820, when the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3). Therefore, unrealized appreciation and depreciation related to such investments categorized within the Level 3 tables below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).

The fair value determination of each portfolio investment categorized as Level 3 requires one or more of the following unobservable inputs:

•

Financial information obtained from each portfolio company, including unaudited statements of operations and balance sheets for the most recent period available as compared to budgeted numbers;

•

Current and projected financial condition of the portfolio company;

•

Current and projected ability of the portfolio company to service its debt obligations;

•

Type and amount of collateral, if any, underlying the investment;

•

Current financial ratios (e.g., fixed charge coverage ratio, interest coverage ratio and net debt/EBITDA ratio) applicable to the investment;

•

Current liquidity of the investment and related financial ratios (e.g., current ratio and quick ratio);

•

Pending debt or capital restructuring of the portfolio company;

•

Projected operating results of the portfolio company;

•

Current information regarding any offers to purchase the investment;

•

Current ability of the portfolio company to raise any additional financing as needed;

•

Changes in the economic environment, which may have a material impact on the operating results of the portfolio company;

•

Internal occurrences that may have an impact (both positive and negative) on the operating performance of the portfolio company;

•

Qualitative assessment of key management;

•

Contractual rights, obligations or restrictions associated with the investment; and

•

Time to exit.

The use of significant unobservable inputs creates uncertainty in the measurement of fair value as of the reporting date. The significant unobservable inputs used in the fair value measurement of the Company’s investments, are (i) earnings before interest, tax, depreciation, and amortization (“EBITDA”) and revenue multiples (both projected and historic), and (ii) volatility assumptions. Significant increases (decreases) in EBITDA and revenue multiple inputs in isolation would result in a significantly higher (lower) fair value measurement. Similarly, significant increases (decreases) in volatility inputs in isolation would result in a significantly higher (lower) fair value assessment. Conversely, significant increases (decreases) in weighted average cost of capital inputs in isolation would result in a significantly lower (higher) fair value measurement. However, due to the nature of certain investments, fair value measurements may be based on other criteria, such as third-party appraisals of collateral and fair values as determined by independent third parties, which are not presented in the tables below.

The Company’s assets measured at fair value by investment type on a recurring basis as of March 31, 2025 were as follows (in thousands):


	Fair Value Measurements at Reporting Date Using
	Quoted Prices		Significant
	in Active		Other		Significant
	Markets for		Observable		Unobservable
	Identical Assets		Inputs		Inputs		Measured at
Assets	(Level 1)		(Level 2)		(Level 3)		Net Asset Value(1)		Total
Secured Loans	$	—	$	—	$	1,330,377	$	—	$	1,330,377
Equipment Financings		—		—		336,728		—		336,728
Warrants		—		—		51,776		—		51,776
Equity		—		—		58,464		15,344		73,808
Total Investments at fair value		—		—		1,777,345		15,344		1,792,689
Cash and cash equivalents		8,386		—		—		—		8,386
Total	$	8,386	$	—	$	1,777,345	$	15,344	$	1,801,075

(1)

In accordance with ASC 820, the Company's equity investments in Senior Credit Corp 2022 LLC and EPT 16 LLC are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value, and thus have not been classified in the fair value hierarchy.

The Company’s assets measured at fair value by investment type on a recurring basis as of December 31, 2024 were as follows (in thousands):


	Fair Value Measurements at Reporting Date Using
	Quoted Prices		Significant
	in Active		Other		Significant
	Markets for		Observable		Unobservable
	Identical Assets		Inputs		Inputs		Measured at
Assets	(Level 1)		(Level 2)		(Level 3)		Net Asset Value(1)		Total
Secured Loans	$	—	$	—	$	1,286,668	$	—	$	1,286,668
Equipment Financings		—		—		315,463		—		315,463
Warrants		—		—		51,454		—		51,454
Equity		—		—		56,584		15,401		71,985
Total Investments at fair value		—		—		1,710,169		15,401		1,725,570
Cash and cash equivalents		9,627		—		—		—		9,627
Total	$	9,627	$	—	$	1,710,169	$	15,401	$	1,735,197

(1)

The methodology for determining the fair value of the Company’s investments is discussed in “Note 2 – Summary of Significant Accounting Policies”. The following table provides a summary of the significant unobservable inputs used to measure the fair value of the Level 3 portfolio investments as of March 31, 2025.


	Fair Value as of
	March 31, 2025		Valuation Techniques/	Unobservable		Weighted
Investment Type	(in thousands)		Methodologies	Inputs (1)	Range	Average (2)

Debt investments	$	1,333,805	Discounted Cash Flows	Hypothetical Market Yield	3.6% - 38.8%		15.8	%

		298,696	Cost approximates fair value (6)	n/a	n/a	n/a

		21,719	Scenario Analysis	Probability Weighting of Alternative Outcomes	3.0% - 97.0%	n/a

Debt investment in the JV		12,885	Enterprise Value (8)	n/a	n/a	n/a

Equity investments		58,464	Market Approach	Revenue Multiple (3)	0.4x - 24.0x		2.6	x
				Volatility (5)	43.6% - 112.1%		54.9	%
				Risk-Free Interest Rate	3.9% - 4.1%		4.0	%
				Estimated Time to Exit (in years)	0.8 - 4.1		2.6

Warrants		51,776	Market Approach	Revenue Multiple (3)	0.2x - 20.4x		3.8	x
				Company Specific Adjustment (4)	n/a	n/a
				Volatility (5)	36.1% - 115.9%		58.6	%
				Risk-Free Interest Rate	3.9% - 4.2%		3.9	%
				Estimated Time to Exit (in years)	0.5 - 4.8		2.3

Total Level 3 Investments	$	1,777,345

(1)

The significant unobservable inputs used in the fair value measurement of the Company’s debt securities are hypothetical market yields and premiums/(discounts). The hypothetical market yield is defined as the exit price of an investment in a hypothetical market to hypothetical market participants where buyers and sellers are willing participants. The significant unobservable inputs used in the fair value measurement of the Company’s equity and warrant securities are revenue multiples and portfolio company specific adjustment factors. Additional inputs used in the option pricing model (“OPM”) include industry volatility, risk free interest rate and estimated time to exit. Significant increases (decreases) in the inputs in isolation would result in a significantly higher (lower) fair value measurement, depending on the materiality of the investment. For some investments, additional consideration may be given to data from the last round of financing, merger or acquisition events near the measurement date.

(2)

Weighted averages are calculated based on the fair value of each investment.

(3)

Represents amounts used when the Company has determined that market participants would use such multiples when pricing the investments.

(4)

Represents amounts used when the Company has determined market participants would take into account these discounts when pricing the investments.

(5)

Represents the range of industry volatility used by market participants when pricing the investment.

(6)

Includes debt investments originated within the past three months, for which cost approximates fair value, unless events have occurred during the period that would indicate a different valuation is warranted.

(7)

Represents investments where there is an observable transaction or pending event for the investment.

(8)

The Company determined the value of its subordinated note of the Senior Credit Corp 2022 LLC based on the total assets less the total liabilities senior to the subordinated notes held at Senior Credit Corp 2022 LLC in an amount not exceeding par under the Enterprise Value technique.

The following table provides a summary of the significant unobservable inputs used to fair value the Level 3 portfolio investments as of December 31, 2024.


	Fair Value as of
	December 31, 2024			Valuation Techniques/	Unobservable		Weighted
Investment Type	(in thousands)			Methodologies	Inputs (1)	Range	Average (2)

Debt investments	$		1,206,947	Discounted Cash Flows	Hypothetical Market Yield	9.6% - 56.3%		16.3	%

			369,600	Cost approximates fair value (6)	n/a	n/a	n/a

			12,699	Scenario Analysis	Probability Weighting of Alternative Outcomes	1.0% - 100.0%	n/a

Debt investment in the JV			12,885	Enterprise Value (8)	n/a	n/a	n/a

Equity investments			56,584	Market Approach	Revenue Multiple (3)	0.5x - 34.9x		3.4	x
					Volatility (5)	40.1% - 118.8%		55.4	%
					Risk-Free Interest Rate	4.2% - 4.3%		4.3	%
					Estimated Time to Exit (in years)	1.0 - 4.5		2.8

Warrants			51,454	Market Approach	Revenue Multiple (3)	0.2x - 34.9x		4.1	x
					Company Specific Adjustment (4)	n/a	n/a
					Volatility (5)	35.4% - 127.9%		61.0	%
					Risk-Free Interest Rate	4.2% - 4.4%		4.3	%
					Estimated Time to Exit (in years)	0.7 - 5.0		2.4

Total Level 3 Investments		$	1,710,169

(1)

(2)

Weighted averages are calculated based on the fair value of each investment.

(3)

Represents amounts used when the Company has determined that market participants would use such multiples when pricing the investments.

(4)

Represents amounts used when the Company has determined market participants would take into account these discounts when pricing the investments.

(5)

Represents the range of industry volatility used by market participants when pricing the investment.

(6)

(7)

Represents investments where there is an observable transaction or pending event for the investment.

(8)

Under the enterprise value technique, the significant unobservable inputs used in the fair value measurement of the Company's investment in debt or equity securities are: (i) EBITDA, (ii) revenue or (iii) asset multiple; as applicable. Increases or decreases in the valuation multiples in isolation may result in a higher or lower fair value measurement, respectively.

The following table provides a summary of changes in the fair value of the Company’s Level 3 debt, including loans and equipment financings (collectively “Debt”), equity and warrant portfolio investments for the three months ended March 31, 2025 (in thousands):


	Type of Investment
	Debt			Equity			Warrants			Total
Fair Value as of December 31, 2024	$	1,602,131		$	56,584		$	51,454		$	1,710,169
Purchases, net of deferred fees		216,327			917			1,214			218,458
Non-cash conversions (1)		—			69			(69	)		—
Transfers into/(out of) Level 3 (2)		—			—			—			—
Proceeds from sales and paydowns		(155,875	)		(471	)		(741	)		(157,087	)
Accretion of OID, EOT, and PIK payments		11,044			—			—			11,044
Net realized gain/(loss)		(2,371	)		(3	)		220			(2,154	)
Net change in unrealized appreciation/(depreciation)		(4,151	)		1,368			(302	)		(3,085	)
Fair Value as of March 31, 2025	$	1,667,105		$	58,464		$	51,776		$	1,777,345

Net change in unrealized appreciation/(depreciation) on Level 3 investments still held as of March 31, 2025	$	(7,051	)	$	1,368		$	(302	)	$	(5,985	)

(1)

The non-cash conversion includes an exercise of a warrant to an equity position.

(2)

During the three months ended March 31, 2025, there were no transfers into or out of Level 3.

The following table provides a summary of changes in the fair value of the Company’s Level 3 Debt, equity, warrant and escrow receivables portfolio investments for the year ended December 31, 2024 (in thousands):


	Type of Investment
	Debt			Equity			Warrants			Escrow Receivables			Total
Fair Value as of December 31, 2023	$	1,222,077		$	15,150		$	31,201		$	2,441		$	1,270,869
Purchases, net of deferred fees		1,180,013			6,709			20,774			—			1,207,496
Non-cash conversion (1)		(25,674	)		31,802			(6,128	)		—			—
Transfers into/(out of) of Level 3 (2)		(28,315	)		—			—			—			(28,315	)
Proceeds from sales and paydowns		(759,113	)		(11,477	)		8,006			(2,441	)		(765,025	)
Accretion of OID and EOT payments		39,574			—			—			—			39,574
Net realized gain/(loss)		(21,294	)		7,826			(9,962	)		—			(23,430	)
Net change in unrealized appreciation/(depreciation)		(5,137	)		6,574			7,563			—			9,000
Fair Value as of December 31, 2024	$	1,602,131		$	56,584		$	51,454		$	—		$	1,710,169

Net change in unrealized appreciation/(depreciation) on Level 3 investments still held as of December 31, 2024	$	(24,105	)	$	4,631		$	1,996		$	—		$	(17,478	)

(1)

The non-cash conversion includes the exercise of debt and warrant positions to equity positions during the period.

(2)

Transfers out of Level 3 during the year ended December 31, 2024, were related to the conversion of debt to equity in one publicly-traded portfolio company. During the year ended December 31, 2024, there were no transfers into Level 3.

Fair Value of Financial Instruments Carried at Cost

As of March 31, 2025 and December 31, 2024, the carrying value of the KeyBank Credit Facility was approximately $392.0 million and $113.0 million, respectively. The carrying value of the KeyBank Credit Facility as of March 31, 2025 and December 31, 2024 approximates the fair value, which was estimated using a relative market yield approach with Level 3 inputs.

As of March 31, 2025 and December 31, 2024, the carrying value of the 4.375% Notes due 2026 (the “August 2026 Notes”) was approximately $124.2 million and $124.1 million, respectively, net of unamortized deferred financing costs and discount of $0.8 million and $1.0 million, respectively. The August 2026 Notes have a fixed interest rate as discussed in “Note 5 – Borrowings.” The fair value of the Company’s August 2026 Notes as of March 31, 2025, and December 31, 2024, was approximately $114.9 million and $114.1 million, respectively, which was estimated using a relative market yield approach with Level 3 inputs.

As of March 31, 2025, and December 31, 2024, the carrying value of the Company’s 4.25% Notes due 2026 (the “December 2026 Notes”) was approximately $74.4 million and $74.3 million, respectively, net of unamortized deferred financing fees of $0.6 million and $0.7 million, respectively. The December 2026 Notes have a fixed interest rate as discussed in “Note 5 – Borrowings.” The fair value of the Company’s December 2026 Notes as of March 31, 2025 and December 31, 2024 was approximately $69.1 million and $68.6 million, respectively, which was estimated using a relative market yield approach with Level 3 inputs.

As of March 31, 2025 and December 31, 2024, the carrying value of the Company's 7.875% Notes due March 2029 (the “March 2029 Notes”) was approximately $112.4 million and $112.1 million, respectively, net of unamortized deferred financing fees of $2.8 million and $2.9 million, respectively. The March 2029 Notes have a fixed interest rate as discussed in “Note 5 – Borrowings.” The fair value of the Company's March 2029 Notes as of March 31, 2025 and December 31, 2024 was approximately $115.9 million and $116.2 million, respectively, based on the market closing price of the March 2029 Notes, which trade on the Nasdaq Global Select Market under the symbol “TRINZ”.

As of March 31, 2025 and December 31, 2024, the carrying value of the Company's 7.875% Notes due September 2029 (the “September 2029 Notes”) was approximately $115.0 million and $111.6 million, respectively, net of unamortized deferred financing fees of $3.4 million and $3.4 million, respectively. The September 2029 Notes have a fixed interest rate as discussed in “Note 5 – Borrowings.” The fair value of the Company's September 2029 Notes as of March 31, 2025 and December 31, 2024 was approximately $119.2 million and $118.0 million, respectively, based on the market closing price of the September 2029 Notes, which trade on the Nasdaq Global Select Market under the symbol “TRINI”.

As of March 31, 2025 and December 31, 2024, the carrying value of the Series A Senior Notes (the “Series A Notes”) was approximately $141.0 million and $140.9 million, respectively, net of unamortized deferred financing costs and discount of $1.5 million and $1.7 million, respectively. The Series A Notes have a fixed interest rate as discussed in “Note 5 – Borrowings.” The fair value of the Company’s Series A Notes as of March 31, 2025 and December 31, 2024 was approximately $142.5 million and $142.5 million, respectively, which was estimated using a relative market yield approach with Level 3 inputs.

Note 5. Borrowings

KeyBank Credit Facility

On October 27, 2021, TCF, a wholly owned subsidiary of the Company, as borrower, and the Company, as servicer, entered into a credit agreement (as amended, the “KeyBank Credit Agreement”) with the lenders from time-to-time party thereto, KeyBank, as administrative agent and syndication agent, and Wells Fargo, National Association, as collateral custodian and paying agent.

The KeyBank Credit Facility includes a commitment of $600.0 million from KeyBank and other banks and allows the Company, through TCF, to borrow up to $690.0 million. Borrowings under the KeyBank Credit Agreement generally bear interest at a rate equal to Adjusted Term SOFR plus 2.85% to 3.25%, subject to the number of eligible loans in the collateral pool. The KeyBank Credit Facility provides for a variable advance rate of up to 62% on eligible first lien loans and up to 47% on eligible second lien loans.

The KeyBank Credit Facility includes a three-year revolving period and a two-year amortization period and matures on July 27, 2029, unless extended. Such credit facility is collateralized by all investment assets held by TCF. The KeyBank Credit Agreement contains representations and warranties and affirmative and negative covenants customary for secured financings of this type, including certain financial covenants such as a consolidated tangible net worth requirement and a required asset coverage ratio.

The KeyBank Credit Agreement also contains customary events of default (subject to certain grace periods, as applicable), including but not limited to the nonpayment of principal, interest or fees; breach of covenants; inaccuracy of representations or warranties in any material respect; voluntary or involuntary bankruptcy proceedings; and change of control of the borrower without the prior written consent of KeyBank.

During the three months ended March 31, 2025, the Company borrowed $398.0 million and made repayments of $119.0 million under the KeyBank Credit Facility.

The Company incurred approximately $9.0 million of initial and additional financing costs in connection with the KeyBank Credit Facility that were capitalized and deferred using the straight-line method over the life of the facility. As of March 31, 2025 and December 31, 2024, unamortized deferred financing costs related to the KeyBank Credit Facility were $6.2 million and $6.6 million, respectively. As of March 31, 2025 and December 31, 2024, the Company had a borrowing availability of approximately $208.0 million and $487.0 million, respectively.

The summary information regarding the KeyBank Credit Facility is as follows (dollars in thousands):


		Three Months Ended				Three Months Ended
		March 31, 2025				March 31, 2024
Stated interest expense	$		6,131		$		4,843
Amortization of deferred financing costs			385				206
Total interest and amortization of deferred financing costs	$		6,516		$		5,049

Weighted average effective interest rate			8.5	%			9.1	%
Weighted average outstanding balance	$		305,296		$		221,086

Unsecured Notes

As of March 31, 2025 and December 31, 2024, the Company had the following outstanding Unsecured Notes (dollars in thousands):


	March 31, 2025		December 31, 2024
Series A Notes, net of $1,529 and $1650, respectively, of unamortized deferred financing costs	$	140,971	$	140,850
August 2026 Notes, net of $805 and $950, respectively, of unamortized deferred financing costs		124,195		124,050
September 2029 Notes, net of $3,387 and $3433, respectively, of unamortized deferred financing costs		115,003		111,567
March 2029 Notes, net of $2,840 and $2879, respectively, of unamortized deferred financing costs		112,421		112,121
December 2026 Notes, net of $636 and $729, respectively, of unamortized deferred financing costs		74,364		74,271
2025 Notes, net of $0 and $81, respectively, of unamortized deferred financing costs		—		152,419
Convertible Notes, net of $0 and $605, respectively, of unamortized deferred financing costs and discount		—		49,395
Total Unsecured Notes, net of $9,197 and $10,327, respectively, of unamortized deferred financing costs	$	566,954	$	764,673

2025 Notes

Concurrent with the completion of the Private Common Stock Offering, on January 16, 2020, the Company completed its offering of $105.0 million in aggregate principal amount of the unsecured 2025 Notes in reliance upon the available exemptions from the registration requirements of the Securities Act (the “144A Note Offering”). Keefe, Bruyette & Woods, Inc. (“KBW”), as the initial purchaser, exercised in full its option to purchase or place additional 2025 Notes and on January 29, 2020, the Company issued and sold an additional $20.0 million in aggregate principal amount of the 2025 Notes. As a result, the Company issued and sold a total of $125.0 million in aggregate principal amount of the 2025 Notes pursuant to the 144A Note Offering.

Concurrent with the closing of the 144A Note Offering, on January 16, 2020, the Company entered into a registration rights agreement for the benefit of the purchasers of the 2025 Notes in the 144A Note Offering. Pursuant to the terms of this registration rights agreement, the Company filed with the SEC a registration statement, which was initially declared effective on October 20, 2020, registering the public resale of the 2025 Notes by the holders thereof that elected to include their 2025 Notes in such registration statement.

The 2025 Notes were issued pursuant to an Indenture dated as of January 16, 2020 (the “Base Indenture”), between the Company and U.S. Bank National Association, as trustee (together with its successor in interest, U.S. Bank Trust Company, National Association, the “Trustee”), and a First Supplemental Indenture, dated as of January 16, 2020 (the “First Supplemental Indenture” and together with the Base Indenture, the “2025 Notes Indenture”), between the Company and the Trustee.

On July 22, 2022, the Company issued $50.0 million in aggregate principal amount of the 2025 Notes in an additional issuance of such 2025 Notes. On July 27, 2022, the underwriters exercised, in full, their option to purchase from the Company an additional $7.5 million in aggregate principal amount of the 2025 Notes solely to cover over-allotments in accordance with the Underwriting Agreement. The 2025 Notes issued pursuant to July 2022 offering were treated as a single series with the then-existing 2025 Notes under the 2025 Notes Indenture (the “Then-Existing 2025 Notes”) and had the same terms as the Then-Existing 2025 Notes (other than issue date and issue price). The 2025 Notes had the same CUSIP number and were fungible and ranked equally.

In connection with the additional issuance of the 2025 Notes, the 2025 Notes began trading on the Nasdaq Global Select Market under the symbol “TRINL” on July 29, 2022.

The 2025 Notes bore interest at a fixed rate of 7.00% per year that was payable quarterly on March 15, June 15, September 15, and December 15 of each year, commencing on March 15, 2020. The 2025 Notes were the direct, general unsecured obligations of the Company and ranked pari passu, or equal in right of payment, with all of the Company’s existing and future unsecured indebtedness or other obligations that were not so subordinated.

On May 17, 2024, the Company redeemed $30.0 million in aggregate principal amount of the $182.5 million in aggregate principal amount of then outstanding 2025 Notes.

On January 16, 2025, the 2025 Notes matured pursuant to their terms and were repaid in full. The 2025 Notes are no longer outstanding or listed on Nasdaq Global Select Market.

Aggregate offering costs in connection with the 2025 Notes issuance, including the underwriters' discount and commissions, were approximately $7.8 million, which were capitalized and deferred. As of March 31, 2025, there were no unamortized deferred financing costs related to the 2025 Notes. As of December 31, 2024, unamortized deferred financing costs related to the 2025 Notes was $0.1 million.

The components of interest expense and related fees for the 2025 Notes are as follows (in thousands):


		Three Months Ended				Three Months Ended
		March 31, 2025				March 31, 2024
Stated interest expense	$		445		$		3,194
Amortization of deferred financing costs			81				498
Total interest and amortization of deferred financing costs	$		526		$		3,692

Weighted average effective interest rate			8.3	%			8.1	%
Weighted average outstanding balance	$		25,417		$		182,500

6.00% Convertible Notes due 2025

On December 11, 2020, the Company completed a private offering (the “Private Convertible Note Offering”) of $50.0 million in aggregate principal amount of its unsecured Convertible Notes in reliance upon the available exemptions from the registration requirements of the Securities Act. KBW acted as the initial purchaser and placement agent in connection with the Private Convertible Note Offering pursuant to a purchase/placement agreement dated December 4, 2020, by and between the Company and KBW.

The Convertible Notes were issued pursuant to the Base Indenture and a Second Supplemental Indenture, dated as of December 11, 2020 (the “Second Supplemental Indenture” and together with the Base Indenture, the “Convertible Notes Indenture”), between the Company and the Trustee. Concurrent with the closing of the Convertible Note Offering, on December 11, 2020, the Company entered into a registration rights agreement for the benefit of the holders of the Convertible Notes and the shares of common stock issuable upon conversion thereof. Aggregate offering costs in connection with the Convertible Note Offering, including the initial purchaser and placement agent discount and commissions, were approximately $1.9 million, which were capitalized and deferred.

The Convertible Notes bore interest at a fixed rate of 6.00% per year, subject to additional interest upon certain events, payable semiannually in arrears on May 1 and November 1 of each year, beginning on May 1, 2021. Had an investment grade rating not been maintained with respect to the Convertible Notes, additional interest of 0.75% per annum would have accrued on the Convertible Notes until such time as the Convertible Notes received an investment grade rating of “BBB-” (or its equivalent) or better. The Convertible Notes rating remained at investment grade through the conversion date. The Convertible Notes would have matured on December 11, 2025.

On February 20, 2025, the holders of the Convertible Notes exercised their right to convert all of the outstanding principal amount of the Convertible Notes, pursuant to the terms of conditions of the Convertible Notes. At its election, the Company paid $66.2 million in cash to satisfy in full its obligation to pay the principal amount of the Convertible Notes and any accrued interest, such settlement amount being determined based on the then existing conversion rate of 81.6439 per $1,000 principal amount of the Convertible Notes. The net amount of the carrying value of the Convertible Notes and cash paid of $15.8 million was recorded in Paid-In Capital in Excess of Par Value on the Consolidated Statements of Assets and Liabilities, and as such, no realized gain/loss was recorded. As of March 31, 2025, the Convertible Notes are no longer outstanding.

The Convertible Notes were direct unsecured obligations of the Company and ranked pari passu, or equal in right of payment, with all of the Company’s then-existing and future unsecured indebtedness or other obligations that were not so subordinated, and senior in right of payment to all of the Company’s future indebtedness or other obligations that were expressly subordinated, or junior, in right of payment to the Convertible Notes.

The Convertible Notes were accounted for in accordance with ASC 470-20, Debt Instruments with Conversion and Other Options. In accounting for the Convertible Notes, the Company estimated at the time of issuance that the values of the debt and the embedded conversion feature of the Convertible Notes were approximately 99.1% and 0.9%, respectively. The original issue discount of 0.9%, or approximately $0.5 million, attributable to the conversion feature of the Convertible Notes was recorded in “capital in excess of par value” in the Consolidated Statements of Assets and Liabilities as of December 31, 2020.

The components of the carrying value of the Convertible Notes were as follows (in thousands):


	March 31, 2025		December 31, 2024
Principal amount of debt	$	—	$	50,000
Unamortized debt financing cost		—		(356	)
Original issue discount, net of accretion		—		(249	)
Carrying value of Convertible Notes	$	—	$	49,395

The components of interest expense and related fees for the Convertible Notes were as follows (in thousands):


		Three Months Ended				Three Months Ended
		March 31, 2025				March 31, 2024
Stated interest expense	$		417		$		750
Amortization of deferred financing costs and original issue discount			89				166
Total interest and amortization of deferred financing costs and original issue discount	$		506		$		916

Weighted average effective interest rate			7.1	%			7.3	%
Weighted average outstanding balance	$		28,333		$		50,000

August 2026 Notes

On August 24, 2021, the Company issued and sold $125.0 million in aggregate principal amount of its unsecured August 2026 Notes under its shelf Registration Statement on Form N-2. The August 2026 Notes were issued pursuant to the Base Indenture and a Third Supplemental Indenture, dated as of August 24, 2021 (together with the Base Indenture, the “August 2026 Notes Indenture”), between the Company and the Trustee. The August 2026 Notes mature on August 24, 2026, unless repurchased or redeemed in accordance with their terms prior to such date. The August 2026 Notes are redeemable, in whole or in part, at any time, or from time to time, at the Company’s option, at a redemption price equal to the greater of (1) 100% of the principal amount of the August 2026 Notes to be redeemed or (2) the sum of the present values of the remaining scheduled payments of principal and interest (exclusive of accrued and unpaid interest to the date of redemption) on the August 2026 Notes to be redeemed, discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) using the applicable treasury rate plus 50 basis points, plus, in each case, accrued and unpaid interest to the redemption date; provided, however, that if the Company redeems any August 2026 Notes on or after July 24, 2026, the redemption price for the August 2026 Notes will be equal to 100% of the principal amount of the August 2026 Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the date of redemption. In addition, if a change of control repurchase event (as defined in the August 2026 Notes Indenture) occurs prior to the maturity date of the August 2026 Notes or the Company’s redemption of all outstanding August 2026 Notes, the Company will be required, subject to certain conditions, to make an offer to the holders thereof to repurchase for cash some or all of the August 2026 Notes at a repurchase price equal to 100% of the principal amount of the August 2026 Notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the date of repurchase.

The August 2026 Notes bear interest at a fixed rate of 4.375% per year payable semiannually on February 15 and August 15 of each year, commencing on February 15, 2022. The August 2026 Notes are direct, general unsecured obligations of the Company and rank pari passu, or equal in right of payment, with all of the Company’s existing and future unsecured indebtedness or other obligations that are not so subordinated.

Aggregate offering costs in connection with the August 2026 Notes issuance, including the underwriters’ discount and commissions, were approximately $2.9 million, which were capitalized and deferred. As of March 31, 2025 and December 31, 2024, unamortized deferred financing costs related to the August 2026 Notes were $0.8 million and $1.0 million, respectively.

The components of interest expense and related fees for the 2026 Notes are as follows (in thousands):


		Three Months Ended				Three Months Ended
		March 31, 2025				March 31, 2024
Stated interest expense	$		1,367		$		1,367
Amortization of deferred financing costs			144				144
Total interest and amortization of deferred financing costs	$		1,511		$		1,511

Weighted average effective interest rate			4.8	%			4.8	%
Weighted average outstanding balance	$		125,000		$		125,000

December 2026 Notes

On December 15, 2021, the Company issued and sold $75.0 million in aggregate principal amount of its unsecured December 2026 Notes under its shelf Registration Statement on Form N-2. The December 2026 Notes were issued pursuant to the Base Indenture and a Fourth Supplemental Indenture, dated as of December 15, 2021 (together with the Base Indenture, the “December 2026 Notes Indenture”), between the Company and the Trustee. The December 2026 Notes mature on December 15, 2026, unless repurchased or redeemed in accordance with their terms prior to such date. The December 2026 Notes are redeemable, in whole or in part, at any time, or from time to time, at the Company’s option, at a redemption price equal to the greater of (1) 100% of the principal amount of the December 2026 Notes to be redeemed or (2) the sum of the present values of the remaining scheduled payments of principal and interest (exclusive of accrued and unpaid interest to the date of redemption) on the December 2026 Notes to be redeemed, discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) using the applicable treasury rate plus 50 basis points, plus, in each case, accrued and unpaid interest to the redemption date; provided, however, that if the Company redeems any December 2026 Notes on or after November 15, 2026, the redemption price for the December 2026 Notes will be equal to 100% of the principal amount of the December 2026 Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the date of redemption. In addition, if a change of control repurchase event (as defined in the December 2026 Notes Indenture) occurs prior to the maturity date of the December 2026 Notes or the Company’s redemption of all outstanding December 2026 Notes, the Company will be required, subject to certain conditions, to make an offer to the holders thereof to repurchase for cash some or all of the December 2026 Notes at a repurchase price equal to 100% of the principal amount of the December 2026 Notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the date of repurchase.

The December 2026 Notes bear interest at a fixed rate of 4.25% per year payable semiannually on June 15 and December 15 of each year, commencing on June 15, 2022. The December 2026 Notes are direct, general unsecured obligations of the Company and rank pari passu, or equal in right of payment, with all of the Company’s existing and future unsecured indebtedness or other obligations that are not so subordinated.

Aggregate offering costs in connection with the December 2026 Notes issuance, including the underwriters’ discount and commissions, were approximately $1.9 million, which were capitalized and deferred. As of March 31, 2025 and December 31, 2024, unamortized deferred financing costs related to the December 2026 Notes were $0.6 million and $0.7 million, respectively.

The components of interest expense and related fees for the December 2026 Notes are as follows (in thousands):


		Three Months Ended				Three Months Ended
		March 31, 2025				March 31, 2024
Stated interest expense	$		797		$		797
Amortization of deferred financing costs			93				99
Total interest and amortization of deferred financing costs	$		890		$		896

Weighted average effective interest rate			4.7	%			4.8	%
Weighted average outstanding balance	$		75,000		$		75,000

March 2029 Notes

On March 28, 2024, the Company issued and sold $115.0 million in aggregate principal amount of its unsecured March 2029 Notes under its shelf Registration Statement on Form N-2, which amount includes the underwriters' exercise, in full, of their option to purchase an additional $15.0 million in aggregate principal amount of the March 2029 Notes.

The March 2029 Notes were issued pursuant to the Base Indenture and a Fifth Supplemental Indenture, dated as of March 28, 2024 (together with the Base Indenture, the “March 2029 Notes Indenture”), between the Company and the Trustee. The March 2029 Notes mature on March 30, 2029, unless repurchased or redeemed in accordance with their terms prior to such date. The March 2029 Notes are redeemable, in whole or in part, at any time, or from time to time, at the Company's option on or after March 30, 2026 upon not less than 30 days’ nor more than 60 days’ written notice prior to the date fixed for redemption thereof, at a redemption price equal to 100% of the outstanding principal amount of the March 2029 Notes, plus accrued and unpaid interest payments otherwise payable for the then-current quarterly interest period accrued to, but excluding, the date fixed for redemption. In addition, if a change of control repurchase event (as defined in the March 2029 Notes Indenture) occurs prior to the maturity date of the March 2029 Notes, unless the Company has exercised its right to redeem the March 2029 Notes in full, holders will have the right, at their option, to require the Company to repurchase for cash some or all of the March 2029 Notes at a repurchase price equal to 100% of the principal amount of the March 2029 Notes being repurchased, plus accrued and unpaid interest, if any, to, but not including, the repurchase date.

The March 2029 Notes bear interest at a fixed rate of 7.875% per year payable quarterly on March 30, June 30, September 30 and December 30 of each year, commencing on June 30, 2024. The March 2029 Notes are direct, general unsecured obligations of the Company and rank pari passu, or equal in right of payment, with all of the Company’s existing and future unsecured indebtedness or other obligations that are not so subordinated.

The March 2029 Notes began trading on the Nasdaq Global Select Market under the symbol “TRINZ” on April 1, 2024.

On February 10, 2025, the Company entered into an open market sale agreement (the “Sales Agreement”) with B. Riley Securities, Inc. (the “Sales Agent”), as sales agent and/or principal thereunder. Under the Sales Agreement, the Company may, but has no obligation to, issue and sell, from time to time, up to $100,000,000 aggregate principal amount of the March 2029 Notes (the “ATM March 2029 Notes”) through the Sales Agent or to the Sale Agent, as principal for its own account. The ATM March 2029 Notes are (or will be) treated as a single series with the existing March 2029 Notes and have the same terms as the existing March 2029 Notes (other than the issue date and issue price). The March 2029 Notes have the same CUSIP number and are fungible and ranked equally. Any ATM March 2029 Notes issued in the future will be issued pursuant to the March 2029 Notes Indenture.

During the three months ended March 31, 2025, the Company issued and sold $0.3 million in aggregate principal amount of its ATM March 2029 Notes and raised $0.3 million of net proceeds after deducting deferred offering costs and commissions to the sales agents on notes sold under the Sales Agreement.

The components of the carrying value of the March 2029 Notes were as follows (in thousands):


	March 31, 2025			December 31, 2024
Principal amount of debt	$	115,261		$	115,000
Unamortized deferred financing cost		(2,842	)		(2,879	)
Issuance premium and/or (discount), net of accretion		2			—
Carrying value of March 2029 Notes	$	112,421		$	112,121

Aggregate offering costs in connection with the March 2029 Notes issuance, including the underwriters’ discount and commissions, were approximately $3.5 million, which were capitalized and deferred.

The components of interest expense and related fees for the March 2029 Notes are as follows (in thousands):


		Three Months Ended				Three Months Ended
		March 31, 2025				March 31, 2024
Stated interest expense	$		2,264		$		75
Amortization of deferred financing costs			173				5
Total interest and amortization of deferred financing costs	$		2,437		$		80

Weighted average effective interest rate			8.5	%			8.5	%
Weighted average outstanding balance	$		115,023		$		3,791

September 2029 Notes

On July 19, 2024, the Company issued and sold $115.0 million in aggregate principal amount of the September 2029 Notes under its shelf Registration Statement on Form N-2, which amount includes the underwriters' exercise, in full, of their option to purchase an additional $15.0 million in aggregate principal amount of additional September 2029 Notes.

The September 2029 Notes were issued pursuant to the Base Indenture and a Sixth Supplemental Indenture, dated as of July 19, 2024, between the Company and the Trustee (together with the Base Indenture, the "September 2029 Notes Indenture"). The September 2029 Notes mature on September 30, 2029, unless repurchased or redeemed in accordance with their terms prior to such date. The September 2029 Notes are redeemable, in whole or in part, at any time, or from time to time, at the Company's option on or after September 30, 2026 upon not less than 30 days’ nor more than 60 days’ written notice prior to the date fixed for redemption thereof, at a redemption price equal to 100% of the outstanding principal amount of the September 2029 Notes, plus accrued and unpaid interest payments otherwise payable for the then-current quarterly interest period accrued to, but excluding, the date fixed for redemption. In addition, if a change of control repurchase event (as defined in the September 2029 Notes Indenture) occurs prior to maturity date of the September 2029 Notes, unless the Company has exercised its right to redeem the September 2029 Notes in full, holders will have the right, at their option, to require the Company to repurchase for cash some or all of the September 2029 Notes at a repurchase price equal to 100% of the principal amount of the September 2029 Notes being repurchased, plus accrued and unpaid interest, if any, to, but not including, the repurchase date.

The September 2029 Notes bear interest at a fixed rate of 7.875% per year payable quarterly on March 30, June 30, September 30 and December 30 of each year, commencing on September 30, 2024. The September 2029 Notes are direct, general unsecured obligations of the Company and rank pari passu, or equal in right of payment, with all of the Company’s existing and future unsecured indebtedness or other obligations that are not so subordinated.

The September 2029 Notes began trading on the Nasdaq Global Select Market under the symbol “TRINI” on July 22, 2024.

On February 10, 2025, the Company entered into the Sales Agreement with the Sales Agent. Under the Sales Agreement, the Company may, but has no obligation to, issue and sell, from time to time, up to $100,000,000 aggregate principal amount of the September 2029 Notes (the “ATM September 2029 Notes”) through the Sales Agent or to the Sale Agent, as principal for its own account. The ATM September 2029 Notes are (or will be) treated as a single series with the existing September 2029 Notes and have the same terms as the existing September 2029 Notes (other than the issue date and issue price). The September 2029 Notes have the same CUSIP number and are fungible and ranked equally. Any ATM September 2029 Notes issued in the future will be issued pursuant to the September 2029 Notes Indenture.

During the three months ended March 31, 2025, the Company issued and sold $3.4 million in aggregate principal amount of its ATM September 2029 Notes and raised $3.4 million of net proceeds after deducting deferred offering costs and commissions to the sales agents on notes sold under the Sales Agreement.

The components of the carrying value of the September 2029 Notes were as follows (in thousands):


	March 31, 2025			December 31, 2024
Principal amount of debt	$	118,390		$	115,000
Unamortized deferred financing cost		(3,417	)		(3,433	)
Issuance premium and/or (discount), net of accretion		30			—
Carrying value of September 2029 Notes	$	115,003		$	111,567

Aggregate offering costs in connection with the September 2029 Notes issuance, including the underwriters’ discount and commissions, were approximately $3.9 million, which were capitalized and deferred.

The components of interest expense and related fees for the September 2029 Notes are as follows (in thousands):


		Three Months Ended				Three Months Ended
		March 31, 2025				March 31, 2024
Stated interest expense	$		2,265		$		—
Amortization of deferred financing costs			184				—
Total interest and amortization of deferred financing costs	$		2,449		$		—

Weighted average effective interest rate			8.5	%			—	%
Weighted average outstanding balance	$		115,251		$		—

Series A Notes

On October 29, 2024, the Company entered into a note purchase agreement (the “Note Purchase Agreement”) governing the issuance of (i) $55.5 million in aggregate principal amount of Series A Senior Notes, Tranche A, due October 29, 2027 (the “Series A 2027 Notes”), (ii) $73.0 million in aggregate principal amount of Series A Senior Notes, Tranche B, due October 29, 2028 (the “Series A 2028 Notes”) and (iii) $14.0 million in aggregate principal amount of Series A Senior Notes, Tranche C, due October 29, 2029 (the “Series A 2029 Notes” and, together with the Series A 2027 Notes and Series A 2028 Notes, collectively, the “Series A Notes”) to certain qualified institutional investors in a private placement.

The Series A Notes were delivered and paid for on October 29, 2024, subject to certain customary closing conditions. The Series A 2027 Notes have a fixed interest rate of 7.54% per year, the Series A 2028 Notes have a fixed interest rate of 7.60% per year and the Series A 2029 Notes have a fixed interest rate of 7.66% per year, subject to a step up to the extent a Below Investment Grade Event (as defined in the Note Purchase Agreement) or a Secured Debt Ratio Event (as defined in the Note Purchase Agreement) occurs. The Series A 2027 Notes will mature on October 29, 2027, the Series A 2028 Notes will mature on October 29, 2028 and the Series A 2029 Notes will mature on October 29, 2029, unless redeemed, purchased or prepaid prior to such date by us in accordance with the terms of the Note Purchase Agreement. Interest on the Series A Notes will be due semiannually in April and October of each year, beginning in April 2025. In addition, the Company is obligated to offer to repay the Series A Notes at par (plus accrued and unpaid interest to, but not including, the date of prepayment) if certain change in control events occur. Subject to the terms of the Note Purchase Agreement, the Company may redeem the Series A Notes in whole or in part at any time or from time to time at our option at par plus accrued interest to the prepayment date and, if the Series A 2027 Notes are redeemed on or before August 31, 2027, the Series A 2028 Notes are redeemed on or before August 31, 2028 or the Series A 2029 Notes are redeemed on or before August 1, 2029, a make-whole premium.

The Series A Notes were offered in reliance on Section 4(a)(2) of the Securities Act. The Series A Notes have not and will not be registered under the Securities Act or any state securities laws and, unless so registered, may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act, as applicable.

Aggregate offering costs in connection with the Series A Notes issuance, including the underwriters’ discount and commissions, were approximately $1.7 million, which were capitalized and deferred. As of March 31, 2025 and December 31, 2024, unamortized deferred financing costs related to the Series A Notes were $1.5 million and $1.7 million, respectively.

The components of interest expense and related fees for the Series A Notes are as follows (in thousands):


		Three Months Ended				Three Months Ended
		March 31, 2025				March 31, 2024
Stated interest expense	$		2,701		$		—
Amortization of deferred financing costs			120				—
Total interest and amortization of deferred financing costs	$		2,821		$		—

Weighted average effective interest rate			7.9	%			—	%
Weighted average outstanding balance	$		142,500		$		—

As of March 31, 2025, the Company was in compliance with the terms of the KeyBank Credit Agreement, the August 2026 Notes Indenture, the December 2026 Notes Indenture, the March 2029 Notes Indenture, the September 2029 Notes Indenture and the Note Purchase Agreement. As of December 31, 2024, the Company was in compliance with the terms of the KeyBank Credit Agreement, the 2025 Notes Indenture, the Convertible Notes Indenture, the August 2026 Notes Indenture, the December 2026 Notes Indenture, the March 2029 Notes Indenture, the September 2029 Notes Indenture and the Note Purchase Agreement.

Note 6. Commitments and Contingencies

Unfunded Commitments

The Company’s commitments and contingencies consist primarily of unused commitments to extend credit in the form of loans or equipment financings to the Company’s portfolio companies. A portion of these unfunded contractual commitments as of March 31, 2025 and December 31, 2024 are generally dependent upon the portfolio company reaching certain milestones before the debt commitment becomes available. Furthermore, the Company’s credit agreements contain customary lending provisions that allow the Company relief from funding obligations for previously made commitments in instances where the underlying portfolio company experiences materially adverse events that affect the financial condition or business outlook for the Company. Since a portion of these commitments may expire without being drawn, unfunded contractual commitments do not necessarily represent future cash requirements. As such, the Company’s disclosure of unfunded contractual commitments as of March 31, 2025 and December 31, 2024 includes only those commitments that are available at the request of the portfolio company and are unencumbered by milestones or additional lending provisions.

The Company has entered into a capital commitment with the JV and EPT 16 in the amount of $21.4 million and $10.0 million, respectively. As of March 31, 2025, the Company had unfunded commitments of $3.0 million and $0.8 million for the JV and EPT 16, respectively. As of March 31, 2025, the Company had aggregate unfunded commitments of $49.7 million to four portfolio companies. As of December 31, 2024, the Company had unfunded commitments of $3.0 million and $0.8 million for the JV and EPT 16, respectively. As of December 31, 2024, the Company had aggregate unfunded commitments of $31.2 million to two portfolio companies. The Company did not have any other off-balance sheet financings or liabilities as of March 31, 2025 or December 31, 2024.

The Company will fund its unfunded commitments, if any, from the same sources it uses to fund its investment commitments that are funded at the time they are made (which are typically through existing cash and cash equivalents and borrowings under its KeyBank Credit Facility) and maintains adequate liquidity to fund its unfunded commitments through these sources.

In the normal course of business, the Company enters into contracts that provide a variety of representations and warranties, and general indemnifications. Such contracts include those with certain service providers, brokers and trading counterparties. Any exposure to the Company under these arrangements is unknown as it would involve future claims that may be made against the Company; however, based on the Company’s experience, the risk of loss is remote and no such claims are expected to occur. As such, the Company has not accrued any liability in connection with such indemnifications.

Leases

ASU No. 2016‑02, Leases (Topic 842) (“ASU 2016‑02”) requires that a lessee evaluate its leases to determine whether they should be classified as operating or finance leases. The Company identified significant operating leases for its headquarters in Phoenix, AZ and office spaces in San Diego, CA. The lease for the Company's Phoenix headquarters commenced on July 10, 2021, and was most recently amended on September 17, 2024. Amendments since commencement include (i) additional office space and (ii) an extension to the term of the lease through May 31, 2031. The lease for Suite 200 in the Company's San Diego office commenced on March 10, 2023, and expires on January 31, 2026. The Company entered into a second lease in San Diego for Suite 203, which commenced on June 1, 2024, and expires on November 14, 2025. As of March 31, 2025, the weighted-average remaining lease term for the operating leases was 5.9 years.

The total lease expense incurred for the three months ended March 31, 2025 and 2024 was $0.4 million and $0.3 million, respectively. As of March 31, 2025 and December 31, 2024, the right of use assets related to the office operating leases were $5.2 million and $5.4 million, respectively, and the lease liabilities were $5.5 million and $5.7 million, respectively. As of March 31, 2025 and December 31, 2024, the weighted-average discount rate determined for the operating lease liabilities was 8.54% and 8.53%, respectively.

The following table shows future minimum payments under the Company’s operating leases as of March 31, 2025 (in thousands):


For the Years Ended December 31,	Total
2025	$	982
2026		1,008
2027		1,021
2028		1,051
2029		1,080
Thereafter		1,565
Total	$	6,707

Legal Proceedings

The Company may, from time to time, be involved in litigation arising out of its operations in the normal course of business or otherwise. Furthermore, third parties may try to seek to impose liability on the Company in connection with the activities of its portfolio companies. As of March 31, 2025, there were no material legal matters or material litigation pending of which the Company is aware.

Note 7. Stockholders' Equity

The Company authorized 200,000,000 shares of its common stock with a par value of $0.001 per share. On September 27, 2019, the Company was initially capitalized by the issuance of 10 shares of its common stock for an aggregate purchase price of $150 to its sole stockholder.

Private Common Stock Offerings

On January 16, 2020, the Company completed the Private Common Stock Offering in reliance upon the available exemptions from the registration requirements of the Securities Act. As a result, the Company issued and sold a total of 7,000,000 shares of its common stock for aggregate net proceeds of approximately $105.0 million. The related over-allotment option was exercised in full on January 29, 2020, pursuant to which the Company issued and sold an additional 1,333,333 shares of its common stock for gross proceeds of approximately $20.0 million. As a result, the Company issued and sold a total of 8,333,333 shares of its common stock pursuant to the Private Common Stock Offering for aggregate net proceeds of approximately $114.4 million, net of offering costs of approximately $10.6 million.

Concurrent with the closing of the Private Common Stock Offering, on January 16, 2020, the Company entered into a registration rights agreement for the benefit of the purchasers of shares of its common stock in such offering and the certain of the investors in the Legacy Funds (the “Legacy Investors”) that received shares of its common stock in connection with the Formation Transactions that were not the Company’s directors, officers and affiliates. Pursuant to the terms of this registration rights agreement, the Company no longer has any registration obligations with respect to such shares because (i) such shares may be sold by any such stockholder in a single transaction without registration pursuant to Rule 144 under the Securities Act, (ii) the Company has been subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), for a period of at least 90 days and is current in the filing of all such required reports and (iii) such shares have been listed for trading on the Nasdaq Global Select Market.

Formation Transactions

On January 16, 2020, immediately following the initial closings of the Private Offerings, the Company used the proceeds from the Private Offerings to complete the Formation Transactions, pursuant to which the Company acquired the Legacy Funds and Trinity Capital Holdings. As consideration for the Legacy Funds, the Company issued 9,183,185 shares of common stock at $15.00 per share for a total value of approximately $137.7 million and paid approximately $108.7 million in cash to certain of the Legacy Investors. As consideration for all of the equity interests in Trinity Capital Holdings, the Company issued 533,332 shares of its common stock at $15.00 per share for a total value of approximately $8.0 million and paid approximately $2.0 million in cash.

Initial Public Offering

On February 2, 2021, the Company completed its initial public offering of 8,006,291 shares of common stock at a price of $14.00 per share, inclusive of the underwriters’ option to purchase additional shares, which was exercised in full. The Company’s common stock began trading on the Nasdaq Global Select Market on January 29, 2021, under the symbol “TRIN.” Proceeds from this offering were primarily used to pay down a portion of the Company's existing indebtedness outstanding under the Credit Suisse Credit Facility.

Equity ATM Program

On November 9, 2021, the Company established an at-the-market equity program (the “ATM Program”), pursuant to which the Company can issue and sell, from time to time, up to $50.0 million in aggregate offering price of shares of its common stock by any method permitted by law and deemed to be part of an “at-the-market” offering (as defined in Rule 415 under the Securities Act). On December 1, 2023, the Company entered into new equity distribution agreements to (i) increase the maximum aggregate offering price of shares of its common stock to be sold through the ATM Program to $145.7 million and (ii) add one additional sales agent to the ATM Program. On August 23, 2024, the Company entered into new equity distribution agreements to (i) increase the maximum aggregate offering price of shares of its common stock to be sold through the ATM Program to $250.0 million and (ii) add one additional sales agent to the ATM Program.

The Company generally uses net proceeds from the ATM Program to make investments in accordance with its investment objective and investment strategy and for general corporate purposes.

During the three months ended March 31, 2025, the Company issued and sold 1,977,463 shares of its common stock at a weighted-average price of $15.61 per share and raised $30.5 million of net proceeds after deducting deferred offering costs and commissions to the sales agents on shares sold under the ATM Program.

During the year ended December 31, 2024, the Company issued and sold 14,161,064 shares of its common stock at a weighted-average price of $14.35 per share and raised $200.2 million of net proceeds after deducting deferred offering costs and commissions to the sales agents on shares sold under the ATM Program.

For additional information regarding the ATM Program, see “Note 14 – Subsequent Events.”

Stock Repurchase Program

On November 7, 2024, the Board authorized a program permitting the Company to repurchase up to $30.0 million of the Company’s common stock (the “2024 Repurchase Program”). Under the 2024 Repurchase Program, the Company may, but is not obligated to, repurchase its outstanding common stock in the open market from time to time, provided that the Company complies with guidelines specified in Rule 10b-18 of the Exchange Act, including certain price, market, volume, and timing constraints. The 2024 Share Repurchase Program is expected to be in effect until November 7, 2025, unless extended or until the aggregate repurchase amount that has been approved by the Board has been expended.

The Board authorized the 2024 Repurchase Program because it believes sustained macroeconomic pressures and other market factors may cause the Company’s common stock to be undervalued from time to time, especially relative to the Company’s performance and its peers, and that such repurchase demonstrates the Company’s stability and strength, including the resilience and creditworthiness of its portfolio. The timing and number of shares to be repurchased will depend on a number of factors, including market conditions and alternative investment opportunities. In addition, any repurchases will be conducted in accordance with the 1940 Act.

The Company did not repurchase shares of its outstanding common stock during the three months ended March 31, 2025 or during the year ended December 31, 2024.

Equity Offerings

On April 7, 2022, the Company issued 2,754,840 shares of the Company’s common stock, par value $0.001 per share, at a public offering price of $18.15 per share, resulting in net proceeds to the Company of approximately $47.9 million, after deducting discounts and commissions and offering expenses. In addition, the underwriters exercised their option to purchase an additional 413,226 shares of common stock, resulting in additional net proceeds to the Company of $7.2 million, after deducting discounts, commissions and offering expenses.

On August 18, 2022, the Company issued 3,587,736 shares of the Company’s common stock, par value $0.001 per share, at a public offering price of $15.33 per share, resulting in net proceeds to the Company of approximately $53.3 million, after deducting discounts and commissions and offering expenses. In addition, the underwriters exercised their option in part to purchase an additional 132,168 shares of common stock, resulting in additional net proceeds to the Company of $2.0 million, after deducting discounts, commissions and offering expenses.

On August 8, 2023, the Company issued 5,190,312 shares of the Company’s common stock, par value $0.001 per share, at a public offering price of $14.45 per share, resulting in net proceeds to the Company of approximately $72.5 million, after deducting discounts and commissions and offering expenses. In addition, the underwriters exercised their option in part to purchase an additional 500,000 shares of common stock, resulting in additional net proceeds to the Company of $6.9 million, after deducting discounts, commissions and offering expenses.

Distribution Reinvestment Plan

The Company’s amended and restated distribution reinvestment plan (“DRIP”) provides for the reinvestment of distributions in the form of common stock on behalf of its stockholders, unless a stockholder has elected to receive distributions in cash. As a result, if the Company declares a cash distribution, its stockholders who have not “opted out” of the DRIP by the opt out date will have their cash distribution automatically reinvested into additional shares of the Company’s common stock. The share requirements of the DRIP may be satisfied through the issuance of common shares or through open market purchases of common shares by the DRIP plan administrator. Newly issued shares will be valued based upon the final closing price of the Company’s common stock on the valuation date determined for each distribution by the Board.

The Company’s DRIP is administered by its transfer agent on behalf of the Company’s record holders and participating brokerage firms. Brokerage firms and other financial intermediaries may decide not to participate in the Company’s DRIP but may provide a similar distribution reinvestment plan for their clients. During the three months ended March 31, 2025, the Company issued 20,349 shares of common stock for a total of approximately $0.3 million under the DRIP.

During the year ended December 31, 2024, the Company issued 90,245 shares of common stock for a total of approximately $1.3 million under the DRIP.

Distributions

The following table summarizes distributions declared and/or paid by the Company since inception:


Declaration Date	Type	Record Date	Payment Date	Per Share Amount
May 7, 2020	Quarterly	May 29, 2020	June 5, 2020	$	0.22
August 10, 2020	Quarterly	August 21, 2020	September 4, 2020		0.27
November 9, 2020	Quarterly	November 20, 2020	December 4, 2020		0.27
December 22, 2020	Quarterly	December 30, 2020	January 15, 2021		0.27
March 23, 2021	Quarterly	March 31, 2021	April 16, 2021		0.28
June 15, 2021	Quarterly	June 30, 2021	July 15, 2021		0.29
September 13, 2021	Quarterly	September 30, 2021	October 15, 2021		0.33
December 16, 2021	Quarterly	December 31, 2021	January 14, 2022		0.36
March 15, 2022	Quarterly	March 31, 2022	April 15, 2022		0.40
March 15, 2022	Supplemental	March 31, 2022	April 15, 2022		0.15
June 15, 2022	Quarterly	June 30, 2022	July 15, 2022		0.42
June 15, 2022	Supplemental	June 30, 2022	July 15, 2022		0.15
September 15, 2022	Quarterly	September 30, 2022	October 14, 2022		0.45
September 15, 2022	Supplemental	September 30, 2022	October 14, 2022		0.15
December 15, 2022	Quarterly	December 30, 2022	January 13, 2023		0.46
December 15, 2022	Supplemental	December 30, 2022	January 13, 2023		0.15
March 14, 2023	Quarterly	March 31, 2023	April 14, 2023		0.47
June 14, 2023	Quarterly	June 30, 2023	July 14, 2023		0.48
June 14, 2023	Supplemental	June 30, 2023	July 14, 2023		0.05
September 13, 2023	Quarterly	September 30, 2023	October 13, 2023		0.49
September 13, 2023	Supplemental	September 30, 2023	October 13, 2023		0.05
December 14, 2023	Quarterly	December 29, 2023	January 12, 2024		0.50
March 14, 2024	Quarterly	March 28, 2024	April 15, 2024		0.51
June 13, 2024	Quarterly	June 28, 2024	July 15, 2024		0.51
September 18, 2024	Quarterly	September 30, 2024	October 15, 2024		0.51
December 12, 2024	Quarterly	December 31, 2024	January 15, 2025		0.51
March 19, 2025	Quarterly	March 31, 2025	April 15, 2025		0.51
			Total	$	9.21

Note 8. Equity Incentive Plans

2019 Long Term Incentive Plan

The Company’s Board initially adopted and approved the 2019 Trinity Capital Inc. Long Term Incentive Plan (as amended, the “2019 Long Term Incentive Plan”) on October 17, 2019 and the Company’s stockholders approved the 2019 Long Term Incentive Plan on June 17, 2021 at the Company’s 2021 Annual Meeting of Stockholders, with the 2019 Long Term Incentive Plan becoming effective on June 17, 2021. The Company’s Board adopted and approved Amendment No. 1 to the 2019 Trinity Capital Inc. Long-Term Incentive Plan on April 23, 2024 to, among other things, increase the total number of shares available for issuance under the 2019 Long Term Incentive Plan by 5,800,000 shares (from 3,600,000 shares to 9,400,000 shares) and the Company’s stockholders approved such amendment on June 12, 2024 at the Company’s 2024 Annual Meeting of Stockholders, with such amendment becoming effective on June 12, 2024.

Under the 2019 Long Term Incentive Plan, awards of restricted stock, incentive stock options and non-statutory stock options (together with incentive stock options, “Options”) may be granted to certain of the Company’s executive officers, employee directors and other employees (collectively, the “Employee Participants”) in accordance with the SEC exemptive order the Company received on May 27, 2021 (the “SEC Exemptive Order”). While the 2019 Long Term Incentive Plan contemplates grants of restricted stock, restricted stock units, Options, dividend equivalent rights, performance awards and other stock-based awards to the Employee Participants, the Company only sought and received exemptive relief from the SEC pursuant to the SEC Exemptive Order to grant awards of restricted stock and Options. As a result, the Company will only grant awards of such securities under the 2019 Long Term Incentive Plan. The Employee Participants will have the right to receive dividends on such awarded restricted stock, unless and until the restricted stock is forfeited.

Subject to certain adjustments under the 2019 Long Term Incentive Plan, the maximum aggregate number of shares of the Company’s common stock authorized for issuance under the 2019 Long Term Incentive Plan is 9,400,000 shares. The 2019 Long Term Incentive Plan is to be administered by the Compensation Committee of the Board (the “Compensation Committee”) in accordance with the terms of the 2019 Long Term Incentive Plan. The 2019 Long Term Incentive Plan will terminate on the day prior to the tenth anniversary of the date it was initially adopted by the Board, unless terminated sooner by action of the Board or the Compensation Committee, as applicable.

For additional information regarding the 2019 Long Term Incentive Plan, please refer to the Company’s Current Reports on Form 8-K filed with the SEC on June 23, 2021 and June 14, 2024, and the Company’s definitive proxy statement for the 2025 Annual Meeting of Stockholders. The following table summarizes issuances, vesting, and retirement of shares under the plan as well as the fair value of granted stock for the three months ended March 31, 2025 and 2024 (dollars in thousands).


		Three Months Ended			Weighted Average			Three Months Ended			Weighted Average
		March 31, 2025			Grant Date Fair Value			March 31, 2024			Grant Date Fair Value
Unvested as of Beginning of Period			1,993,459		$	14.53			1,326,891		$	14.56
Shares Granted			319,956			15.83			753,051			14.80
Shares Vested and Forfeited			(285,251	)		14.81			(287,793	)		14.19
Unvested as of Ending of Period			2,028,164		$	14.70			1,792,149		$	14.72

Fair Value of Granted Stock	$		5,065				$		11,145
Compensation Cost Recognized	$		2,559				$		2,391

As of March 31, 2025, there was approximately $28.8 million of total unrecognized compensation costs related to the non-vested restricted stock awards. These costs are expected to be recognized over a weighted average period of 3.0 years. As of December 31, 2024, there was approximately $26.3 million of total unrecognized compensation costs related to non-vested restricted stock awards. These costs were expected to be recognized over a weighted average period of 3.0 years. Shares vested and forfeited primarily relate to shares acquired of common stock held by employees who tendered owned shares to satisfy tax withholding obligations.

Option Awards

On March 14, 2025 (the “Option Awards Grant Date”), the Company's Board approved grants of non-statutory stock options to certain executive officers of the Company each to purchase up to 300,000 shares of the Company’s common stock pursuant to the 2019 Long Term Incentive Plan (the “Option Awards”) for a total of 1,500,000 shares. Each Option Award is subject to certain time-based and market-based vesting conditions, which are set forth in the Company's Non-Statutory Stock Option Award Agreement.

Within four years following the Option Awards Grant Date, the volume weighted average trading price (“VWAP”) per share of the Company’s common stock on any established stock exchange or national market system for ninety (90) consecutive calendar days ending on the last trading day preceding the applicable day must be equal to or greater than $23.75. If the VWAP condition is satisfied, and the applicable recipient of the Option Award remains in the continuous employment of the Company through the applicable vesting date (subject to certain limited exceptions), the stock option will vest as follows: 25% on March 14, 2026 with the remaining 75% vesting pro rata over the twelve (12) full calendar quarters immediately following March 14, 2026. The Option Awards expire on March 14, 2035.

The $15.83 exercise price of the Option Awards was calculated based on the closing stock price on the Option Awards Grant Date. As of March 31, 2025, there were no Option Awards exercised as time-based and market-based vesting conditions have not been met.

During the three months ended March 31, 2025, there was less than $0.1 million of total compensation costs related to the Option Awards. As of March 31, 2025, there was approximately $1.7 million of total unrecognized compensation costs expected to be recognized over a weighted average period of 4.0 years. The fair value of the Option Awards as of March 31, 2025 was approximately $1.7 million.

2019 Restricted Stock Plan

The Company’s Board initially adopted and approved the Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan (as amended, the “2019 Restricted Stock Plan”) on October 17, 2019 and the Company’s stockholders approved the 2019 Restricted Stock Plan on June 17, 2021 at the Company’s 2021 Annual Meeting of Stockholders, with the 2019 Restricted Stock Plan becoming effecting on June 17, 2021. The Company’s Board adopted and approved Amendment No. 1 to the Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan on April 23, 2024 to increase the total number of shares available for issuance under the 2019 Restricted Stock Plan by 60,000 shares (from 60,000 shares to 120,000 shares) and the Company’s stockholders approved such amendment on June 12, 2024 at the Company’s 2024 Annual Meeting of Stockholders, with such amendment becoming effective on June 12, 2024.

The 2019 Restricted Stock Plan provides for grants of restricted stock awards (“Non-Employee Director Awards”) to the Company’s non-employee directors (the “Non-Employee Director Participants”), which are directors who are not “interested persons” of the Company (as such term is defined in Section 2(a)(19) of the 1940 Act) in accordance with the SEC Exemptive Order. The Non-Employee Director Participants will have the right to receive dividends on such awarded restricted stock, unless and until the restricted stock is forfeited.

Subject to certain adjustments under the 2019 Restricted Stock Plan, the total number of shares of the Company’s common stock that may be subject to Non-Employee Director Awards is 120,000 shares. The 2019 Restricted Stock Plan is to be administered by the Compensation Committee, subject to the discretion of the Board. The 2019 Restricted Stock Plan will terminate on the day prior to the tenth anniversary of the date it was approved by the Company’s stockholders, unless terminated sooner by action of the Board.

For additional information regarding the 2019 Restricted Stock Plan, please refer to the Company’s Current Reports on Form 8-K, filed with the SEC on June 23, 2021 and June 14, 2024, and the Company’s definitive proxy statement for the 2025 Annual Meeting of Stockholders. The following table summarizes issuances, vesting, and retirement of shares under the plan as well as the fair value of granted stock for the three months ended March 31, 2025 and 2024 (dollars in thousands).


		Three Months Ended		Weighted Average			Three Months Ended		Weighted Average
		March 31, 2025		Grant Date Fair Value			March 31, 2024		Grant Date Fair Value
Unvested as of Beginning of Period,			13,340	$	14.99			15,196	$	13.16
Shares Granted			—		—			—		—
Shares Vested and Forfeited			—		—			—		—
Unvested as of Ending of Period,			13,340	$	14.99			15,196	$	13.16

Fair Value of Granted Stock	$		—			$		—
Compensation Cost Recognized	$		50			$		50

As of March 31, 2025, there was less than $0.1 million of total unrecognized compensation costs related to non-vested restricted stock awards. These costs are expected to be recognized over a three-month period. As of December 31, 2024, there was approximately $0.1 million of total unrecognized compensation costs related to non-vested restricted stock awards. These costs were expected to be recognized over a six-month period.

Note 9. Earnings Per Share

The following table sets forth the computation of the basic and diluted earnings per common share for the three months ended March 31, 2025 and 2024 (in thousands except shares and per share information):


	Three Months Ended		Three Months Ended
	March 31, 2025		March 31, 2024
Earnings per common share - basic
Numerator for basic earnings per share	$	27,087	$	14,508
Denominator for basic weighted average shares		62,555,531		46,748,386
Earnings/(Loss) per common share - basic	$	0.43	$	0.31
Earnings per common share - diluted
Numerator for increase in net assets per share		27,087		14,508
Adjustment for dilutive effect of Option Awards and Convertible Notes		—		916
Numerator for diluted earnings per share		27,087		15,424
Denominator for basic weighted average shares		62,555,531		46,748,386
Adjustment for dilutive effect of Option Awards and Convertible Notes		—		3,847,265
Denominator for diluted weighted average shares		62,555,531		50,595,651
Earnings/(Loss) per common share - diluted	$	0.43	$	0.30

Diluted earnings (loss) available to each share of common stock outstanding during the reporting period included any additional shares of common stock that would be issued if all potentially dilutive securities were exercised. In accordance with ASU 2020-06, the Company is required to disclose diluted EPS using (i) the treasury stock method for Option Awards that assumes shares were exercised at the beginning of the reporting period (or at time of issuance, if later) and is intended to show the dilution effect to common stockholders and (ii) the if-converted method for the Convertible Notes that assumes the conversion of convertible securities at the beginning of the reporting period and is intended to show the maximum dilution effect to common stockholders regardless of how the conversion can occur. During the three months ended March 31, 2025, the market-based conditions for the Option Awards were not met and the Convertible Notes were converted in full and are no longer outstanding, as such, both were not considered in the calculation of diluted EPS. During the three months ended March 31, 2024, the adjustments for diluted EPS included additional effects for the Convertible Notes.

Note 10. Income Taxes

The Company has elected to be treated, currently qualifies, and intends to continue to qualify annually as, a RIC under Subchapter M of the Code for U.S. federal tax purposes. In order to maintain its treatment as a RIC, the Company is generally required to distribute at least annually to its stockholders at least the sum of 90% of its investment company taxable income (which generally includes its net ordinary taxable income and realized net short-term capital gains in excess of realized net long-term capital losses) and 90% of its net tax-exempt income (if any). The Company generally will not be subject to U.S. federal income tax on these distributed amounts, but will pay U.S. federal income tax at corporate rates on any retained amounts.

The amount of taxable income to be paid out as a distribution is determined by the Board each quarter and is generally based upon the annual earnings estimated by management of the Company. Net capital gains, if any, are distributed at least annually, although the Company may decide to retain all or some of those capital gains for investment and pay U.S. federal income tax at corporate rates on those retained amounts. If the Company chooses to do so, this generally will increase expenses and reduce the amount available to be distributed to stockholders. In the event the Company’s taxable income (including any net capital gains) for a fiscal year falls below the amount of distributions declared and paid with respect to that year, however, a portion of the total amount of those distributions may be deemed a return of capital for tax purposes to the Company’s stockholders.

Because federal income tax regulations differ from GAAP, distributions in accordance with tax regulations may differ from net investment income and realized gains recognized for financial reporting purposes. Differences may be permanent or temporary in nature. Permanent differences are reclassified among capital accounts in the financial statements to reflect their appropriate tax character. Temporary differences arise when certain items of income, expense, gain or loss are recognized at some time in the future.

For the three months ended March 31, 2025 and 2024, $0.6 million and $0.6 million, respectively, was recorded for U.S. federal excise tax.

The following table sets forth the tax cost basis and the estimated aggregate gross unrealized appreciation and depreciation from investments for federal income tax purposes as of March 31, 2025 and December 31, 2024 (in thousands):


	March 31, 2025		December 31, 2024
Tax Cost of Investments	$	1,833,444	$	1,763,183


	March 31, 2025			December 31, 2024
Unrealized appreciation	$	66,552		$	60,872
Unrealized depreciation		(107,584	)		(113,528	)
Net change in unrealized appreciation/(depreciation) from investments	$	(41,032	)	$	(52,656	)

Note 11. Financial Highlights

The following presents financial highlights (in thousands except share and per share information):


	Three Months Ended				Three Months Ended
	March 31, 2025				March 31, 2024
Per Share Data: (1)
Net asset value, beginning of period	$	13.35			$	13.19

Net investment income		0.52				0.54
Net realized and unrealized gains/(losses) on investments (2)		(0.09	)			(0.23	)
Net increase/(decrease) in net assets resulting from operations		0.43				0.31

Offering costs		(0.01	)			(0.01	)
Effect of shares issued and repurchased (3)		(0.21	)			(0.10	)
Distributions (4)		(0.51	)			(0.51	)
Total increase/(decrease) in net assets		(0.30	)			(0.31	)

Net asset value, end of period	$	13.05			$	12.88

Shares outstanding, end of period		63,880,330				48,643,194
Weighted average shares outstanding		62,555,531				46,748,386
Total return based on net asset value (5)		1.6		%		1.5		%
Total return based on market value (6)		8.4		%		4.5		%

Ratio/Supplemental Data:
Per share market value at end of period	$	15.16			$	14.68
Net assets, end of period	$	833,395			$	626,316
Ratio of total expenses to average net assets		16.2		%		16.4		%
Ratio of net investment income to average net assets		15.9		%		16.3		%
Ratio of interest and credit facility expenses to average net assets		8.6		%		7.9		%
Portfolio turnover rate (7)		8.9		%		11.4		%
Asset coverage ratio (8)		186.1		%		184.9		%

(1)

Based on actual number of shares outstanding at the end of the corresponding period or the weighted average shares outstanding for the period, unless otherwise noted, as appropriate.

(2)

Net realized and unrealized gains/(losses) on investments include rounding adjustments to reconcile the change in net asset value per share.

(3)

Includes the impact of the different share amounts as a result of calculating certain per share data based on the weighted-average basic shares outstanding during the period and certain per share data based on the shares outstanding as of a period end or transaction date. Also includes the impact of the issuance of shares related to the equity incentive plans, the accretive effect of DRIP issuance and stock offerings (issuing shares above NAV per share), and the impact of share repurchases under the 2024 Repurchase Program.

(4)

The per share data reflects the actual amount of distributions declared per share for the applicable period.

(5)

Total return based on net asset value is calculated as the change in net asset value per share during the period plus declared distributions per share during the period, divided by the beginning net asset value per share.

(6)

Total return based on market value is calculated as the change in market value per share during the period, taking into account dividends.

(7)

Portfolio turnover rate is calculated using the lesser of year-to-date cash sales/repayments or year-to-date cash purchases over the average of the total investments at fair value.

(8)

Based on outstanding debt of $968.2 million and $737.5 million as of March 31, 2025 and 2024, respectively.

(9)

Not annualized.

(10)

Annualized.

Senior Securities

Information about the Company’s senior securities (including debt securities and other indebtedness) is shown in the following table as of March 31, 2025, and December 2024, 2023, 2022, 2021 and 2020. No senior securities were outstanding as of December 31, 2019.


Class and Period	Total Amount Outstanding Exclusive of Treasury Securities (1) (in thousands)			Asset Coverage per Unit (2)		Involuntary Liquidating Preference per Unit (3)		Average Market Value per Unit (4)
Credit Suisse Credit Facility
March 31, 2025 (Unaudited)(5)		$	—		—		—	$	—
December 31, 2024(5)			—		—		—		—
December 31, 2023(5)			—		—		—		—
December 31, 2022(5)			—		—		—		—
December 31, 2021			10,000		1,958		—		—
December 31, 2020			135,000		1,770		—		—

KeyBank Credit Facility
March 31, 2025 (Unaudited)		$	392,000		1,861		—	$	—
December 31, 2024			113,000		1,927		—		—
December 31, 2023			213,000		1,947		—		—
December 31, 2022			187,500		1,741		—		—
December 31, 2021			81,000		1,958		—		—
December 31, 2020			—		—		—		—

2025 Notes
March 31, 2025 (Unaudited)(6)		$	—		—		—	$	—
December 31, 2024			152,500		1,927		—		1,009
December 31, 2023			182,500		1,947		—		1,006
December 31, 2022			182,500		1,741		—		1,006
December 31, 2021			125,000		1,958		—		—
December 31, 2020			125,000		1,770		—		—

Convertible Notes
March 31, 2025 (Unaudited)(7)		$	—		—		—	$	—
December 31, 2024			50,000		1,927		—		—
December 31, 2023			50,000		1,947		—		—
December 31, 2022			50,000		1,741		—		—
December 31, 2021			50,000		1,958		—		—
December 31, 2020			50,000		1,770		—		—

August 2026 Notes
March 31, 2025 (Unaudited)		$	125,000		1,861		—	$	—
December 31, 2024			125,000		1,927		—		—
December 31, 2023			125,000		1,947		—		—
December 31, 2022			125,000		1,741		—		—
December 31, 2021			125,000		1,958		—		—
December 31, 2020			—		—		—		—

December 2026 Notes
March 31, 2025 (Unaudited)		$	75,000		1,861		—	$	—
December 31, 2024			75,000		1,927		—		—
December 31, 2023			75,000		1,947		—		—
December 31, 2022			75,000		1,741		—		—
December 31, 2021			75,000		1,958		—		—
December 31, 2020			—		—		—		—


Class and Period, Continued	Total Amount Outstanding Exclusive of Treasury Securities (1) (in thousands)			Asset Coverage per Unit (2)		Involuntary Liquidating Preference per Unit (3)		Average Market Value per Unit (4)
March 2029 Notes
March 31, 2025 (Unaudited)		$	115,261		1,861		—	$	1,012
December 31, 2024			115,000		1,927		—		1,012
December 31, 2023			—		—		—		—
December 31, 2022			—		—		—		—
December 31, 2021			—		—		—		—
December 31, 2020			—		—		—		—

September 2029 Notes
March 31, 2025 (Unaudited)		$	118,390		1,861		—	$	1,014
December 31, 2024			115,000		1,927		—		1,014
December 31, 2023			—		—		—		—
December 31, 2022			—		—		—		—
December 31, 2021			—		—		—		—
December 31, 2020			—		—		—		—

Series A Notes
March 31, 2025 (Unaudited)		$	142,500		1,861		—	$	—
December 31, 2024			142,500		1,927		—		—
December 31, 2023			—		—		—		—
December 31, 2022			—		—		—		—
December 31, 2021			—		—		—		—
December 31, 2020			—		—		—		—

Total
March 31, 2025 (Unaudited)		$	968,151		1,861		—	$	—
December 31, 2024			888,000		1,927		—		—
December 31, 2023			645,500		1,947		—		—
December 31, 2022			620,000		1,741		—		—
December 31, 2021			466,000		1,958		—		—
December 31, 2020			310,000		1,770		—		—

(1)

Total amount of each class of senior securities outstanding at the end of the period presented.

(2)

Asset coverage per unit is the ratio of the carrying value of total assets, less all liabilities excluding indebtedness represented by senior securities in this table to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $1,000 of indebtedness and is calculated on a consolidated basis.

(3)

The amount to which such class of senior security would be entitled upon the Company’s involuntary liquidation in preference to any security junior to it. The “—” in this column indicates information that the SEC expressly does not require to be disclosed for certain types of senior securities.

(4)

Not applicable because the senior securities are not registered for public trading, with the exception of the 2025 Notes, March 2029 Notes and September 2029 Notes. The average market value per unit calculated for the 2025 Notes, March 2029 Notes and September 2029 Notes are based on the average daily price of such notes and are expressed in terms of dollar amounts per $1,000 of indebtedness.

(5)

The Credit Suisse Credit Facility matured on January 8, 2022, in accordance with its terms, and all outstanding indebtedness thereunder was repaid.

(6)

The 2025 Notes matured on January 16, 2025 pursuant to their terms and were repaid in full.

(7)

The Convertible Notes were converted on February 20, 2025 and repaid in full pursuant to their terms and conditions.

Note 12. Related Party Transactions

During the three months ended March 31, 2025 and the year ended December 31, 2024, certain related parties received distributions from the Company relating to their shares held. Refer to “Note 7 – Stockholder’s Equity” for further details on the Company’s DRIP and the distributions declared.

During the three months ended March 31, 2025 and the year ended December 31, 2024, the Company’s directors and executive officers and certain employees received restricted stock awards under the 2019 Long Term Incentive Plan and the 2019 Restricted Stock Plan. Refer to “Note 8 – Equity Incentive Plans” for further details on the Company’s stock-based compensation plans.

The Company has entered into indemnification agreements with its directors and executive officers. The indemnification agreements are intended to provide the Company’s directors and executive officers the maximum indemnification permitted under Maryland law and the 1940 Act. Each indemnification agreement provides that the Company shall indemnify the director or executive officer who is a party to the agreement, or an “Indemnitee,” including the advancement of legal expenses, if, by reason of his or her corporate status, the Indemnitee is, or is threatened to be, made a party to or a witness in any threatened, pending, or completed proceeding, to the maximum extent permitted by Maryland law and the 1940 Act.

The Company and its executives and directors are covered by directors and officers insurance. In addition, each of our directors and officers have entered into an indemnification agreement with us pursuant to which our directors and officers are indemnified by us to the maximum extent permitted by Maryland law subject to the restrictions of the 1940 Act.

Senior Credit Corp 2022 LLC

As disclosed in “Note 1 - Organization and Basis of Presentation”, the Company entered into a joint venture agreement with certain funds and accounts managed by a specialty credit manager (collectively, the “JV Partner”) on December 5, 2022 to co-manage the JV. The JV invests in secured loans and equipment financings to growth-oriented companies that have been originated by the Company. The Company and the JV Partner committed to initially contribute $21.4 million and $150.0 million, respectively, of capital in the form of 8.5% notes and preferred equity in the JV. The JV is capitalized as investment transactions are completed and all portfolio decisions and generally all other actions in respect of the JV must be approved by the board of managers of the JV consisting of an equal number of representatives of the Company and the JV Partner. Capital contributions are called from each JV member on a pro-rata basis based on their total capital commitments, with 70% of each such capital contribution invested in the JV’s 8.5% notes and the remaining 30% invested in the JV's preferred equity. As of March 31, 2025, the Company’s and the JV Partner’s ownership of the JV was 12.5% and 87.5%, respectively.

The Company has agreed to offer the JV the opportunity to purchase a percentage of each secured loan and equipment financing advance originated by the Company during the period commencing on September 1, 2022 and ending on June 5, 2026. The JV is required to pay the Company a fee equal to 100 basis points of the total principal amount of each loan or equipment financing advance acquired by the JV from the Company, with 50% of the fee for each such particular loan or advance payable by the JV to the Company within two business days of the date of such acquisition or advance and the remaining 50% payable in equal monthly installments over 24 months following the date of such acquisition or advance. In addition, the JV shall pay the Company an administrative agent fee equal to 75 basis points of the daily average aggregate value of the JV’s outstanding loans and equipment financings.

As of March 31, 2025, the Company contributed $18.4 million of capital to the JV, which consisted of a debt investment of $12.9 million and an equity investment of $5.5 million. As of December 31, 2024, the Company contributed $18.4 million of capital to the JV, which consisted of a debt investment of $12.9 million and an equity investment of $5.5 million. As of March 31, 2025 and December 31, 2024, the Company's unfunded commitment of capital to the JV was $3.0 million and $3.0 million, respectively.

As of March 31, 2025 and December 31, 2024, the JV’s total investment portfolio on a fair value basis was $234.6 million and $219.1 million, respectively. During the three months ended March 31, 2025, the Company received $29.0 million in net proceeds from the sale of investments to the JV. During the year ended December 31, 2024, the Company received $157.3 million in net proceeds from the sale of investments to the JV.

During the three months ended March 31, 2025 and 2024, the Company earned approximately $0.7 million and $0.9 million, respectively, for originations and administrative agent fees which are recognized as fee income on the Consolidated Statements of Operations. As of March 31, 2025 and December 31, 2024, the Company had approximately $1.0 million and $1.1 million, respectively, in unsettled receivables due from the JV that were included in other assets in the accompanying Consolidated Statements of Assets and Liabilities.

Trinity Capital Adviser LLC

As disclosed in “Note 1 - Organization and Basis of Presentation”, the Company formed the Adviser Sub on March 16, 2023 as a wholly owned subsidiary of the Company. The Company was granted exemptive relief by the SEC that permits the Company to organize, acquire, wholly own and operate the Adviser Sub as an investment adviser registered under the Advisers Act. The Adviser Sub may provide investment advisory and related services to the Adviser Funds with ownership by one or more External Parties and receives fee income for such services. The Adviser Sub commenced operations on June 28, 2024.

The Company has entered into a resource sharing agreement (“Sharing Agreement”) with the Adviser Sub, through which the Adviser Sub has access to the Company's human capital resources, facilities and systems. Under the terms of Sharing Agreement, the Company allocates the related expenses of such shared resources to the Adviser Sub pro rata based on total assets under management by the Adviser Sub and the Company. The Company's total expenses are net of such expenses allocated to the Adviser Sub of $0.4 million for the three months ended March 31, 2025. There were no allocated expenses during the three months ended March 31, 2024. As of March 31, 2025 and December 31, 2024, there was $2.3 million and $1.8 million, respectively, receivable from the Adviser Sub.

The Adviser Sub has entered into an investment management agreement with EPT 16 and may enter into additional investment management agreements with other Adviser Funds in the future, pursuant to which the Adviser Sub receives management fees and/or incentive fees based on the assets under management and the performance of the Adviser Funds, respectively. With respect to such fee income, the Adviser Sub expects to declare and pay dividend distributions to the Company. During the three months ended March 31, 2025 and 2024, no dividend distributions were declared and paid by the Adviser Sub to the Company.

EPT 16 LLC

As disclosed in “Note 1 - Organization and Basis of Presentation”, the Company and a specialty credit manager (the “Class A Member”) funded a portion of their respective capital commitments on June 28, 2024 to commence the operations of a credit fund, EPT 16. EPT 16 has acquired and intends to acquire, hold and, as applicable, dispose of investments that have been originated by the Company. The Company and the Class A Member had capital commitments to EPT 16 in the amount of $10.0 million and $50.0 million, respectively. As of March 31, 2025, the Company's and the Class A Member’s ownership percentages were 16.7% and 83.3%, respectively. EPT 16 has entered into an investment management agreement with the Adviser Sub, pursuant to which the Adviser Sub will earn certain base management and incentive fees in exchange for providing advisory services to EPT 16.

As of March 31, 2025 and December 31, 2024, the Company had contributed $9.2 million of capital to EPT 16. As of March 31, 2025 and December 31, 2024, the Company's unfunded commitment was $0.8 million and $0.8 million, respectively.

As of March 31, 2025 and December 31, 2024, EPT 16’s total investment portfolio on a fair value basis was $70.4 million and $66.9 million, respectively. During the three months ended March 31, 2025, the Company received $6.0 million in net proceeds from the sale of investments to the EPT 16. During the year ended December 31, 2024, the Company received $74.7 million in net proceeds from the sale of investments to the EPT 16.

Note 13. Segment Reporting

The Company has determined that is has a single operating segment in accordance with Topic 280, Segment Reporting (“ASC 280”). The Company’s Chief Operating Decision Maker (“CODM”) is the Chief Executive Officer (“CEO”). While the Company derives income and capital appreciation by providing debt to growth-oriented companies across various industries, the Company and the CODM evaluate and monitor performance of the business on a consolidated basis. Further, each investment is evaluated and managed using similar processes and shared operations support functions such as deal origination, underwriting, loan servicing in addition to the administrative functions of human resources, legal, finance and information technology. The accounting policies of the segment align with those outlined in “Note 2 - Summary of Significant Accounting Policies” included in the notes of the consolidated financial statements.

The CODM uses consolidated net investment income and net increase/(decrease) in net assets resulting from operations when allocating resources and assessing the Company’s performance. Net investment income is comprised of consolidated total investment income (“segment revenues”) and consolidated total net operating expenses (“significant segment expenses”). The net increase/(decrease) in net assets is comprised of consolidated net investment income and consolidated net realized gain/(loss) from investments and consolidated net change in unrealized appreciation/(depreciation) from investments. These performance metrics are considered the key segment measure of profit or loss received by the CODM. As the Company’s operations comprise of a single reporting segment, the segment assets are reflected on the accompanying Consolidated Statements of Assets and Liabilities as Total Assets, investments held on the Consolidated Statements of Investments, and the significant segment expenses are listed on the accompanying Consolidated Statements of Operations.

Note 14. Recent Accounting Pronouncements

In November 2024, the Financial Accounting Standards Board (“FASB”) issued ASU 2024-03—Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”) related to expense disclosures. The amendments in ASU 2024-03 require public entities to provide disaggregated disclosure of expenses included within relevant income statement expense captions, as well as additional disclosures about selling expenses. This update will become effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. The Company is currently evaluating the impact of adopting this guidance with respect to the consolidated financial statements.

Note 15. Subsequent Events

The Company’s management evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. Except as noted below, there have been no subsequent events that occurred during such period that would require recognition or disclosure.

Equity ATM Program

For the period from April 1, 2025 to May 5, 2025, the Company issued and sold 752,845 shares of its common stock at a weighted-average price of $14.15 per share and raised $10.5 million of net proceeds after deducting commissions to the sales agents on shares sold under the Equity ATM Program.

Debt ATM Program

For the period from April 1, 2025 to May 5, 2025, the Company issued and sold $0.5 million of its ATM September 2029 Notes and raised $0.5 million of net proceeds after deducting deferred offering costs and commissions to the sales agents on notes sold under the Sales Agreement.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Except where the context suggests otherwise, the terms “we,” “us,” “our,” and “the Company” refer to Trinity Capital Inc. and its consolidated subsidiaries. The information contained in this section should be read in conjunction with our consolidated financial statements and related notes thereto appearing elsewhere in this Quarterly Report on Form 10‑Q.

Forward-Looking Statements

This quarterly report contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors, and undue reliance should not be placed thereon. Any statements about our expectations, beliefs, plans, predictions, forecasts, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but not always, made through the use of words or phrases such as “anticipate,” “believes,” “can,” “could,” “may,” “predicts,” “potential,” “should,” “will,” “estimate,” “plans,” “projects,” “continuing,” “ongoing,” “expects,” “intends” and similar words or phrases. Accordingly, these statements are only predictions and involve estimates, known and unknown risks, assumptions and uncertainties that could cause actual results to differ materially from those expressed in them. Our actual results could differ materially from those anticipated in such forward-looking statements as a result of several factors discussed under Item 1A. “Risk Factors” of Part II of this quarterly report and Item 1A. "Risk Factors" of Part I of our Annual Report on Form 10-K, filed with the Securities and Exchange Commission ("SEC") on February 26, 2025, including but not limited to the following:

•

our future operating results;

•

our dependence upon our management team and key investment professionals;

•

our ability to manage our business and future growth;

•

risks related to investments in growth-oriented companies, other venture capital-backed companies and generally U.S. companies;

•

the ability of our portfolio companies to achieve their objectives;

•

the use of leverage;

•

risks related to the uncertainty of the value of our portfolio investments;

•

changes in political, economic or industry conditions, including as a result of supply chain disruptions, disruptions related to tariffs or other trade or sanction related issues, the interest rate and inflation rate environments or conditions affecting the financial and capital markets;

•

uncertainty surrounding domestic and/or global financial and/or political stability;

•

the dependence of our future success on the general economy and its impact on the industries in which we invest;

•

risks related to changes in interest rates and inflation rates, our expenses, and other general economic conditions and the effect on our net investment income;

•

the impact of changes in laws or regulations (including the interpretation thereof), including tax laws, on our operations and/or the operations of our portfolio companies;

•

risks related to market volatility, including general price and volume fluctuations in stock markets;

•

our ability to make distributions; and

•

our ability to maintain our status as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”), and qualify annually for tax treatment as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

Additionally, there may be other risks that are otherwise described from time to time in the reports that we file with the SEC. Any forward-looking statements in this Quarterly Report on Form 10-Q should be considered in light of various important factors, including the risks and uncertainties listed above, as well as others. All forward-looking statements are necessarily only estimates of future results, and there can be no assurance that actual results will not differ materially from expectations, and, therefore, you are cautioned not to place undue reliance on such statements. Any forward-looking statements are qualified in their entirety by reference to the risk factors discussed throughout this quarterly report. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. Because we are an investment company, the forward-looking statements and projections contained in this quarterly report are excluded from the safe harbor protections provided by Section 27A(b)(2)(B) of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Exchange Act (the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995).

Overview

We are a specialty lending company providing debt, including loans, equipment financings and asset based lending, to growth-oriented companies, including institutional investor-backed companies. We are an internally managed, closed-end, non-diversified management investment company that has elected to be regulated as a BDC under the 1940 Act. We have elected to be treated, and intend to qualify annually, as a RIC under Subchapter M of the Code for U.S. federal income tax purposes. As a BDC and a RIC, we are required to comply with certain regulatory requirements.

Our investment objective is to generate current income and, to a lesser extent, capital appreciation through our investments across five distinct vertical markets. We seek to achieve our investment objective by making investments consisting primarily of term loans, equipment financings, and asset based lending and, to a lesser extent, working capital loans, equity and equity-related investments. In addition, we may obtain warrants or contingent exit fees at funding from many of our portfolio companies, providing an additional potential source of investment returns. We generally are required to invest at least 70% of our total assets in qualifying assets in accordance with the 1940 Act but may invest up to 30% of our total assets in non-qualifying assets, as permitted by the 1940 Act.

We target investments in growth-oriented companies, which are typically private companies, including institutional investor-based companies. We define “growth-oriented companies” as companies that have significant ownership and active participation by sponsors, such as institutional investors or private equity firms, and expected annual revenues of up to $100 million. Subject to the requirements of the 1940 Act, we are not limited to investing in any particular industry or geographic area and seek to invest in under-financed segments of the private credit markets.

Our loans generally may have initial interest-only periods of up to 24 months, and our equipment financings generally begin amortizing immediately. Our loans and equipment financings generally have a total term of up to 60 months. These investments are typically secured by a blanket first position lien, a specific asset lien on mission-critical assets and/or a blanket second position lien. We may also make a limited number of direct equity and equity-related investments in conjunction with our debt investments. We target growth-oriented companies that have recently issued equity to raise cash to offset potential cash flow needs related to projected growth, have achieved positive cash flow to cover debt service, or have institutional investors committed to providing additional funding. A loan or equipment financing may be structured to tie the amortization of the loan or equipment financing to the portfolio company’s projected cash balances while cash is still available for operations. As such, the loan or equipment financing may have a reduced risk of default. We believe that the amortizing nature of our investments will mitigate risk and significantly reduce the risk of our investments over a relatively short period. We focus on protecting and recovering principal in each investment and structure our investments to provide downside protection.

Our History

Trinity Capital Inc. was incorporated under the general corporation laws of the State of Maryland on August 12, 2019 and commenced operations on January 16, 2020. Prior to January 16, 2020, we had no operations, except for matters relating to our formation and organization as a BDC.

On January 16, 2020, through a series of transactions, we acquired Trinity Capital Investment, LLC, Trinity Capital Fund II, L.P., Trinity Capital Fund III, L.P., Trinity Capital Fund IV, L.P., and Trinity Sidecar Income Fund, L.P. (collectively, the “Legacy Funds”) and all of their respective assets, including their respective investment portfolios (the “Legacy Portfolio”), as well as Trinity Capital Holdings, LLC, a holding company whose subsidiaries managed and/or had the right to receive fees from certain of the Legacy Funds. In order to complete these transactions, we used a portion of the proceeds from our private equity offering and private debt offering that occurred on January 16, 2020 (the “Private Offerings”).

On February 2, 2021, we completed our initial public offering of 8,006,291 shares of our common stock at a price of $14.00 per share, inclusive of the underwriters’ option to purchase additional shares, which was exercised in full. Our common stock began trading on the Nasdaq Global Select Market on January 29, 2021 under the symbol “TRIN.” Proceeds from this offering were primarily used to pay down a portion of our existing indebtedness outstanding.

On December 5, 2022, we entered into a joint venture agreement with certain funds and accounts managed by a specialty credit manager to co-manage Senior Credit Corp 2022 LLC, a Delaware limited liability company (the “JV”). The JV invests in secured loans and equipment financings to growth-oriented companies that have been originated by us.

On March 16, 2023, we formed an unconsolidated wholly owned subsidiary, Trinity Capital Adviser LLC, a Delaware limited liability company (“Adviser Sub”). We were granted exemptive relief by the SEC that permits us to organize, acquire, wholly own and operate the Adviser Sub as an investment adviser registered under the Investment Advisers Act of 1940, as amended (the “Adviser Act”). The Adviser Sub may provide investment advisory and related services to one or more investment vehicles (the “Adviser Funds”) with ownership by one or more unrelated third-party investors and receive fee income for such services.

On June 28, 2024, we and a specialty credit manager funded a portion of their respective capital commitments to commence operations of a credit fund, EPT 16 LLC, a Delaware limited liability company (“EPT 16”). EPT 16 has acquired and intends to acquire, hold and, as applicable, dispose of investments that have been originated by us.

Critical Accounting Estimates and Policies

The preparation of our financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”) requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Changes in the economic environment, financial markets and any other parameters used in determining such estimates could cause actual results to differ materially. Our critical accounting estimates, including those relating to valuation of investments and income recognition, are described below. Please refer to “Note 2 – Summary of Significant Accounting Policies” in the notes to the consolidated financial statements included in this Quarterly Report on Form 10-Q for a discussion of our significant accounting policies.

Valuation of Investments

The most significant estimate inherent in the preparation of the Company’s consolidated financial statements is the valuation of investments and the related amounts of unrealized appreciation and depreciation of investments recorded. The Company’s investments are carried at fair value in accordance with the 1940 Act and Accounting Standards Codification (“ASC”) 946, Financial Services — Investment Companies (“ASC 946”) and measured in accordance with ASC 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the observability of inputs used to measure fair value, and provides disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that each of the portfolio investments is sold in a hypothetical transaction in the principal or, as applicable, most advantageous market using market participant assumptions as of the measurement date. Market participants are defined as buyers and sellers in the principal market that are independent, knowledgeable and willing and able to transact. The Company values its investments at fair value as determined in good faith by the Company’s Board of Directors (the “Board”) in accordance with the provisions of ASC 820 and the 1940 Act.

While the Board is ultimately and solely responsible for determining the fair value of the Company’s investments, the Company has engaged independent valuation firms to provide the Company with valuation assistance with respect to its investments. The Company engages independent valuation firms on a discretionary basis. Specifically, on a quarterly basis, the Company identifies portfolio investments with respect to which an independent valuation firm assists in valuing certain investments. The Company selects these portfolio investments based on a number of factors, including, but not limited to, the potential for material fluctuations in valuation results, size, credit quality and the time lapse since the last valuation of the portfolio investment by an independent valuation firm.

Investments recorded on our Consolidated Statements of Assets and Liabilities are categorized based on the inputs to the valuation techniques as follows:

Given the nature of lending to venture capital-backed growth-oriented companies, substantially all of the Company’s investments in these portfolio companies are considered Level 3 assets under ASC 820 because there is no known or accessible market or market indexes for these investment securities to be traded or exchanged. The Company uses an internally developed portfolio investment rating system in connection with its investment oversight, portfolio management and analysis and investment valuation procedures. This system takes into account both quantitative and qualitative factors of the portfolio companies. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material.

Fair value estimates are made at discrete points in time based on relevant information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amounts of the Company’s financial instruments, consisting of cash, investments, receivables, payables and other liabilities approximate the fair values of such items due to the short-term nature of these instruments.

Income Recognition

The Company recognizes interest income on an accrual basis and recognizes it as earned in accordance with the contractual terms of the loan agreement to the extent that such amounts are expected to be collected. Original issue discount (“OID”) initially includes the estimated fair value of detachable warrants obtained in conjunction with the origination of debt securities, and is accreted into interest income over the term of the loan as a yield enhancement based on the effective yield method. Interest income from payment-in-kind (“PIK”) represents contractually deferred interest added to the loan balance recorded on an accrual basis to the extent such amounts are expected to be collected.

In addition, the Company may also be entitled to an end-of-term (“EOT”) payment. EOT payments to be paid at the termination of the debt agreement are accreted into interest income over the contractual life of the debt based on the effective yield method. When a portfolio company pre-pays their indebtedness prior to the scheduled maturity date, the acceleration of the unaccreted OID and EOT is recognized as interest income.

Income related to application or origination payments, including facility commitment fees, net of related expenses and generally collected in advance, are accreted into interest income over the contractual life of the loan. The Company recognizes nonrecurring fees and additional OID and EOT received in consideration for contract modifications commencing in the quarter relating to the specific modification.

The Company records dividend income on an accrual basis to the extent amounts are expected to be collected. Dividend income is recorded when dividends are declared by the portfolio company or at such other time that an obligation exists for the portfolio company to make a distribution. During three months ended March 31, 2025, the Company recorded $0.8 million in dividend income. During the three months ended March 31, 2024, the Company recorded $0.2 million in dividend income.

Portfolio Composition and Investment Activity

Portfolio Composition

As of March 31, 2025, our investment portfolio had an aggregate fair value of approximately $1,792.7 million and was comprised of approximately $1,330.4 million in secured loans, $336.7 million in equipment financings, and $125.6 million in equity and warrants, across 155 portfolio companies. As of December 31, 2024, our investment portfolio had an aggregate fair value of approximately $1,725.6 million and was comprised of approximately $1,286.7 million in secured loans, $315.5 million in equipment financings, and $123.4 million in equity and warrants, across 151 portfolio companies.

A summary of the composition of our investment portfolio at cost and fair value as a percentage of total investments are shown in the following table as of March 31, 2025 and December 31, 2024:


	March 31, 2025						December 31, 2024
Type	Cost			Fair Value			Cost			Fair Value
Secured Loans		74.9	%		74.2	%		75.1	%		74.5	%
Equipment Financings		18.5	%		18.8	%		18.1	%		18.3	%
Equity		4.3	%		4.1	%		4.5	%		4.2	%
Warrants		2.3	%		2.9	%		2.3	%		3.0	%
Total		100.0	%		100.0	%		100.0	%		100.0	%

The following table shows the composition of our investment portfolio by geographic region at cost and fair value as a percentage of total investments as of March 31, 2025 and December 31, 2024. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.


	March 31, 2025						December 31, 2024
Geographic Region	Cost			Fair Value			Cost			Fair Value
United States
West		32.5	%		33.3	%		30.7	%		31.5	%
Northeast		26.9	%		26.6	%		28.1	%		27.6	%
Mountain		10.3	%		9.7	%		10.9	%		10.5	%
Southeast		9.9	%		9.6	%		10.5	%		10.4	%
South		8.6	%		8.7	%		9.2	%		9.5	%
Midwest		6.0	%		5.7	%		5.9	%		5.6	%
Multi-Sector Holdings (1)		1.5	%		2.0	%		1.6	%		1.9	%
International:
Western Europe		3.7	%		3.8	%		2.4	%		2.4	%
Canada		0.6	%		0.6	%		0.7	%		0.6	%
Total		100.0	%		100.0	%		100.0	%		100.0	%

(1)

Multi-Sector Holdings consist of the Company's investments in Senior Credit Corp 2022 LLC, Trinity Capital Adviser LLC and EPT 16 LLC. These entities invest or manage investments in secured loans and equipment financings to growth-oriented companies that have been originated by the Company. The portfolio companies held by the Multi-Sector Holdings represent a diverse set of geographical classifications, which are similar to those in which the Company invests directly. See “Note 12 – Related Party Transactions” in the notes to the consolidated financial statements included in this Quarterly Report on Form 10-Q for further discussion.

Set forth below is a table showing the industry composition of our investment portfolio at cost and fair value as a percentage of total investments as of March 31, 2025 and December 31, 2024:


	March 31, 2025						December 31, 2024
Industry	Cost			Fair Value			Cost			Fair Value
Finance and Insurance		16.9	%		17.6	%		18.1	%		18.7	%
Medical Devices		12.3	%		12.7	%		9.7	%		10.0	%
SaaS		10.0	%		10.4	%		8.2	%		8.5	%
Green Technology		8.1	%		9.1	%		8.3	%		9.2	%
Other Healthcare Services		8.5	%		8.7	%		8.1	%		8.3	%
Space Technology		8.0	%		8.1	%		8.0	%		8.2	%
Real Estate Technology		5.5	%		5.0	%		5.8	%		5.4	%
Artificial Intelligence & Automation		4.2	%		4.4	%		4.7	%		4.9	%
Healthcare Technology		3.9	%		3.4	%		4.5	%		4.2	%
Biotechnology		3.1	%		3.2	%		3.2	%		3.4	%
Consumer Products & Services		2.9	%		2.9	%		3.2	%		3.2	%
Transportation Technology		3.6	%		2.4	%		3.6	%		2.4	%
Connectivity		2.1	%		2.0	%		2.1	%		2.0	%
Multi-Sector Holdings (1)		1.5	%		2.0	%		1.6	%		1.9	%
Human Resource Technology		1.9	%		1.6	%		1.9	%		1.7	%
Education Technology		1.8	%		1.6	%		1.9	%		1.7	%
Marketing, Media, and Entertainment		1.6	%		1.6	%		2.2	%		2.2	%
Supply Chain Technology		1.7	%		1.6	%		1.7	%		1.7	%
Food and Agriculture Technologies		1.6	%		1.2	%		1.8	%		1.4	%
Industrials		0.2	%		0.2	%		0.7	%		0.6	%
Construction Technology		0.5	%		0.2	%		0.5	%		0.2	%
Digital Assets Technology and Services		0.1	%		0.1	%		0.2	%		0.2	%
Total		100.0	%		100.0	%		100.0	%		100.0	%

(1)

As of March 31, 2025 and December 31, 2024, the debt, including loans and equipment financings, in our portfolio had a weighted average time to maturity of approximately 3.1 years and 3.2 years, respectively. Additional information regarding our portfolio is set forth in the Consolidated Schedule of Investments and the related notes thereto included with this Quarterly Report on Form 10-Q.

Concentrations of Credit Risk

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount. Industry and sector concentrations will vary from period to period based on portfolio activity.

As of March 31, 2025 and December 31, 2024, the Company’s ten largest portfolio companies represented approximately 27.0% and 26.7%, respectively, of the total fair value of the Company’s investments in portfolio companies. As of March 31, 2025 and December 31, 2024, the Company had five and seven portfolio companies, respectively, that represented 5% or more of the Company’s net assets.

Investment Activity

During the three months ended March 31, 2025, we invested approximately $94.8 million in six new portfolio companies, and approximately $125.6 million in 19 existing portfolio companies, excluding deferred fees. During the three months ended March 31, 2025, we received an aggregate of $157.1 million in proceeds from repayments and sales of our investments, including proceeds of approximately $62.4 million from scheduled/amortizing debt payments, $59.1 million from early repayments on our debt investments, $35.4 million from investments sold primarily to Multi-Sector Holdings and $0.2 million from warrant and equity exits.

During the year ended December 31, 2024, we invested approximately $969.1 million in 39 new portfolio companies, approximately $244.1 million in 28 existing portfolio companies, and approximately $16.6 million in the Multi-Sector Holdings, excluding deferred fees. During the year ended December 31, 2024, we received an aggregate of $807.9 million in proceeds from repayments and sales of our investments, including proceeds of approximately $313.2 million from early repayments on our debt investments, $45.7 million from warrant and equity exits, $207.3 million from scheduled/amortizing debt payments and $241.7 million from investments sold primarily to Multi-Sector Holdings.

The following table provides a summary of the changes in the investment portfolio for the three months ended March 31, 2025 and the year ended December 31, 2024 (in thousands):


	Three Months Ended			Year Ended
	March 31, 2025			December 31, 2024
Beginning Portfolio, at fair value	$	1,725,570		$	1,275,180
Purchases, net of deferred fees		218,458			1,218,931
Principal payments received on investments		(62,385	)		(207,328	)
Proceeds from early debt repayments		(59,097	)		(313,207	)
Sales of investments		(35,605	)		(287,331	)
Accretion of OID, EOT, and PIK payments		11,044			39,574
Net realized gain/(loss)		(2,154	)		(9,730	)
Net change in unrealized appreciation/(depreciation)		(3,142	)		9,481
Ending Portfolio, at fair value	$	1,792,689		$	1,725,570

The level of our investment activity can vary substantially from period to period depending on many factors, including the amount of debt, including loans and equipment financings, and equity capital required by growth-oriented companies, the general economic environment and market conditions and the competitive environment for the types of investments we make.

Portfolio Asset Quality

Our portfolio management team uses an ongoing investment risk rating system to characterize and monitor our outstanding loans and equipment financings. Our portfolio management team monitors and, when appropriate, recommends changes to the investment risk ratings. Our investment committee reviews the recommendations and/or changes to the investment risk ratings, which are submitted on a quarterly basis to the Board and its audit committee.

For our investment risk rating system, we review seven different criteria and, based on our review of such criteria, we assign a risk rating on a scale of 1 to 5, as set forth in the following illustration.

The following table shows the distribution of our secured loan and equipment financing investments on the 1 to 5 investment risk rating scale range at fair value as of March 31, 2025 and December 31, 2024 (dollars in thousands):


		March 31, 2025					December 31, 2024
Investment Risk Rating		Investments at		Percentage of			Investments at		Percentage of
Scale Range	Designation	Fair Value		Total Portfolio			Fair Value		Total Portfolio
4.0 - 5.0	Very Strong Performance	$	92,956		5.6	%	$	89,716		5.6	%
3.0 - 3.9	Strong Performance		567,581		34.0	%		453,584		28.3	%
2.0 - 2.9	Performing		928,455		55.7	%		972,001		60.7	%
1.6 - 1.9	Watch		50,072		3.0	%		62,883		3.9	%
1.0 - 1.5	Default/Workout		15,156		0.9	%		11,062		0.7	%
Total Debt Investments excluding Senior Credit Corp 2022 LLC			1,654,220		99.2	%		1,589,246		99.2	%
.	Senior Credit Corp 2022 LLC (1)		12,885		0.8	%		12,885		0.8	%
Total Debt Investments		$	1,667,105		100.0	%	$	1,602,131		100.0	%

(1)

An investment risk rating is not applied to Senior Credit Corp 2022 LLC.

As of March 31, 2025 and December 31, 2024, our debt investments had a weighted average risk rating score of 2.9 and 2.9, respectively.

Debt Investments on Non-Accrual Status

When a debt security becomes 90 days or more past due, or if our management otherwise does not expect that principal, interest, and other obligations due will be collected in full, we will generally place the debt security on non-accrual status and cease recognizing interest income on that debt security until all principal and interest due has been paid or we believe the borrower has demonstrated the ability to repay its current and future contractual obligations. Any uncollected interest is reversed from income in the period that collection of the interest receivable is determined to be doubtful. However, we may make exceptions to this policy if the investment has sufficient collateral value and is in the process of collection.

As of March 31, 2025, loans to three portfolio companies and equipment financings to two portfolio company were on non-accrual status with a total cost of approximately $49.7 million, and a total fair value of approximately $15.2 million, or 0.9%, of the fair value of the Company’s debt investment portfolio. As of December 31, 2024, loans to three portfolio companies and equipment financings to two portfolio companies were on non-accrual status with a total cost of approximately $43.3 million, and a total fair value of approximately $12.7 million, or 0.8%, of the fair value of the Company’s debt investment portfolio.

Results of Operations

The following discussion and analysis of our results of operations encompasses our consolidated results for the three months ended March 31, 2025 and 2024.

Investment Income

The following table sets forth the components of investment income (in thousands):


	Three Months Ended		Three Months Ended
	March 31, 2025		March 31, 2024
Stated interest income	$	50,193	$	37,840
Amortization of OID and EOT		6,922		6,310
Acceleration of OID and EOT		3,258		951
PIK interest income		1,500		4,091
Prepayment penalty and related fees		312		—
Dividend income		800		200
Other fee income		2,400		1,061
Total investment income	$	65,385	$	50,453

For the three months ended March 31, 2025, total investment income was approximately $65.4 million which represents an approximate effective yield of 15.3% on the average investments during the year. For the three months ended March 31, 2024, total investment income was approximately $50.5 which represents an approximate effective yield of 15.8% on the average investments during the year. The increase in investment income for the three months ended March 31, 2025 is due to higher interest income and amortization of OID and EOT based on an increased principal value of income producing debt investments.

Net Operating Expenses and Excise Taxes

Our operating expenses are comprised of interest and fees on our borrowings, employee compensation, professional fees, general and administrative expenses, and excise taxes. Our operating expenses totaled approximately $33.0 million and $25.3 million for the three months ended March 31, 2025 and 2024, respectively. The increase in our operating expenses for the three months ended March 31, 2025 is discussed with respect to each component of such expenses below.

Interest Expense and Other Debt Financing Costs

Our interest expense and other debt financing costs are primarily comprised of interest and fees related to our secured borrowings, the 4.375% Notes due 2026 (the “August 2026 Notes”), the 4.25% Notes due 2026 (the “December 2026 Notes”), the 7.875% Notes due March 2029 (the “March 2029 Notes”), the 7.875% Notes due September 2029 (the “September 2029 Notes”), the 7.54% Notes due 2027 (the “Series A 2027 Notes”), the 7.60% Notes due 2028 (the “Series A 2028 Notes”) and the 7.66% Notes due 2029 (the “Series A 2029 Notes” and together with the Series A 2027 Notes and Series A 2028 Notes, the “Series A Notes”). Interest expense and other debt financing costs on our borrowings totaled approximately $17.7 million and $12.1 million for the three months ended March 31, 2025 and 2024, respectively. Our weighted average effective interest rate, comprised of interest and amortization of fees and discount, was approximately 7.6% and 7.4% for the three months ended March 31, 2025 and 2024, respectively. The increase in interest expense for the three months ended March 31, 2025 was primarily due to the issuance of the Series A Notes and to increased borrowings under our credit facility with KeyBank, National Association (the “KeyBank Credit Facility”).

Employee Compensation and Benefits

Employee compensation and benefits totaled approximately $10.6 million and $9.9 million for the three months ended March 31, 2025 and 2024, respectively. The increase in employee compensation expenses for the three months ended March 31, 2025 relates primarily to the increased variable compensation related to a higher headcount and stock-based compensation. As of March 31, 2025 and 2024, the Company had 94 and 73 employees, respectively.

Professional Fees Expenses

Professional fees expenses, consisting of legal fees, accounting fees, third-party valuation fees, and talent acquisition fees, totaled approximately $2.0 million and $0.7 million for the three months ended March 31, 2025 and 2024, respectively. The increase in professional fees expenses for the three months ended March 31, 2025 resulted primarily from an increase in legal fees, third-party valuation fees and other consulting fees.

General and Administrative Expenses

General and administrative expenses include insurance premiums, rent, state taxes and various other expenses related to our ongoing operations. Our general and administrative expenses totaled approximately $2.5 million and $2.0 million for the three months ended March 31, 2025 and 2024, respectively. The increase in general and administrative expenses for the three months ended March 31, 2025 was primarily due to additional office rent and related expenses.

Allocated Expenses to Trinity Capital Adviser, LLC

The resource sharing agreement (the “Sharing Agreement”) with the Adviser Sub provides the Adviser Sub with access to the Company's human capital resources, facilities and systems. Under the terms of the Sharing Agreement, we allocate the related expenses of such shared resources to the Adviser Sub based on total assets under management by the Adviser Sub and us. The Company's total expenses are net of such expenses allocated to the Adviser Sub of $0.4 million for the three months ended March 31, 2025. There were no expenses allocated to the Adviser Sub during the three months ended March 31, 2024. As of March 31, 2025 and December 31, 2024, there was $2.3 million and $1.8 million, respectively, receivable due from the Adviser Sub.

Excise Taxes

Our excise taxes totaled approximately $0.6 million and $0.6 million for the three months ended March 31, 2025 and 2024, respectively.

Net Investment Income

For the three months ended March 31, 2025 and 2024, we recognized approximately $65.4 million and $50.5 million, respectively, in total investment income as compared to approximately $33.0 million and $25.3 million, respectively, in total expenses, including excise tax expense, resulting in net investment income of $32.4 million and $25.2 million, respectively.

Net Realized Gains and Losses

Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption of an investment or a financial instrument and the cost basis of the investment or financial instrument, without regard to unrealized appreciation or depreciation previously recognized, and includes investments written off during the period.

During the three months ended March 31, 2025, our gross realized gains primarily consisted of the repayment of one warrant position. Our gross realized losses primarily consisted of the sale of one equipment financing position. During the three months ended March 31, 2024, our gross realized gains primarily consisted of the repayment of one equipment financing position, and our gross realized losses primarily consisted of the partial sale of one equity position in a portfolio company.

The net realized gains (losses) from the sales, repayments, or exits of investments for the three months ended March 31, 2025 and 2024 were comprised of the following (in thousands):


		Three Months Ended				Three Months Ended
		March 31, 2025				March 31, 2024
Net realized gain/(loss) on investments:
Gross realized gains	$		374		$		4,277
Gross realized losses			(2,528	)			(2,926	)
Total net realized gains/(losses) on investments	$		(2,154	)	$		1,351

Net Change in Unrealized Appreciation / (Depreciation) from Investments

Net change in unrealized appreciation/(depreciation) from investments primarily reflects the net change in the fair value of the investment portfolio and financial instruments and the reclassification of any prior period unrealized appreciation or depreciation on exited investments and financial instruments to realized gains or losses.

Net unrealized appreciation and depreciation on investments for the three months ended March 31, 2025 and 2024 is comprised of the following (in thousands):


	Three Months Ended			Three Months Ended
	March 31, 2025			March 31, 2024
Gross unrealized appreciation	$	18,891		$	19,057
Gross unrealized depreciation		(24,933	)		(28,980	)
Net unrealized appreciation/(depreciation) reclassified related to net realized gains or losses		2,900			(2,077	)
Total net unrealized gains/(losses) on investments	$	(3,142	)	$	(12,000	)

During the three months ended March 31, 2025, our net unrealized depreciation totaled approximately $3.1 million, which included net unrealized depreciation of $4.1 million from our debt investments, net unrealized appreciation of $1.3 million from our equity investments and net unrealized depreciation of $0.3 million from our warrant investments.

During the three months ended March 31, 2024, our net unrealized depreciation totaled approximately $12.0 million, which included net unrealized appreciation of $3.8 million from our warrant investments, net unrealized depreciation of $3.4 million from our equity investments and net unrealized depreciation of $12.4 million from our debt investments.

Net Increase (Decrease) in Net Assets Resulting from Operations

Net increase in net assets resulting from operations during the three months ended March 31, 2025, totaled approximately $27.1 million. Net increase in net assets resulting from operations during the three months ended March 31, 2024, totaled approximately $14.5 million.

Net Increase (Decrease) in Net Assets Resulting from Operations and Earnings Per Share

For the three months ended March 31, 2025, basic and diluted net increase in net assets per common share were $0.43 and $0.43, respectively.

For the three months ended March 31, 2024, basic and diluted net decrease in net assets per common share were $0.31 and $0.30, respectively.

Financial Condition, Liquidity and Capital Resources

Our liquidity and capital resources are generated primarily from the net proceeds of offerings of our securities, including our “at-the-market” offering, the August 2026 Notes offering, the December 2026 Notes offering, the March 2029 Notes offering, the September 2029 Notes offering and the Series A Notes offering and borrowings under the KeyBank Credit Facility, each of which were outstanding as of March 31, 2025, as well as cash flows from our operations, including investment sales and repayments and income earned on investments and cash equivalents. Our primary use of our funds includes investments in portfolio companies, payments of interest on our outstanding debt, and payments of fees and other operating expenses we incur. We also expect to use our funds to pay distributions to our stockholders. We have used, and expect to continue to use, our borrowings, including under the KeyBank Credit Facility or any future credit facility, as well as proceeds from the turnover of our portfolio, to finance our investment objectives and activities.

From time to time, we may enter into additional credit facilities, increase the size of our existing KeyBank Credit Facility, or issue additional securities in private or public offerings. Any such incurrence or issuance would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions, and other factors.

During the three months ended March 31, 2025, we experienced a net decrease in cash and cash equivalents in the amount of $1.2 million, which is the net result of $62.2 million of cash provided by financing activities, offset by $63.3 million of cash used in operating activities and $0.1 million of cash used in investing activities. During the three months ended March 31, 2024, we experienced a net increase in cash and cash equivalents in the amount of $7.2 million, which is the net result of $88.6 million of cash provided by financing activities, offset by $81.4 million of cash used in operating activities and less than $0.1 million of cash used in investing activities.

As of March 31, 2025 and December 31, 2024, we had cash and cash equivalents of $8.4 million and $9.6 million, respectively, of which $3.3 million and $3.8 million, respectively, was held in the Goldman Sachs Financial Square Government Institutional Fund. Cash held in demand deposit accounts may exceed the Federal Deposit Insurance Corporation (“FDIC”) insured limit and therefore is subject to credit risk. All of the Company’s cash deposits are held at large established high credit quality financial institutions, and management believes that the risk of loss associated with any uninsured balances is remote.

As of March 31, 2025 and December 31, 2024, we had approximately $208.0 million and $487.0 million, respectively, of available borrowings under the KeyBank Credit Facility, subject to its terms and regulatory requirements. Cash and cash equivalents, taken together with available borrowings under the KeyBank Credit Facility, as of March 31, 2025, are expected to be sufficient for our investing activities and to conduct our operations in the near term and long term.

Refer to “Note 5 – Borrowings” in the notes to our consolidated financial statements included in this Quarterly Report on Form 10-Q for additional information, including a discussion of our borrowings.

Asset Coverage Requirements

In accordance with the 1940 Act, with certain limited exceptions, we are only allowed to incur borrowings, issue debt securities or issue preferred stock, if immediately after the borrowing or issuance, the ratio of total assets (less total liabilities other than indebtedness) to total indebtedness plus preferred stock, is at least 150%. On September 27, 2019, the Board, including a “required majority” (as such term is defined in Section 57(o) of the 1940 Act) and our initial stockholder approved the application to us of the 150% minimum asset coverage ratio set forth in Section 61(a)(2) of the 1940 Act. As a result, we are permitted to potentially borrow $2 for investment purposes of every $1 of investor equity. As of March 31, 2025, our asset coverage ratio was approximately 186.1% and our asset coverage ratio per unit was approximately $1,861. As of December 31, 2024, our asset coverage ratio was approximately 192.7% and our asset coverage ratio per unit was approximately $1,927.

Commitments and Off-Balance Sheet Arrangements

The Company has entered into a capital commitment with the JV and EPT 16 in the amount of $21.4 million and $10.0 million, respectively. As of March 31, 2025, unfunded commitments were $3.0 million and $0.8 million for the JV and EPT 16, respectively. As of March 31, 2025, the Company also had unfunded commitments of approximately $49.7 million to four portfolio companies. As of December 31, 2024, unfunded commitments were $3.0 million for the JV and $0.8 million for EPT 16, respectively. As of December 31, 2024, the Company also had unfunded commitments of $31.2 million to two portfolio companies. The Company did not have any other off-balance sheet financings or liabilities as of March 31, 2025 or December 31, 2024.

The Company’s commitments and contingencies consist primarily of unfunded commitments to extend credit in the form of loans to the Company’s portfolio companies. A portion of these unfunded contractual commitments as of March 31, 2025 and December 31, 2024 are dependent upon the portfolio company reaching certain milestones before the debt commitment becomes available. Furthermore, the Company’s credit agreements with its portfolio companies generally contain customary lending provisions that allow the Company relief from funding obligations for previously made commitments in instances where the underlying portfolio company experiences materially adverse events that affect the financial condition or business outlook for the company. Since a portion of these commitments may expire without being drawn, unfunded contractual commitments do not necessarily represent future cash requirements. As such, the Company’s disclosure of unfunded contractual commitments includes only those which are available at the request of the portfolio company and unencumbered by milestones. The Company will fund future unfunded commitments from the same sources it uses to fund its investment commitments that are funded at the time they are made (which are typically through existing cash and cash equivalents and borrowings under the KeyBank Credit Facility).

Contractual Obligations

A summary of our contractual payment obligations as of March 31, 2025, is as follows (in thousands):


	Payments Due by Period
	Less than 1
	year		1 - 3 years		4 - 5 years		After 5 years		Total
KeyBank Credit Facility	$	—	$	—	$	392,000	$	—	$	392,000
August 2026 Notes		—		125,000		—		—		125,000
December 2026 Notes		—		75,000		—		—		75,000
March 2029 Notes		—		—		115,261		—		115,261
September 2029 Notes		—		—		118,390		—		118,390
Series A Notes		—		55,500		87,000		—		142,500
Operating Leases		982		2,029		2,131		1,565		6,707
Total Contractual Obligations	$	982	$	257,529	$	714,782	$	1,565	$	974,858

Distributions

We intend to pay quarterly distributions to our stockholders out of assets legally available for distribution. All distributions will be paid at the discretion of the Board and will depend on our earnings, financial condition, maintenance of our tax treatment as a RIC, compliance with applicable BDC regulations and such other factors as the Board may deem relevant from time to time.

The following table summarizes distributions declared and/or paid by the Company since inception:


Declaration Date	Type	Record Date	Payment Date	Per Share Amount
May 7, 2020	Quarterly	May 29, 2020	June 5, 2020	$	0.22
August 10, 2020	Quarterly	August 21, 2020	September 4, 2020		0.27
November 9, 2020	Quarterly	November 20, 2020	December 4, 2020		0.27
December 22, 2020	Quarterly	December 30, 2020	January 15, 2021		0.27
March 23, 2021	Quarterly	March 31, 2021	April 16, 2021		0.28
June 15, 2021	Quarterly	June 30, 2021	July 15, 2021		0.29
September 13, 2021	Quarterly	September 30, 2021	October 15, 2021		0.33
December 16, 2021	Quarterly	December 31, 2021	January 14, 2022		0.36
March 15, 2022	Quarterly	March 31, 2022	April 15, 2022		0.40
March 15, 2022	Supplemental	March 31, 2022	April 15, 2022		0.15
June 15, 2022	Quarterly	June 30, 2022	July 15, 2022		0.42
June 15, 2022	Supplemental	June 30, 2022	July 15, 2022		0.15
September 15, 2022	Quarterly	September 30, 2022	October 14, 2022		0.45
September 15, 2022	Supplemental	September 30, 2022	October 14, 2022		0.15
December 15, 2022	Quarterly	December 30, 2022	January 13, 2023		0.46
December 15, 2022	Supplemental	December 30, 2022	January 13, 2023		0.15
March 14, 2023	Quarterly	March 31, 2023	April 14, 2023		0.47
June 14, 2023	Quarterly	June 30, 2023	July 14, 2023		0.48
June 14, 2023	Supplemental	June 30, 2023	July 14, 2023		0.05
September 13, 2023	Quarterly	September 30, 2023	October 13, 2023		0.49
September 13, 2023	Supplemental	September 30, 2023	October 13, 2023		0.05
December 14, 2023	Quarterly	December 29, 2023	January 12, 2024		0.50
March 14, 2024	Quarterly	March 28, 2024	April 15, 2024		0.51
June 13, 2024	Quarterly	June 28, 2024	July 15, 2024		0.51
September 18, 2024	Quarterly	September 30, 2024	October 15, 2024		0.51
December 12, 2024	Quarterly	December 31, 2024	January 15, 2025		0.51
March 19, 2025	Quarterly	March 31, 2025	April 15, 2025		0.51
			Total	$	9.21

Price Range of Common Stock

Our common stock began trading on the Nasdaq Global Select Market (“Nasdaq”) on January 29, 2021 under the symbol “TRIN” in connection with our IPO, which closed on February 2, 2021. Prior to our IPO, the shares of our common stock were offered and sold in transactions exempt from registration under the Securities Act. As such, there was no public market for shares of our common stock during year ended December 31, 2020. Since our IPO, our common stock has traded at prices both above and below our net asset value per share.

The following table sets forth the net asset value per share of our common stock, the range of high and low closing sales prices of our common stock reported on Nasdaq, the closing sales price as a premium (discount) to net asset value and the dividends declared by us in each fiscal quarter since we began trading on Nasdaq. On May 5, 2025, the last reported closing sales price of our common stock on Nasdaq was $14.14 per share, which represented a premium of approximately 8.4% to our net asset value per share of $13.05 as of March 31, 2025. As of May 5, 2025, we had approximately 48 stockholders of record, which does not include stockholders for whom shares are held in nominee or “street” name.


			Price Range
Class and Period	Net Asset Value(1)		High		Low		High Sales Price Premium (Discount) to Net Asset Value(2)			Low Sales Price Premium (Discount) to Net Asset Value(2)				Cash Dividend Per Share(3)
Year Ending December 31, 2025
Second Quarter (through May 5, 2025)	*		$	15.52	$	13.53	*			*				*
First Quarter	$	13.05	$	16.56	$	14.26		26.9	%		9.3		%	$	0.51
Year Ending December 31, 2024
Fourth Quarter	$	13.35	$	14.87	$	13.11		11.4	%		(1.8	)	%	$	0.51
Third Quarter	$	13.13	$	14.74	$	13.57		12.3	%		3.4		%	$	0.51
Second Quarter	$	13.12	$	15.26	$	14.03		16.3	%		7.0		%	$	0.51
First Quarter	$	12.88	$	15.08	$	13.68		17.1	%		6.2		%	$	0.51
Year Ending December 31, 2023
Fourth Quarter	$	13.19	$	15.40	$	13.33		16.7	%		1.0		%	$	0.50
Third Quarter	$	13.17	$	15.29	$	13.75		16.1	%		4.4		%	$	0.54	(4)
Second Quarter	$	13.15	$	13.91	$	11.36		5.8	%		(13.6	)	%	$	0.53	(4)
First Quarter	$	13.07	$	14.26	$	10.91		9.1	%		(16.5	)	%	$	0.47

(1)

Net asset value per share is determined as of the last day in the relevant quarter and therefore may not reflect the net asset value per share on the date of the high and low closing sales prices. The net asset values shown are based on outstanding shares at the end of the relevant quarter.

(2)

Calculated as the respective high or low closing sales price less net asset value, divided by net asset value (in each case, as of the applicable quarter).

(3)

Represents the dividend or distribution declared in the relevant quarter.

(4)

Consists of a quarterly dividend and a supplemental dividend.


*	Not determined at time of filing.

Shares of BDCs may trade at a market price that is less than the value of the net assets attributable to those shares. At times, our shares of common stock have traded at prices both above and below our net asset value per share. The possibility that our shares of common stock will trade at a discount from net asset value per share or at premiums that are unsustainable over the long term are separate and distinct from the risk that our net asset value per share will decrease. It is not possible to predict whether our common stock will trade at, above, or below net asset value per share.


Maryland	35-2670395
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)


1 N. 1st Street Suite 302 Phoenix, Arizona	85004
(Address of principal executive offices)	(Zip Code)


Large accelerated filer	☐	Accelerated filer	☒
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☒


		PAGE NO.

PART I	FINANCIAL INFORMATION	3
Item 1.	Consolidated Financial Statements	3
	Consolidated Statements of Assets and Liabilities as of March 31, 2025 (unaudited) and December 31, 2024	3
	Consolidated Statements of Operations for the Three Months Ended March 31, 2025 and 2024 (unaudited)	4
	Consolidated Statements of Changes in Net Assets for the Three Months Ended March 31, 2025 and 2024 (unaudited)	5
	Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2025 and 2024 (unaudited)	6
	Consolidated Schedule of Investments as of March 31, 2025 (unaudited)	8
	Consolidated Schedule of Investments as of December 31, 2024	39
	Notes to Consolidated Financial Statements (unaudited)	70
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	115
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	132
Item 4.	Controls and Procedures	134
PART II	OTHER INFORMATION	134
Item 1.	Legal Proceedings	134
Item 1A.	Risk Factors	134
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	135
Item 3.	Defaults Upon Senior Securities	135
Item 4.	Mine Safety Disclosures	135
Item 5.	Other Information	135
Item 6.	Exhibits	135

SIGNATURES		137


☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


Title of Each Class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.001 per share	TRIN	Nasdaq Global Select Market
7.875% Notes Due 2029	TRINZ	Nasdaq Global Select Market
7.875% Notes Due 2029	TRINI	Nasdaq Global Select Market


	March 31,			December 31,
	2025			2024
	(Unaudited)
ASSETS
Investments at fair value:
Control investments (cost of $81,861 and $82,391, respectively)	$	90,018		$	89,249
Affiliate investments (cost of $39,102 and $34,309, respectively)		39,164			34,727
Non-Control / Non-Affiliate investments (cost of $1,709,524 and $1,643,526, respectively)		1,663,507			1,601,594
Total investments (cost of $1,830,487 and $1,760,226, respectively)		1,792,689			1,725,570
Cash and cash equivalents		8,386			9,627
Interest receivable		16,626			16,542
Deferred credit facility costs		6,230			6,586
Other assets		33,345			15,916
Total assets	$	1,857,276		$	1,774,241

LIABILITIES
KeyBank Credit Facility	$	392,000		$	113,000
Unsecured Notes, net of $9,197 and $10,327, respectively, of unamortized deferred financing costs		566,954			764,673
Distribution payable		32,579			31,451
Security deposits		7,015			8,472
Accounts payable, accrued expenses and other liabilities		25,333			33,663
Total liabilities		1,023,881			951,259

Commitments and contingencies (Note 6)

NET ASSETS
Common stock, $0.001 par value per share (200,000,000 authorized, 63,880,330 and 61,669,059 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively)		64			62
Paid-in capital in excess of par		845,531			829,626
Distributable earnings/(accumulated deficit)		(12,200	)		(6,706	)
Total net assets		833,395			822,982
Total liabilities and net assets	$	1,857,276		$	1,774,241
NET ASSET VALUE PER SHARE	$	13.05		$	13.35


	Interest			Interest			Net
	Income			Expense			Income/(Loss)
Up 300 basis points	$	38,239		$	11,760		$	26,479
Up 200 basis points		25,493			7,840			17,653
Up 100 basis points		12,746			3,920			8,826
Down 100 basis points		(4,645	)		(3,920	)		(725	)
Down 200 basis points		(8,752	)		(7,840	)		(912	)
Down 300 basis points		(10,532	)		(11,760	)		1,228



Exhibit Number		Description of Exhibits
3.1		Articles of Amendment and Restatement (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed June 30, 2023).
3.2		Bylaws (incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form 10 filed on January 16, 2020).
4.1		Form of 7.875% Note due March 2029 (Debt ATM) (incorporated by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on February 10, 2025).
4.2		Form of 7.875% Note due September 2029 (Debt ATM) (incorporated by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on February 10, 2025).
10.1		Open Market Sale Agreement, dated February 10, 2025, by and between Trinity Capital Inc. and B. Riley Securities, Inc. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on February 10, 2025).
10.2		Amended and Restated Employment Offer Letter, dated March 14, 2025, by and between the Company and Kyle Brown (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on March 20, 2025).
10.3		Amended and Restated Employment Offer Letter, dated March 14, 2025, by and between the Company and Steven L. Brown (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on March 20, 2025).
10.4		Amended and Restated Employment Offer Letter, dated March 14, 2025, by and between the Company and Gerald Harder (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on March 20, 2025).


10.5		Employment Offer Letter, dated March 14, 2025, by and between the Company and Michael Testa (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed on March 20, 2025).
10.6*		Amended and Restated Employment Offer Letter, dated March 14, 2025, by and between the Company and Ronald Kundich.
10.7*		Employment Offer Letter, dated March 14, 2025, by and between the Company and Sarah Stanton.
10.8		Retention Agreement, dated March 14, 2025, by and between the Company and Kyle Brown (incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K filed on March 20, 2025).
10.9		Form of Non-Statutory Stock Option Award Agreement (Trinity Capital Inc. 2019 Long Term Incentive Plan) (incorporated by reference to Exhibit 10.6 to the Company’s Current Report on Form 8-K filed on March 20, 2025).
10.10		Form of Restricted Stock Agreement (incorporated by reference to Exhibit 4.5 to the Company's Registration Statement on Form S-8 filed September 13, 2024).
31.1*		Certification of Principal Executive Officer Pursuant to Rules 13a 14(a) and 15d 14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*		Certification of Principal Financial Officer Pursuant to Rules 13a 14(a) and 15d 14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS		Inline XBRL Instance Document-the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document
101.SCH		Inline XBRL Taxonomy Extension Schema Document with Embedded Linkbase Documents
104		Cover Page formatted as Inline XBRL and contained in Exhibit 101


	TRINITY CAPITAL INC.

Dated: May 7, 2025	By:	/s/ Kyle Brown
		Kyle Brown
		Chief Executive Officer, President and Chief
		Investment Officer (Principal Executive Officer)




Dated: May 7, 2025	By:	/s/ Michael Testa
		Michael Testa
		Chief Financial Officer and Treasurer
		(Principal Financial and Accounting Officer)

OTHER INFORMATION

SIGNATURES

PART I: FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

Note 1. Organization and Basis of Presentation

Basis of Presentation

Principles of Consolidation

Note 2. Summary of Significant Accounting Policies

Use of Estimates

Investment Transactions

Valuation of Investments

Cash and Cash Equivalents

Other Assets

Equity Offering Costs

Security Deposits

Debt Financing Costs

Income Recognition

Stock-Based Compensation

Income Taxes

Distributions

Note 3. Investments

Debt Securities

Warrant Investments

Equity Investments

Portfolio Composition

Certain Risk Factors

Note 4. Fair Value of Financial Instruments

Note 5. Borrowings

KeyBank Credit Facility

Unsecured Notes

2025 Notes

6.00% Convertible Notes due 2025

August 2026 Notes

December 2026 Notes

March 2029 Notes

September 2029 Notes

Note 6. Commitments and Contingencies

Unfunded Commitments

Leases

Legal Proceedings

Note 7. Stockholders' Equity

Private Common Stock Offerings

Formation Transactions

Initial Public Offering

Equity ATM Program

Stock Repurchase Program

Equity Offerings

Distribution Reinvestment Plan

Distributions

Note 8. Equity Incentive Plans

Note 9. Earnings Per Share

Note 10. Income Taxes

Note 11. Financial Highlights

Note 12. Related Party Transactions

Note 14. Recent Accounting Pronouncements

Note 15. Subsequent Events

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

Our History

Critical Accounting Estimates and Policies

Valuation of Investments

Income Recognition

Portfolio Composition and Investment Activity

Debt Investments on Non-Accrual Status

Results of Operations

Financial Condition, Liquidity and Capital Resources

Asset Coverage Requirements

Commitments and Off-Balance Sheet Arrangements

Contractual Obligations

Distributions

Price Range of Common Stock

Related Party Transactions

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Valuation Risk

Interest Rate Risk

Currency Risk

Hedging

Item 4. Controls and Procedures

Item 3. Defaults Upon Senior Securities

Item 4. Mine Safety Disclosures